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1 Summary
W hile from a genetic perspective all cells of an or-ganism are identical, they vary greatly in type
and function. Major determinants of cellular diver-
sity are epigenetic alterations, including post-synthetic
modifications of nucleic acids. In DNA, the best-studied
chemical modification is the methylation of cytosine at
carbon C5. 5-methylcytosine (5mC) plays a central role
in the regulation of gene expression and has been im-
plicated in a variety of biological processes and dis-
eases. While initially considered as a relatively stable
epigenetic mark, a family of proteins named Ten eleven
translocation (Tet), were recently shown to catalyze the
conversion of 5mC to 5-hydroxymethylcytosine (5hmC),
5-formylcytosine (5fC) and 5-carboxylcytosine (5caC) in
an iterative oxidation reaction. These oxidized deriva-
tives have been shown to modulate gene expression
and control cellular metabolism. Hence, to avert the for-
mation of aberrant, pathogenic DNA modifications, Tet
activity must be precisely regulated.
Here, we analyzed the potential of methyl-CpG binding
domain (MBD) proteins to control Tet dioxygenase acti-
vity in vitro and in vivo. We demonstrate that prior bind-
ing of Mecp2 and Mbd2 to DNA protects 5mC from Tet1
mediated oxidation in a concentration dependent man-
ner. The mechanism is based on competitive, sequence
unspecific binding to DNA and correlates with nucleic
acid coverage and retention time of MBD proteins on
DNA. Accordingly, we find increased levels of the Tet
oxidation product 5hmC at pericentric heterochromatin
in neurons of Mecp2 deficient mice with concomitant
reactivation of highly methylated major satellite DNA
repeats. Moreover, we find increased expression and
retrotransposition of endogenous and engineered long
interspersed nuclear elements (LINE1) as potential con-
sequence of unconfined Tet1 activity in human cells.
Similar to DNA, RNA contains a variety of post-synthetic
modifications that extend their chemical information
and properties. One out of < 100 noncanonical ribonuc-
leobases is C5-methylated cytosine, which is present in
various types of RNA, including ribosomal RNA (rRNA).
Recent studies have shown that Tet proteins do not ex-
clusively hydroxylate methylcytosine in DNA, but also
act on 5mC in single-stranded ribonucleic acids. Since
modification of rRNA potentially requires the localization
of Tet proteins to the nucleolus, the place of rRNA syn-
thesis and ribosome assembly, it is important to under-
stand the general principles of protein targeting to this
subnuclear compartment. Therefore, we determined
the molecular requirements that are necessary and suf-
ficient for the localization and accumulation of peptides
and proteins inside nucleoli of living cells. Our data indi-
cate that peptide units composed of consecutive, posi-
tively charged arginines with an isoelectric point ≥ 12.6
meet the chemical conditions for nucleolar localization.
Consistent with this, we mapped an arginine-rich region
within the low complexity insert of Tet2, which accu-
mulated in nucleoli upon deletion of its regulatory N-
terminal domain. Using a pH sensitive dye, we revealed
that the nucleolus is relatively acidic. Accordingly, we
show that arginine-rich peptides, which carry a net posi-
tive charge under these electrochemical conditions, in-
teract with negatively charged RNA in vitro. This inter-
action in turn, is consistent with the conservation of this
nucleolar targeting principle from insects to man. Finally
we developed a detailed protocol for the visualization
of nucleoli in living cells using fluorescently tagged cell-
penetrating peptides (CPP), which allows precise nucle-
olar localization analysis of various proteins, such as Tet.
In summary, our data contribute to understanding the
regulation of Tet activity outside and (Tet) protein locali-
zation inside of nucleoli.
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1 SUMMARY/ZUSAMMENFASSUNG
1 Zusammenfassung
A us genetischer Sicht sind alle Zellen eines Or-ganismus identisch, jedoch unterscheiden sie sich
deutlich in ihrer Art und Funktionsweise. Wichtige
Determinanten zellulärer Diversität sind epigenetische
Änderungen, darunter post-synthetische Modifikationen
von Nukleinsäuren. Die am besten untersuchte che-
mische Modifikation von DNA ist die Methylierung von
Cytosin am fünften Kohlenstoffatom. 5-Methylcytosin
(5mC) spielt eine wichtige Rolle bei der Regulation
der Genexpression und steht in Verbindung mit einer
Vielzahl biologischer Prozesse und Krankheiten. Ob-
wohl zunächst angenommen wurde, dass 5mC eine
relativ stabile epigenetische Modifikation ist, wurde
kürzlich gezeigt, dass eine Familie von Proteinen, Ten
eleven translocation (Tet), die Umsetzung von 5mC zu
5-Hydroxymethylcytosin (5hmC), 5-Formylcytosin (5fC)
und 5-Carboxylcytosin (5caC) katalysiert. Es wurde
gezeigt, dass diese oxidativen Derivate an der Mo-
dulierung der Genexpression und Steuerung des Zell-
stoffwechsels beteiligt sind. Um der Bildung aber-
ranter, krankheitsverursachender DNA Modifikationen
vorzubeugen, muss daher die Aktivität von Tet Proteinen
präzise reguliert werden.
In dieser Arbeit wurde das Potenzial von Proteinen mit
Methyl-CpG-Bindedomäne untersucht, die Dioxygenase-
Aktivität von Tet Proteinen in vitro und in vivo zu kontrol-
lieren. Wir zeigen, dass vorzeitiges Binden von Mecp2
und Mbd2 an DNA 5mC vor Tet1-katalysierter Oxidation
in Abhängigkeit ihrer Konzentration schützt. Der Mecha-
nismus basiert auf kompetitiver, sequenzunspezifischer
Bindung an DNA und korreliert mit der Abdeckung von
Nukleinsäuren und der Verweildauer von MBD Proteinen
an DNA. Folglich finden wir erhöhte Level des Tet Oxi-
dationsprodukts 5hmC an perizentrischem Heterochro-
matin in Neuronen von Mecp2 defizienten Mäusen mit
einhergehender Reaktivierung stark methylierter "ma-
jor satellite DNA repeats". Darüber hinaus messen wir
eine erhöhte Expression und Retrotransposition von en-
dogenen und konstruierten "long interspersed nuclear
elements" (LINE1) als mögliche Folge uneingeschränk-
ter Tet Aktivität in humanen Zellen. RNA enthält, ähn-
lich wie DNA, eine Vielzahl post-synthetischer Modifika-
tionen, die deren chemische Information und Eigen-
schaften erweitern. Eine von mehr als 100 nicht-
kanonischen Ribonukleobasen ist C5-methyliertes Cy-
tosin, das in unterschiedlichen RNA Typen, darunter ri-
bosomaler RNA, vorhanden ist. Neuste Studien haben
gezeigt, dass Tet Proteine nicht ausschließlich Methyl-
cytosin von DNA, sondern auch 5mC einzelsträngiger
RNA hydroxylieren. Da eine Modifikation ribosomaler
RNA möglicherweise eine Lokalisation von Tet Proteinen
im Nukleolus, dem Ort der rRNA Synthese und Zusam-
mensetzung von Ribosomen, voraussetzt, ist es wichtig,
die allgemeinen Prinzipien der gezielten nukleolaren
Lokalisation von Proteinen und Peptiden zu verstehen.
Hierfür haben wir die molekularen Anforderungen, die
für eine Lokalisation und Akkumulierung im Nukleolus
lebender Zellen notwendig und ausreichend sind, un-
tersucht. Unsere Daten zeigen, dass Peptideinheiten
aus aneinandergereihten, positiv geladenen Argininen
mit einem isoelektrischen Punkt ≥ 12.6, die chemischen
Bedingungen für eine nukleolare Lokalisation erfüllen.
Diesem Prinzip entsprechend, identifizierten wir eine
Arginin-reiche Region innerhalb des "low complexity in-
serts" von Tet2 Proteinen, die nach Deletion des regula-
torischen N-terms im Nukleolus akkumulieren. Mit Hilfe
eines pH-sensitiven Farbstoffs konnten wir visualisieren,
dass der Nukleolus relativ sauer ist. Folglich zeigen wir,
dass Peptide und Proteine mit hohem isoelektrischen
Punkt, die unter diesen elektrochemischen Bedingun-
gen eine positive Ladung tragen, mit negativ geladener
RNA in vitro interagieren. Diese Interaktion erklärt
2
wiederum die evolutionäre Konservierung dieses Lokali-
sationsprinzips von Insekten bis zum Mensch. Letzt-
lich entwickelten wir ein Protokoll zur Visualisierung von
Nukleoli in lebenden Zellen, wodurch die nukleolare
Lokalisation unterschiedlicher Proteine, wie beispiels-
weise Tet, genau analysiert werden kann. Zusammen-
fassend tragen unsere Daten dem Verständnis der Tet
Regulation außerhalb und der Lokalisation von (Tet) Pro-
teinen innerhalb von Nukleoli bei.
3


2 GENERAL INTRODUCTION
2 General introduction
2.1 Modifiers and Readers of DNA Modifications and Their Impact on Genome
Structure, Expression, and Stability in Disease
A.K. Ludwig wrote the text, prepared figures (4, 5, 6, 7, 8) and tables (3, 6) for sections 2 (DNA modification read-
ers), 2.1 (MBD protein family), 2.1.1 (Mecp2), 2.1.2 (Mbd1), 2.1.3 (Mbd2), 2.1.4 (Mbd3), 2.1.5 (Mbd4), 2.2 (Kaiso),
2.3 (SRA domain protein family), 3.3 (MBP proteins in disease), 4 (Concluding remarks). A.K. Ludwig prepared
table 4 together with P. Zhang.
Content of figures:
Figure 4: Overview of 5-(Hydroxy)methylcytosine readers. Figure 5: Schematic representation of the MBD
protein family. Figure 6: Schematic representation of the Kaiso-like protein family. Figure 7: Schematic rep-
resentation of the SRA domain protein family. Figure 8: Graphical summary of how DNA modification writers,
readers, and translators can impact on chromatin composition, structure, as well as genome expression and sta-
bility.
Content of tables:
Table 3: Phenotype of initial MBD-deficient mouse models. Table 6: Summary of disease-related MBP alterations.
Table 4: Comparison of human proteins and their mouse orthologs.
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Modifiers and Readers of DNA
Modifications and Their Impact on
Genome Structure, Expression, and
Stability in Disease
Anne K. Ludwig†, Peng Zhang† and M. C. Cardoso*
Cell Biology and Epigenetics, Department of Biology, Technische Universität Darmstadt, Darmstadt, Germany
Cytosine base modifications in mammals underwent a recent expansion with the
addition of several naturally occurring further modifications of methylcytosine in the
last years. This expansion was accompanied by the identification of the respective
enzymes and proteins reading and translating the different modifications into chromatin
higher order organization as well as genome activity and stability, leading to the
hypothesis of a cytosine code. Here, we summarize the current state-of-the-art on DNA
modifications, the enzyme families setting the cytosine modifications and the protein
families reading and translating the different modifications with emphasis on the mouse
protein homologs. Throughout this review, we focus on functional and mechanistic
studies performed on mammalian cells, corresponding mouse models and associated
human diseases.
Keywords: cytosine modifications, Dnmt, epigenetics, hydroxymethylcytosine, MBD, methylcytosine, mouse
models, Tet
DNA MODIFICATIONS AND MODIFIERS
Cytosine Modifiers: Dnmts
In mammals, the modified cytosine was initially described by Hotchkiss (1948) and was further
extensively studied since the 1970s (Razin and Cedar, 1977). Recently, evidence for methylation of
adenine has been also reported in mammals (Koziol et al., 2016). Here, we will focus on cytosine
modifications in mammals.
DNA cytosine methylation is catalyzed by DNA methyltransferases (Dnmts) that transfer a
methyl group from S-adenosyl methionine to the fifth carbon of a cytosine residue to form 5-
methylcytosine (5mC). The majority of 5mC bases are present in CpG dinucleotides, however,
non-CpG methylation was also observed especially in mouse embryonic stem cells (mESCs) and
brain tissue (Guo et al., 2014). DNA methylation plays a major role in gene expression, cellular
differentiation, genomic imprinting, X-inactivation, inactivation of transposable elements, and
embryogenesis.
Cytosine methylation patterns are mainly established by de novo methyltransferases Dnmt3a,
Dnmt3b and their regulatory unit Dnmt3l during early embryonic and germ cell development.
Once the patterns are established, they are maintained throughout cell generations by Dnmt1
(Bestor et al., 1988; Li et al., 1992). Unlike Dnmt1 and Dnmt3a/3b, Dnmt2 is a RNA
methyltransferase rather than a DNA methyltransferase (Okano et al., 1998; Yoder and Bestor,
1998; Goll et al., 2006). A summary of the mouse Dnmt protein family and their domains
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is shown in Figure 1 and a summary of the respective knockout
mice phenotypes is shown in Table 1.
De novo DNA Methylation
Overexpression of Dnmt3a and Dnmt3b is capable of methylating
both native and synthetic DNA with no preference for
hemimethylated DNA (Okano et al., 1999). The domain structure
for de novo methyltransferases Dnmt3a and Dnmt3b is similar,
including a DNA binding domain PWWP domain (Qiu et al.,
2002) and a C-terminal catalytic domain (Okano et al., 1999;
Figure 1). However, several studies showed that the distribution
and expression of Dnmt3a and Dnmt3b varies among cell
types.
Dnmt3a is expressed relatively ubiquitously and two isoforms
of Dnmt3a have been identified. One binds to euchromatic and
the other to heterochromatic regions (Okano et al., 1998; Chen
et al., 2002). Dnmt3a knockout mice developed to term and
appeared to be normal at birth but most of the homozygous
mutant mice became runted and died at about 4 weeks of age
(Table 1).
Dnmt3b is highly expressed in embryonic implantation stages,
as well as in stem cells and progenitor cells and is the major
methyltransferase in early embryogenesis (Watanabe et al., 2002,
2004). Several isoforms were identified and among all isoforms
only Dnmt3b1 and Dnmt3b2 possess DNA methyltransferase
activity (Aoki et al., 2001). No viable Dnmt3b knockout mice
were recovered at birth, further highlighting its functions in early
embryogenesis (Table 1). The major substrates of Dnmt3a/3b are
CpGs, but non-CpG methylation activity of Dnmt3a/3b was also
detected (Aoki et al., 2001).
FIGURE 1 | Schematic representation of the Dnmt protein family. Shown are domain structures of mouse Dnmt proteins and the initial references. Numbers
represent amino acid positions. DMAP, Dnmt1-associated protein binding domain; PBD, proliferating cell nuclear antigen (PCNA)-binding domain; TS, targeting
sequence; CXXC, CXXC zinc finger domain; PBHD, polybromo-1 protein homologous domain; MTase, methyltransferase; PWWP,
proline-tryptophan-tryptophan-proline motif; Cys, cysteine-rich domain.
TABLE 1 | Phenotypes of initial Dnmt knockout mouse models.
Genotype Phenotype Reference
Dnmt1 null Homozygous knockout Dnmt1 were stunted, delayed in development, and did not survive past midgestation Li et al., 1992
Dnmt3a null Knockout mice developed to term and appeared to be normal at birth but most of homozygous mutant mice became
runted and died at about 4 weeks of age
Okano et al., 1999
Dnmt3b null No viable Dnmt3b knockout mice were recovered at birth Okano et al., 1999
Dnmt2 null Mice homozygous for this Trdmt1 (formerly Dnmt2) knock-out have abnormal RNA methylation while genomic DNA
methylation patterns are not detectably altered
Goll et al., 2006
Dnmt3l null Disruption of Dnmt3l caused azoospermia in homozygous males and heterozygous progeny of homozygous female
died before midgestation
Bourc’his et al., 2001
Frontiers in Genetics | www.frontiersin.org 2 June 2016 | Volume 7 | Article 115
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Although Dnmt3l does not possess DNA methylation activity
(Bourc’his et al., 2001), it strongly interacts with Dnmt3a/3b and
enhances their methylation activity (Aapola et al., 2000; Suetake
et al., 2004; Hu et al., 2008). However, high expression levels of
Dnmt3l are found only in germ cells and early stage embryos but
not in somatic cells (Watanabe et al., 2004) indicating that the
methylation activity enhancement is cell type and developmental
stage dependent. Disruption of Dnmt3l caused azoospermia in
homozygous males and heterozygous progeny of homozygous
female died before midgestation (Table 1).
Maintenance DNA Methylation
Dnmt1 has a preference for hemi-methylated DNA substrates
(Song et al., 2011) and is the enzyme responsible for the
maintenance of DNA methylation after DNA replication
(Leonhardt et al., 1992). Homozygous knockout Dnmt1 mice
were runted, delayed in development and did not survive past
midgestation (Table 1). The major isoform of Dnmt1 in mice
contains 1620 amino acids and includes an N-terminal regulatory
domain and a C-terminal catalytic domain (Tucker et al., 1996;
Yoder et al., 1996). However, one isoform lacking the most
N-terminal 118 amino acids was shown to accumulate in mouse
oocytes (Mertineit et al., 1998).
The Dnmt1-associated protein (DMAP) binding domain is
located at the beginning of the N-terminus of Dnmt1 and
it recruits DMAP1 to further maintain the heterochromatin
state (Rountree et al., 2000). With the contribution of Uhrf1
[ubiquitin-like with plant homeodomain (PHD) and ring finger
domains 1], Dnmt1 methylates hemi-methylated DNA generated
upon DNA replication by a mechanism encompassing base
flipping (Song et al., 2011, 2012).
In most mouse cells, Dnmt1 localizes to the cell nucleus.
In fact, Dnmt1 contains several functional nuclear localization
sequences within its N-terminal regulatory domain (Cardoso and
Leonhardt, 1999). In early embryos (Cardoso and Leonhardt,
1999) and in post-mitotic neurons (Inano et al., 2000) though, it
is retained in the cytoplasm. Although highly expressed in mouse
embryos, the exclusion of Dnmt1 from nuclei might inhibit DNA
methylation conservation after DNA replication (Grohmann
et al., 2005), implying that localization of Dnmt1 also regulates
its methylation activity. Within the cell nucleus, the distribution
of Dnmt1 is cell cycle dependent (Leonhardt et al., 1992). In
G1-phase, it is diffusely distributed throughout the nucleoplasm.
In early S-phase, its proliferating cell nuclear antigen (PCNA)-
binding domain (PBD) targets Dnmt1 to replication sites and
in late S-phase, the targeting sequence (TS) further enhances
Dnmt1 binding to replicating pericentromeric heterochromatin
(Schermelleh et al., 2007; Schneider et al., 2013). In G2-phase,
Dnmt1 is de novo loaded onto pericentromeric heterochromatin
via a replication independent mechanism (Easwaran et al., 2004).
Besides its PBD and TS domains, the polybromo-1 protein
homologous domain (PBHD) is also involved in targeting Dnmt1
to replication foci (Liu et al., 1998). Between the TS and PBHD
domains, a CXXC domain can be found in Dnmt1. The CXXC
domain of Dnmt1 occludes access of Dnmt1 catalytic site to
non-methylated CpGs and allows Dnmt1 to bind and specifically
methylate hemi-methylated CpGs (Song et al., 2011).
DNA Base Modifications
The stable covalent C–C bond formed between the methyl group
and the cytosine is difficult to be directly removed and, therefore,
5mC is thought to be a long-lived epigenetic mark. After DNA
replication, Dnmt1 association with the replication machinery
ensures the maintenance of the methylation pattern onto the
newly synthesized strand. Failure to do so, e.g., by retention
in the cytoplasm as mentioned above, leads to gradual passive
loss of DNA methylation over cell generations. DNA replication
independent (active) loss of global DNA methylation was also
observed in some biological processes such as reprogramming
of the paternal genome after fertilization (Mayer et al., 2000)
and development of primordial germ cells (PGC; Hajkova
et al., 2002). The active loss of DNA methylation allows
rapid reprogramming of the genome in a short time. Similar
observations were made in post-mitotic neurons indicating that
active loss of DNA methylation also occurs in somatic cells and
might have important roles in the regulation of gene expression
(Martinowich et al., 2003).
For several decades, scientists have been interested in
identifying pathways or proteins involved in the active loss
of DNA methylation. Lacking the evidence to show that
C–C bonds can be directly broken in mammals, multi-
step processes have been proposed to be involved in the
active removal of DNA methylation marks. In 1972, several
additional modifications of cytosines were described in rat,
mouse, and frog brain tissue including 5-hydroxymethylcytosine
(5hmC), 5-formylcytosine (5fC), 5-carboxylcytosine (5caC), and
5-hydroxymethyluracil (5hmU; Penn et al., 1972; Figure 2).
However, these modifications were considered to be oxidative
damage products of DNA (de Rojas-Walker et al., 1995; Tardy-
Planechaud et al., 1997). Three decades later, 5hmC was re-
discovered in mouse brain tissue (Kriaucionis and Heintz,
2009) and embryonic stem cells (ESCs; Tahiliani et al., 2009).
Furthermore, a family of proteins (ten-eleven translocation, TET)
was identified that oxidize 5mC to 5hmC both in humans
(Tahiliani et al., 2009) and mice (Ito et al., 2010). TET1 was
first described in 2003 as a fusion partner of the mixed lineage
leukemia (MLL) gene in acute myeloid leukemia (AML; Lorsbach
et al., 2003) and 6 years later it was re-discovered as an oxygenase,
which can convert 5mC to 5hmC (Tahiliani et al., 2009). Further
studies showed that Tet proteins also convert 5hmC to 5fC and
5caC (Ito et al., 2011; Pfaffeneder et al., 2011).
Deaminases such as Aid and Apobec can recognize 5mC and
5hmC and further convert 5mC to thymine (T) and 5hmC to
5hmU. Although the deaminase activity is quite low, it is still
a possible pathway for DNA demethylation (Guo et al., 2011).
In addition, Tets were also shown to oxidize T to 5hmU in
mESCs (Pfaffeneder et al., 2014), which additionally leads to loss
of DNA methylation. The oxidation products like 5fC, 5caC,
and 5hmU can be recognized and excised by the glycosylases
Tdg (Maiti and Drohat, 2011) and Neil (Muller et al., 2014)
to create an abasic site on DNA, which is further repaired by
enzymes of the base excision repair (BER) pathway. In addition
to Tdg, 5hmU can also be recognized by other glycosylases like
Mbd4 (Hashimoto et al., 2012b) and Smug1 (Kemmerich et al.,
2012). Accordingly, a combination of oxidation, deamination
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FIGURE 2 | DNA base modifications with respective enzymes. Dnmts catalyze the addition of a methyl group to cytosine bases. Tet proteins oxidize
methylated cytosines to 5hmC, 5fC, and 5caC in an iterative manner. 5mC and 5hmC can be further deaminated by Aid/Apobec to T and 5hmU. T, 5hmU, 5fC, and
5caC can be removed by the indicated glycosylases. Initial references are indicated.
and BER might contribute to the active removal of DNA
methylation. In mouse zygotes, the decrease of 5mC and increase
of 5hmC suggests that 5hmC might be an intermediate of
DNA methylation removal. However, recent studies showed that
loss of 5mC mainly happens before S-phase, whereas gain of
5hmC occurred after DNA replication (Amouroux et al., 2016),
indicating that besides the conversion of 5mC to 5hmC, other
pathways might contribute to methylation removal before DNA
replication in mouse zygotes.
Methylcytosine Modifiers
Until now three members of the Tet protein family named Tet1
(mouse homolog of human TET1), Tet2 (mouse homolog of
human TET2), and Tet3 (mouse homolog of human TET3) have
been identified in mice and humans. All three Tets share a
conserved C-terminal catalytic domain including a cysteine-rich
and a double-stranded β-helix (DSBH) domain, which belong
to the cupin-like dioxygenase superfamily; and exhibit iterative
iron- and oxoglutarate-dependent oxidation activity (Figure 3).
Tissue and Genome-Wide Distribution of Tet
During mouse embryo development, Tet3 is highly expressed in
oocytes and zygotes. Female mice depleted of Tet3 in the germ
line showed severely reduced fecundity and their heterozygous
mutant offspring lacking maternal Tet3 suffer an increased
incidence of developmental failure. Since Tet1, Tet2 as well as
Tet1 and Tet2 double knockout mice are viable, this suggests that
Tet1 and Tet2 are not essential for mouse development (Table 2).
Tet-mediated 5mC to 5hmC conversion is though involved
in reprogramming the paternal genome (Gu et al., 2011; Iqbal
et al., 2011; Wossidlo et al., 2011; Zhang et al., 2012) and also
in reprogramming donor cell DNA during somatic cell nuclear
transfer (Gu et al., 2011). In addition, HIV-1 Vpr binding protein
(VprBP)-mediated monoubiquitylation promotes Tet binding
to chromatin and enhances 5hmC formation (Nakagawa et al.,
2015) in mouse embryos. This process is involved in female germ
cell development and genome reprogramming in zygotes (Yu
et al., 2013).
During PGC reprogramming, Tet1 and Tet2 are highly
expressed (Hackett et al., 2013). However, genome-wide DNA
methylation removal is unaffected by the absence of Tet1 and
Tet2 and, thus, 5hmC, indicating that the first comprehensive
5mC loss does not involve 5hmC formation. Instead Tet1 and
Tet2 have a locus specific role in shaping the PGC epigenome
during subsequent development (Vincent et al., 2013). Further
studies showed that Tet1 has a critical role in the erasure of
genomic imprinting (Yamaguchi et al., 2013) and it controls
meiosis by regulating meiotic gene expression (Yamaguchi et al.,
2012).
In mESCs, both Tet1 and Tet2, as well as their oxidation
product 5hmC are highly abundant (Ito et al., 2010). While Tet2
preferentially acts on gene bodies, Tet1 preferentially acts on
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FIGURE 3 | Schematic representation of the Tet protein family. Shown are domain structures of mouse Tet proteins and the initial references. Numbers
represent amino acid positions. CXXC, CXXC zinc finger domain; Cys, cysteine-rich domain; DSBH, double-stranded β-helix.
TABLE 2 | Phenotypes of initial Tet knockout mouse models.
Genotype Phenotype Reference
Tet1 null Mice are viable, fertile, and grossly normal though some mutant mice have a slightly smaller body size at birth Dawlaty et al., 2011
Tet1 null Animals exhibited abnormal hippocampal long-term depression and impaired memory extinction Rudenko et al., 2013;
Zhang et al., 2013
Tet2 null Approximately one-third of Tet2−/− and 8% of Tet2+/− mice died within 1 year of age because of the development of
myeloid malignancies resembling characteristics of chronic myelomonocytic leukemia, myeloproliferative disorder-like
leukemia, and myelodysplastic syndrome
Li et al., 2011
Tet3 null Female mice depleted of Tet3 in the germ line show severely reduced fecundity and their heterozygous mutant offspring
lacking maternal Tet3 suffer an increased incidence of developmental failure. Oocytes lacking Tet3 also seem to have a
reduced ability to reprogram the injected nuclei from somatic cells
Gu et al., 2011
Tet1 and Tet2 null Double deficient mice had reduced 5hmC and increase 5mC levels and abnormal methylation at various imprinted loci.
Animals of both sexes were fertile with females having smaller ovaries and reduced fertility
Dawlaty et al., 2014
promoters and transcription start sites (TSS; Huang et al., 2014).
Tet1 and Tet2 double knockout ESCs remained pluripotent,
but were depleted of 5hmC and caused developmental defects
in chimeric embryos (Dawlaty et al., 2014). During somatic
reprogramming, Tet2 is required for 5hmC formation at the
Nanog locus (Doege et al., 2012). Further studies showed that
the recruitment of Tet1 by Nanog facilitates the expression of a
subset of reprogramming target genes, such as Oct4 (Costa et al.,
2013). Accordingly, Tet1 can replace Oct4 during somatic cell
reprogramming in conjunction with Sox2, Klf4, and c-Myc (Gao
et al., 2013). The data above indicate that Tet-mediated 5hmC
formation is not only important for ESCs differentiation but also
for somatic reprogramming.
In mouse brain, 5hmC is a constituent of nuclear DNA
(Kriaucionis and Heintz, 2009). Tet1 plays an important
role in regulating neural progenitor cell (NPC) proliferation
in adult mouse brain (Zhang et al., 2013) and is critical
for neuronal activity-regulated gene expression and memory
extinction (Table 2; Rudenko et al., 2013).
Regulation of Tet Activity
Similar to Dnmt1, Tet proteins use a base flipping mechanism to
oxidize 5mC, which includes binding of DNA by a Watson–Crick
polar hydrogen and van der Waals interactions, flipping out 5mC
(Hu et al., 2013; Hashimoto et al., 2014) and oxidation of 5mC
to 5hmC (Hashimoto et al., 2015; Hu et al., 2015). Although Tet
proteins successively oxidize 5mC to 5caC, recent experimental
data showed that, in comparison with 5hmC and 5fC, 5mC is the
preferential substrate for Tet2 (Hu et al., 2015). This preference
was further confirmed by computer simulations (Lu et al., 2016).
In cultured cells, the majority of genomic 5hmC nucleotides
are stable (Bachman et al., 2014), indicating that 5hmC is not
only involved in loss of DNA methylation, but represents an
additional stable epigenetic mark. The global content of 5hmC
varies in mouse tissues, does not correlate with 5mC content
and rapidly decreases as the cells adapt to cell culture conditions
(Nestor et al., 2012). The cell-, tissue-, and developmental stage-
specific distribution of 5hmC indicates that the conversion of
5mC to 5hmC is highly regulated.
Although the N-terminal domain (NTD) of Tet proteins was
shown to be dispensable for their catalytic activity, it was shown
to possess regulatory functions. A CXXC domain, which usually
binds specifically to unmethylated CpGs can be found in the
N-terminus of Tet1 and Tet3 (Liu et al., 2013). While the CXXC
domain of Tet1 cannot bind to DNA in vitro (Frauer et al., 2011b),
it binds to unmodified C, 5mC- or 5hmC-modified CpGs in vivo
(Zhang et al., 2010; Xu Y. et al., 2011). Moreover, binding of the
CXXC domain to DNA was shown to control DNA methylation
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levels by preventing unwanted DNA methyltransferase activity
in ESCs (Xu Y. et al., 2011) or aberrant methylation spreading
into CpG islands (CGIs) in differentiated cells (Jin et al., 2014).
The CXXC domain of Xenopus Tet3 recognizes non-methylated
cytosines in either CpG or non-CpG context, and it is critical for
specific Tet3 targeting (Xu et al., 2012). Although Tet2 proteins
do not have a CXXC domain, recent studies showed that the
ancestral CXXC domain of Tet2 is encoded by a distinct gene
named Idax. Unlike the CXXC domain of Tet1 and Tet3, the
CXXC domain of Idax binds unmethylated CpGs. Through direct
protein–protein interactions of Tet2 and Idax, Tet2 is recruited to
DNA. Furthermore, Tet2 is degraded by caspase activation, which
is triggered by the CXXC of Idax (Ko et al., 2013).
Two parts of the DSBH domain are connected by a potential
regulatory spacer region. Although the spacer region was shown
to be dispensable for 5mC catalytic activity (Hu et al., 2013), post-
translational modifications (PTMs), such as phosphorylation
and O-GlcNAcylation were observed in the spacer region
(Bauer et al., 2015) indicating that it might exhibit regulatory
functions. O-GlcNAc transferase (Ogt) directly interacts with Tet
proteins and consequently Tet proteins are GlcNAcylated. The
GlcNAcylation does not affect the hydroxylation activity of Tet2
and Tet3, rather Tet2 and Tet3 were shown to promote Ogt
activity (Deplus et al., 2013) by enhancing the localization of Ogt
to chromatin (Chen et al., 2013; Ito et al., 2014). However, it was
shown that Ogt drives Tet3 out of the nucleus further affecting its
activity on DNA (Zhang et al., 2014). In mESCs, Ogt is recruited
to unmethylated CpG promoters in a Tet1-dependent manner
(Vella et al., 2013). In addition to PTMs, mutations within the
spacer region of Tet2 were observed in myelodysplastic syndrome
(MDS), thus further highlighting the importance of this region
(Ko et al., 2010).
In vivo, besides PTMs, Tet activity is regulated by protein–
protein interactions, such as with Sin3a. In mESCs, the
interaction between Sin3a and Tet1 allows Sin3a to repress a
subset of Tet1 target genes (Williams et al., 2011). In mouse
zygotes, Tet3-mediated 5mC to 5hmC conversion is involved in
reprogramming of the paternal but not the maternal genome
although they share the same cytoplasm (Mayer et al., 2000). The
resistance of the maternal genome to reprogramming is achieved
by a protein named developmental pluripotency associated 3
(Dppa3, or PGC7). Dppa3 binds to histone H3K9me2 (Nakamura
et al., 2012) and interacts with Tet3 further blocking the activity of
Tet3 (Bian and Yu, 2014). Dazl, an RNA-binding protein known
to play a key role in germ cell development, was shown to enhance
Tet1-mediated 5mC to 5hmC conversion by enhancing Tet1
protein translation (Welling et al., 2015). In addition, growth
arrest and DNA damage inducible protein 45 (Gadd45) interacts
with Tet1 and Tdg and promotes loss of DNA methylation by
enhancing 5fC/5caC removal (Kienhöfer et al., 2015; Li et al.,
2015).
Finally, Tet-mediated 5mC to 5hmC conversion was shown
to be regulated by Tet cofactors. 2-Ketoglutarate (2-KG), one
of the cofactors for Tet oxidation is produced by isocitrate
dehydrogenase 1/2 (Idh1/2) in vivo. However, mutated Idh1/2
produce 2-hydroxyglutarate, a competitive inhibitor of 2-KG,
which can further inhibit 5mC to 5hmC conversion (Konstandin
et al., 2011). Vitamin C is a potential cofactor for Tet-mediated
oxidation and was shown to enhance Tet activity, which leads
to increased global 5hmC in ESCs (Blaschke et al., 2013). ATP
was also shown to be involved in regulating Tet activity. In vitro,
the reaction of Tet-mediated 5mC to 5caC can be enhanced by
addition of ATP (He et al., 2011).
Hydroxymethylcytosine maintenance
Dnmt1 recognizes hemi-mC DNA and methylates the nascent
DNA strand after replication during the S-phase of the cell
cycle. However, in vitro studies showed a 60-fold decreased
binding ability of Dnmt1 to hemi-hmC DNA compared to hemi-
mC DNA (Hashimoto et al., 2012a), indicating that hemi-hmC
DNA might not be a substrate for Dnmt1. Previous studies
showed that Np95 can recognize 5hmC and bind to hemi-
hmC DNA (Frauer et al., 2011a), indicating that Np95 might
target Dnmt1 to hemi-hmC containing replication forks to
maintain hmC after DNA replication. In addition, Dnmt3a and
Dnmt3b recognize hemi-hmC DNA (Hashimoto et al., 2012a)
and are necessary for methylation maintenance at repeat genomic
elements (Chen et al., 2003) suggesting Dnmt3a/3b might play
a role in maintaining 5hmC after DNA replication in repeat
elements.
In vivo, the majority of 5hmC is present in CpG dinucleotides.
However, 5hmC has also been observed in non-CpG context,
especially in gene bodies (Pastor et al., 2011; Xu Y. et al.,
2011). One important role of CpG methylation in gene
promoter regions is the repression of gene expression by directly
or indirectly preventing interactions between promoter and
transcription factors. Hydroxymethylated CpGs might affect
binding of transcription factors and/or 5mC readers to DNA.
DNA MODIFICATION READERS
In mammals, the methylome is specifically read by a variety of
proteins known as methyl-CpG binding proteins (MBPs), which
based on structural features are further classified into three main
families: the methyl-CpG binding domain (MBD) protein family
(Lewis et al., 1992; Cross et al., 1997; Hendrich and Bird, 1998;
Hendrich and Tweedie, 2003; Laget et al., 2010; Baymaz et al.,
2014), the Kaiso protein family (Daniel and Reynolds, 1999;
Filion et al., 2006), and the SET and RING (really interesting new
gene) finger associated (SRA) domain protein family (Hopfner
et al., 2000; Mori et al., 2002). While initially identified as 5mC
binding proteins, recent studies indicate that a distinct and
dynamic set of MBPs binds the Tet oxidation product 5hmC
during differentiation (Figure 4; Frauer et al., 2011a; Mellen et al.,
2012; Spruijt et al., 2013). Through further interactions with
multiple protein partners, MBPs provide a link between cytosine
derivatives and functional chromatin states in a temporally and
spatially regulated fashion.
MBD Protein Family
Presently, the MBD protein family consists of eleven members
(Mecp2, Mbd1–6, SETDB1, SETDB2, TIP5/BAZ2A, and BAZ2B;
Lewis et al., 1992; Cross et al., 1997; Hendrich and Bird, 1998;
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FIGURE 4 | 5-(Hydroxy)methylcytosine readers. Shown are MBPs that
read 5mC and 5hmC as indicated and the initial references.
Hendrich and Tweedie, 2003; Laget et al., 2010; Baymaz et al.,
2014). All of them share a common protein motif, the 70–
85 amino acids long MBD, which enables some, but not all
family members, to selectively bind to single methylated CpG
dinucleotides. With the exception of Mbd2 and Mbd3, MBD
proteins bear little resemblance outside their MBD (Hendrich
and Bird, 1998). Instead, MBD proteins comprise several
distinct domains that confer unique DNA binding, as well
as other functional features. Since this review covers DNA
(hydroxy)methylation-dependent processes, we will thereafter
focus on MBD family members (Figure 5) capable of binding
to (hydroxy)methylated CpG dinucleotides, i.e., methyl-CpG
binding protein 2 (Mecp2) and methyl-CpG binding domain
proteins 1–4 (Mbd1–4).
Mecp2
The first protein described to selectively recognize and bind
single, symmetrically methylated CpG dinucleotides was Mecp2
(Lewis et al., 1992). It is abundantly expressed in the central
nervous system with the highest protein levels in post-mitotic
neurons (Akbarian et al., 2001; Traynor et al., 2002; Jung et al.,
2003). Of the two alternatively spliced isoforms (Mecp2 e1
and e2), which differ in their N-terminus, Mecp2 e2 was first
identified and is, therefore, best characterized (Kriaucionis and
Bird, 2004; Mnatzakanian et al., 2004). Although both isoforms
distribute differently in developing and post-natal mouse brains,
no functional differences have been identified so far (Dragich
et al., 2007).
Both Mecp2 variants include two functionally characterized
domains, the MBD and the transcriptional repression domain
(TRD). While the MBD proved sufficient to direct specific
binding to methylated cytosines (Nan et al., 1993), the TRD was
originally identified as the region required for transcriptional
repression in vitro and in vivo (Lewis et al., 1992; Nan et al.,
1997; Jones et al., 1998; Kaludov and Wolffe, 2000). Circular
dichroism and protease digestion analysis revealed that outside
these functional domains the full-length protein is largely devoid
of secondary structure (Adams et al., 2007). With almost 60%
unstructured regions, Mecp2 is reckoned among the intrinsically
disordered proteins, which often undergo a disorder-to-order
transition upon binding to other macromolecules (Adams et al.,
2007). Indeed, recent studies demonstrate that Mecp2 gains
secondary structure and acquires substantial thermal stabilization
upon binding to DNA (Ghosh et al., 2010). Unlike its name
implies DNA binding is, however, not solely mediated via its
5mC specific MBD. Instead, as indicated by the release of Mecp2
upon salt extraction, regions outside the MBD contribute to
the overall binding energy through electrostatic interactions
(Meehan et al., 1992). As shown by electrophoretic mobility
shift assays (EMSAs), these sequence-unspecific DNA binding
motifs include the TRD and, based on their relative location
to the MBD and TRD, the so-called intervening domain, as
well as the C-terminal domain alpha (Ghosh et al., 2010). The
NTD of Mecp2 in contrast, contributes indirectly to the overall
binding affinity by enhancing the methylation specificity of the
MBD through conformational coupling (Ghosh et al., 2010).
An analog synergistic increase in DNA binding efficiency was
observed through interdomain interactions between the TRD
and the C-terminal part of the protein (Ghosh et al., 2010).
Similar to the NTD, the C-terminal domain beta (CTD beta)
does not directly interact with DNA (Ghosh et al., 2010).
Nevertheless, the overall chromatin binding efficiency was lost
upon its deletion (Nikitina et al., 2007b). Consistent with this,
the CTD beta induced moderate and reproducible shifts with
nucleosomal arrays, but not with naked DNA (Ghosh et al.,
2010), suggesting that the most C-terminal 192 residues of Mecp2
harbor a chromatin interaction surface (Nikitina et al., 2007b).
Indeed, Mecp2 has been shown to interact with histone H3 and,
similar to the linker histone H1, binds to nucleosomes close
to the linker DNA entry–exit site (Nikitina et al., 2007b). As a
result, the entering and exiting linker DNA segments are brought
in close proximity to form a stem-like motif (Nikitina et al.,
2007a), which bears strong resemblance to structures induced
by H1 (Hamiche et al., 1996; Bednar et al., 1998). The modes
of chromatin compaction, however, differ significantly from each
other. While histone H1 arranges nucleosomes and linker DNA
into regular zigzag-shaped chromatin fibers (Woodcock, 2006),
Mecp2 forms highly compacted globular structures in vitro due
to its multiple DNA and chromatin binding domains (Georgel
et al., 2003). Accordingly, Mecp2 was shown to induce clustering
of pericentric heterochromatin in a dose-dependent manner
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FIGURE 5 | Schematic representation of the MBD protein family. Shown are domain structures of mouse MBD proteins and the initial references. Numbers
represent amino acid positions. MBD, methyl-CpG binding domain; CXXC, CXXC zinc finger domain; TRD, transcriptional repression domain; GR, glycine/arginine;
E, glutamic acid.
in vivo to establish a locally repressive chromatin environment
(Brero et al., 2005; Agarwal et al., 2011). More recently, Szulwach
et al. (2011) provided evidence that binding of Mecp2 to
methylated CpG dinucleotides may protect 5mC against Tet-
mediated oxidation thereby preventing reactivation of silenced
genes. The underlying mechanism, however, has so far not been
described.
An additional level of regulation is achieved through various
protein–protein interactions. While direct homo- and hetero-
interactions of Mecp2 and Mbd2 were shown to cross-link
chromatin fibers (Becker et al., 2013), physical associations of
Mecp2 with the transcriptional co-repressor Sin3a and histone
deacetylase 2 (HDAC2) via its TRD contribute to the global
heterochromatin architecture through histone hypoacetylation
(Jones et al., 1998; Nan et al., 1998). Consequently, Mecp2
deficiency was demonstrated to result in global changes in
neuronal chromatin architecture, elevated histone acetylation
levels, and increased transcriptional noise in a DNA methylation-
dependent manner (Skene et al., 2010; Cohen et al., 2011).
A number of other repressive protein partners of Mecp2
have been identified including the co-repressors c-Ski (Kokura
et al., 2001), CoREST (Lunyak et al., 2002), and NCoR/SMRT
(Stancheva et al., 2003), as well as DNA methyltransferase Dnmt1
(Kimura and Shiota, 2003) and H3K9 methyltransferase (Fuks
et al., 2003).
Both, binding of Mecp2 to DNA, as well as interactions
with protein partners are affected by PTMs. Neuronal activity
induced phosphorylation and dephosphorylation of Mecp2 was
shown to modulate its association with promoters of specific
genes, as well as with interaction partners (reviewed in Li and
Chang, 2014). More recently, poly(ADP-ribosyl)ation of Mecp2
in mouse brain tissue was reported, which anticorrelated with
its chromatin binding affinity and clustering ability (Becker
et al., 2016). Furthermore, ubiquitylation (Gonzales et al., 2012),
SUMOylation (Cheng et al., 2014), acetylation (Zocchi and
Sassone-Corsi, 2012), and methylation (Jung et al., 2008) were
shown to substantially contribute to the functional versatility of
Mecp2.
Another unanticipated level of functional complexity was
demonstrated by recent work of Spruijt et al. (2013) who
identified Mecp2 as reader of 5hmC in mESC by quantitative
mass-spectrometry-based proteomics. Moreover, independent
studies of Mellen et al. (2012), revealed Mecp2 as the major
5hmC-binding protein in mouse brain, which moreover turned
out to bind both, 5hmC- and 5mC-containing substrates with
similar affinity.
Finally, chip-chip analysis using antibodies against MECP2
in a human neuronal cell line demonstrated that around two-
third of strongly MECP2 bound promoters were transcriptionally
active (Yasui et al., 2007). Subsequent analysis of gene expression
patterns in Mecp2 knockout and overexpressing mice concurred
that Mecp2 functions as an activator as well as a repressor of
transcription (Chahrour et al., 2008).
Hence, the traditional view of Mecp2 as a 5mC-dependent
transcriptional silencer may be incomplete and its biology
appears far more complicated than previously assumed.
Frontiers in Genetics | www.frontiersin.org 8 June 2016 | Volume 7 | Article 115
2.1 Modifiers and Readers of DNA Modifications and Their Impact on Genome Structure, Expression, and Stability in Disease
15
fgene-07-00115 June 18, 2016 Time: 16:32 # 9
Ludwig et al. DNA Modifications, Readers and Modifiers
Both, male and female mice lacking Mecp2 (Table 3)
developed an uncoordinated gait and reduced spontaneous
movement between 3 and 8 weeks of age and most died
between 6 and 12 weeks (Chen et al., 2001; Guy et al.,
2001). Furthermore, most animals developed hind limb clasping,
irregular breathing, misaligned jaws and uneven wearing of
teeth. Mutant brains were reduced in weight, however, no
structural abnormalities or signs of neurodegeneration were
detected, suggesting that stability of brain function, not brain
development per se, is impaired in the absence of Mecp2.
Consistent with this hypothesis, re-expression of the Mecp2
gene in Mecp2lox−Stop/y mice proved sufficient to reverse the
neurological symptoms of Rett syndrome (RTT), indicating
that Mecp2-deficient neurons develop normally and are not
irreversibly damaged (Guy et al., 2007). Further microarray
analyses revealed that knockout of Mecp2 implicates only minor
changes in gene expression (Tudor et al., 2002). Subsequent
studies demonstrating increased expression restricted to non-
coding RNA in brain of Mecp2-deficient mice (Muotri et al.,
2010; Skene et al., 2010), indicated that Mecp2 may not
act as a gene-specific transcriptional repressor, but might
instead dampen transcriptional noise genome-wide in a DNA
methylation-dependent manner (Skene et al., 2010). Accordingly,
expression of repetitive elements (Muotri et al., 2010; Skene et al.,
2010) as well as retrotransposition of LINE1 was increased in
brain of Mecp2-deficient mice (Muotri et al., 2010).
Mbd1
Mbd1, initially termed PCM1, is expressed in somatic cells
and represents the largest member of the MBD family (Cross
et al., 1997; Hendrich and Bird, 1998). Similar to Mecp2, Mbd1
contains a MBD and a TRD, which have analog functions to that
of Mecp2 (Ng et al., 2000). In addition, depending on the isoform,
Mbd1 contains two or three CXXC zinc finger motifs (Fujita
et al., 1999; Jorgensen et al., 2004). The most C-terminal one,
referred to as CXXC3, is homolog to zinc fingers found in Dnmt1,
CpG binding protein CGBP, histone H3K4 methyltransferase
MLL and histone H3K36 deacetylases of the Jumonji family
JHDM1A and JHDM1B (Jorgensen et al., 2004; Lee and Skalnik,
2005; Tsukada et al., 2006). While CXXC3 was shown to bind
unmethylated CpG dinucleotides in vitro (Birke et al., 2002; Lee
and Skalnik, 2002, 2005; Jorgensen et al., 2004), the remaining
zinc finger motifs of Mbd1 lack a conserved glutamine residue
and the characteristic KFFG motif necessary for binding to DNA
(Jorgensen et al., 2004). Accordingly, Mbd1 isoforms containing
the first two CXXC domains preferentially bind methylated DNA
via their MBD, whereas isoforms comprising a complete set
of zinc fingers have the ability to bind both, methylated and
unmethylated substrates (Jorgensen et al., 2004; Baubec et al.,
2013).
As a transcriptional repressor, Mbd1 was thus shown to
inhibit transcription from both, methylated and unmethylated
promoters in reporter gene assays (Fujita et al., 1999; Jorgensen
et al., 2004). While methylation-dependent silencing is mediated
by the MBD and TRD, suppression of non-methylated reporter
constructs required the presence of the CXXC3 domain
(Jorgensen et al., 2004). Although, a precise association between
Mbd1 and HDACs has not been described, transcriptional
repression was partially sensitive to trichostatin A (TSA), an
HDAC inhibitor (Ng et al., 2000). In most assays, however, Mbd1
behaved as an HDAC-independent repressor (Ng et al., 2000).
Instead, MBD1 has been found associated with histone H3K9
methyltransferases SETDB1 (Sarraf and Stancheva, 2004) and
Suv39h1 (Fujita et al., 2003). Association to SETDB1 mediates
transcriptional repression throughout the cell cycle (Sarraf and
Stancheva, 2004). During S-phase, however, MBD1 was shown
to recruit SETDB1 to the large subunit of chromatin assembly
factor CAF-1 to form an S-phase specific complex that mediates
methylation of H3K9 in a post-replicative manner (Sarraf and
Stancheva, 2004). Accordingly, H3K9 methylation is lost in the
absence of MBD1 and results in activation of specific genes, such
as p53BP2 (Sarraf and Stancheva, 2004).
MBD1-mediated transcriptional repression and hetero-
chromatin maintenance was shown to be regulated by
SUMOylation (Lyst et al., 2006; Uchimura et al., 2006). In human
cells, two E3 SUMO-ligases (PIAS1 and PIAS3) were shown to
SUMOylate MBD1 (Lyst et al., 2006). While SUMO1-conjugation
blocks the MBD1 and SETDB1 interaction, modification with
SUMO2/3 recruits SETDB1 thereby stimulating its repressive
function (Uchimura et al., 2006).
Although mice lacking Mbd1 (Table 3) developed normally
and appeared healthy throughout life, they were impaired
in spatial learning, had decreased neurogenesis and reduced
long-term potentiation in the dentate gyrus of the hippocampus
TABLE 3 | Phenotype of initial MBP-deficient mouse models.
Genotype Phenotype Reference
Mecp2 null Rett syndrome-like phenotype. Between 3 and 5 weeks: uncoordinated gait, reduced spontaneous movement, hind
limb clasping, irregular breathing, misaligned jaws, uneven wearing of teeth, reduced brain weight, and neuronal cell
size. Between 6 and 12 weeks: rapid weight loss and death.
Chen et al., 2001;
Guy et al., 2001
Mbd1 null Viable and fertile. Impaired spatial learning, decreased neurogenesis, reduced long-term potentiation, decreased
genomic stability.
Zhao et al., 2003
Mbd2 null Viable, fertile. Maternal nurturing defects: reduced litter size and weight of pups. Hendrich et al., 2001
Mbd3 null Early embryonic lethality Hendrich et al., 2001
Mbd4 null Viable and fertile. Increased number of C:G to T:A transitions at CpG sites. Millar et al., 2002
Kaiso null Viable and fertile. Reduced tumorigenesis Prokhortchouk et al., 2006
Np95 null Early gestational lethality. Developmental arrest shortly after gastrulation. Sharif et al., 2007
Np97 null Phenotype not described. Li et al., 2013
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(Zhao et al., 2003). Moreover, Mbd1-deficient neural stem cells
differentiated less and had decreased genomic stability (Zhao
et al., 2003).
Mbd2
Mbd2 and Mbd3 are the only known members of the MBD
protein family with significant sequence similarity beyond the
MBD (Hendrich and Bird, 1998) and, thus, are believed to
have arisen from an ancient duplication during evolution of
the vertebrate lineage (Hendrich and Tweedie, 2003). Consistent
with this, a homolog Mbd2/3 like protein was identified in
invertebrates, including Drosophila (Lyko et al., 2000; Marhold
et al., 2004). Despite the high degree of sequence similarity,
Mbd3 lacks the amino-terminal extension of Mbd2, which
contains a repeat consisting of glycine and arginine residues
(Hendrich and Bird, 1998). While both, Mbd2 and Mbd3 contain
a C-terminal coiled coil (CC) domain that mediates protein–
protein interactions, Mbd3 was shown to comprise an additional
glutamic acid repeat at its extreme COOH-terminus (Hendrich
and Bird, 1998; Gnanapragasam et al., 2011; Becker et al., 2013).
Mbd2 contains two in-frame start codons, which give rise to
Mbd2a and the truncated version Mbd2b, which lacks the first
140 amino acids (Hendrich and Bird, 1998). In vivo, however,
only Mbd2a, but not Mbd2b, has been detected (Ng et al., 1999).
Inclusion of an alternative third exon gives rise to an additional
isoform of Mbd2, named Mbd2c, which lacks the C-terminal
TRD and CC domain due to an early stop codon (Hendrich and
Bird, 1998).
Tethering of Mbd2a near a promoter via a GAL4 DNA
binding domain was shown to mediate transcriptional repression
that is sensitive to TSA (Ng et al., 1999). Similarly, Mbd2b
enhanced transcriptional repression of methylated reporter
constructs in co-transfection assays (Boeke et al., 2000). Different
from other MBD family members, the sequence required for TRD
partially overlapped with the MBD (Boeke et al., 2000), indicating
a strong interrelation of methylation binding and transcriptional
silencing. In line with this, the TRD directly interacts with the
transcriptional repressor Sin3A (Boeke et al., 2000). Moreover,
Mbd2 co-purified with a large protein complex known as NuRD
(nucleosome remodeling and histone deacetylation), which
includes chromatin remodeling ATPase Mi-2, as well as HDAC1
and HDAC2 (Ng et al., 1999; Wade et al., 1999; Zhang et al., 1999;
Mahajan et al., 2005; Le Guezennec et al., 2006). EMSAs indicated
that Mbd2a directs the NuRD complex, which is implicated
in transcriptional silencing, to methylated DNA (Zhang et al.,
1999). Finally, immunoprecipitation analysis showed that Mbd2
associates with HDAC1 in mammalian cells and is the long
sought methyl-CpG binding component of the 400–800 kDa
MeCP1 complex (Meehan et al., 1989; Ng et al., 1999).
Mbd2 was shown to bind 5mC in a manner similar to the
isolated MBD of Mecp2 (Hendrich and Bird, 1998; Wade et al.,
1999). Binding of oxidative 5mC derivatives, however, has not
been observed (Hashimoto et al., 2012a; Mellen et al., 2012;
Spruijt et al., 2013).
Mbd2b has also been reported to have DNA demethylase
activity (Bhattacharya et al., 1999), but this finding has been
questioned (Ng et al., 1999; Wade et al., 1999).
Mbd2-deficient mice (Table 3) are viable and fertile, but
exhibit a maternal nurturing defect resulting in reduced litter size
and weight of pups (Hendrich et al., 2001).
Mbd3
The smallest member of the MBD family, coding for a protein
of approximately 30 kDa is Mbd3 (Hendrich and Bird, 1998). It
appears in a rich diversity of splice variants and is expressed in
ESCs as well as somatic tissues (Hendrich and Bird, 1998; Roloff
et al., 2003).
DNA binding properties of Mbd3 seem to vary with
species. While mammalian Mbd3 is unable to interact with
methylated DNA, its amphibian counterpart binds methylated
CpG dinucleotides in vitro and in vivo (Hendrich and Bird,
1998; Wade et al., 1999; Saito and Ishikawa, 2002). Sequence
comparison of 5mC binding competent MBD domains revealed
two highly conserved residues, which are altered in mammalian
Mbd3: a largely solvent exposed tyrosine, as well as an amino-
terminal lysine or arginine residue (Ohki et al., 1999; Wakefield
et al., 1999; Saito and Ishikawa, 2002).
Despite its inability to recognize 5mC, three different Mbd3
isoforms (Mbd3a–c) that vary in their amino termini were
detected within the NuRD repression complex in embryonic stem
cells (Zhang et al., 1999; Kaji et al., 2006). ESCs lacking Mbd3-
NuRD displayed a severe defect in differentiation that lead to
persistent self-renewal even in the absence of leukemia inhibitory
factor (Kaji et al., 2006). More recently, depletion of Mbd3 in
somatic cells was shown to enhance the reprogramming efficiency
of the four Yamanaka factors (Oct4, Sox2, Klf4, and Myc; Luo
et al., 2013; Rais et al., 2013). Accordingly, Mbd3 was proposed
to play a key role in lineage commitment and pluripotency
(Yildirim et al., 2011; Reynolds et al., 2012; Whyte et al., 2012).
Contradictory studies using neural and epiblast-derived stem
cells, however, indicate a role for Mbd3 in facilitating induction of
pluripotency and argue that its function may be context specific
(dos Santos et al., 2014).
Binding sites of Mbd3 have been mapped genome-wide in
mouse and human cells (Yildirim et al., 2011; Baubec et al.,
2013; Gunther et al., 2013; Shimbo et al., 2013). While Yildirim
et al. (2011) identified Mbd3 bound to TSS of CpG-rich,
hydroxymethylation marked promoters, Baubec et al. (2013)
found Mbd3 bound to enhancers independent of CpG density
and (hydroxy)methylation status. Further data questioning the
interaction of Mbd3 with hydroxymethylated DNA was provided
by Spruijt et al. (2013), who did not detect Mbd3 among
hydroxymethylation-specific readers.
Although both, Mbd2 and Mbd3 associate with the NuRD
complex, the two MBD containing complexes appear to have
no functional overlap since knockout of Mbd3 in mice is
embryonic lethal, whereas Mbd2-deficient mice are viable and
fertile (Hendrich et al., 2001; Table 3).
Mbd4
Mbd4, also referred to as MED1 (Bellacosa et al., 1999), is the
only known member of the MBD protein family not associated
with HDAC activity (Hendrich and Bird, 1998). Instead, several
lines of evidence suggest that Mbd4 plays a role in DNA repair
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(Bader et al., 1999; Bellacosa et al., 1999; Hendrich et al.,
1999; Riccio et al., 1999; Petronzelli et al., 2000; Millar et al.,
2002). In addition to its MBD, Mbd4 contains a C-terminal
catalytic domain that is highly homologous to bacterial DNA
damage specific endonucleases that exhibit glycosylase activity
during BER (Michaels et al., 1990; Hendrich and Bird, 1998).
Accordingly, Mbd4 was shown to remove thymine or uracil
from mismatched CpG sites through glycosidic bond cleavage.
As genomic G/T mismatches are the expected product of 5mCpG
deamination, Mbd4 has been designated a methylation specific
DNA repair enzyme (Hendrich et al., 1999; Petronzelli et al.,
2000; Hashimoto et al., 2012b). Furthermore, Mbd4 has been
implicated in DNA demethylation as it was shown in vitro to
excise 5hmU, the deamination product of 5hmC (Hashimoto
et al., 2012b).
Knockout and rescue experiments in embryonic stem cells,
however, demonstrated that oxidation-dependent reactivation of
methylated reporter genes is mediated by the action of thymine
DNA glycosylase (TDG), but not by Mbd4 (Muller et al., 2014).
Accordingly, deamination of 5hmC to 5hmU and subsequent
excision by Mbd4 does not play a major role in ESCs (Hashimoto
et al., 2012b). A contribution of Mbd4 to Tet-initiated DNA
demethylation in NPCs, however, cannot be excluded, since
Mbd4 was shown to bind to 5hmC at this developmental stage
(Spruijt et al., 2013).
Mice lacking Mbd4 are viable and fertile (Millar et al., 2002).
However, compared to wild-type mice, Mbd4 knockout lead to
a 3.3-fold higher number of C:G to T:A transitions at CpG sites
(Millar et al., 2002). Moreover, Mbd4−/− mice that were made
heterozygous for the Min allele of the adenomatous polyposis coli
gene (ApcMin), which pre-disposes mice to develop spontaneous
intestinal neoplasia (Su et al., 1992), showed markedly reduced
survival compared to Mbd4+/+ controls. Accordingly, Mbd4
plays an important role in the repair of 5mC deamination
at mCpGs. The relatively mild phenotype of Mbd4 knockout
mice (Table 3), however, suggests that its absence might be
compensated for by other glycosylases, such as TDG.
Kaiso Protein Family
Members of the Kaiso-like protein family (Figure 6) present
a second class of proteins capable of binding specifically
to methylated DNA (Filion et al., 2006). In contrast to
members of the MBD protein family, Kaiso, Zbtb4, and Zbtb38
contain a conserved BTB/POZ (Bric-a-brac, tramtrack, broad
complex/poxvirus and zinc finger) domain involved in protein–
protein interactions and three Kruppel-like C2H2 zinc finger
motifs, of which two were found essential for binding to
methylated DNA (Filion et al., 2006). Similar to MBD proteins,
members of the Kaiso family function as HDAC-dependent
transcriptional repressors (Sasai et al., 2005). Several lines of
evidence, however, including their variable binding modes,
protein partners and expression patterns, suggest that Kaiso-like
proteins have different biological functions (Daniel and Reynolds,
1999; Kiefer et al., 2005; Park et al., 2005; Filion et al., 2006).
While Kaiso was shown to require at least two methylated
CpG dinucleotides, a single mCpG proved sufficient for efficient
binding of the Zbtb4 and Zbtb38 proteins (Prokhortchouk et al.,
2001; Filion et al., 2006). Besides its ability to bind methylated
DNA, in vitro synthesized Kaiso was shown to interact specifically
with an unmethylated consensus sequence, the Kaiso binding
site (KBS, TCCTGCNA), which can be found at promoters of
Wnt target genes (Daniel and Reynolds, 1999; Park et al., 2005).
Accordingly, the xWnt11 gene, a target of non-canonical Wnt
signaling, was shown to be regulated by Kaiso in Xenopus (Daniel
and Reynolds, 1999; Prokhortchouk et al., 2001). Moreover,
Kaiso-mediated repression of non-canonical and canonical Wnt
targets was repressed by interactions with p120-catenin (Kim
et al., 2004), as it competes with DNA for the access to the
Kaiso zinc finger domains (Daniel et al., 2002). The ability to
bind unmethylated KBS sequences is shared by Zbtb4. Zbtb38,
however, was shown to interact with the E-box motif (CACCTG)
of the rat tyrosine hydroxylase gene promoter (Kiefer et al., 2005),
but failed to bind a labeled KBS probe (Filion et al., 2006). More
recently, Kaiso was found to bind 5hmC in NPCs and Zbtb4
was pulled down with hydroxymethylated DNA from brain tissue
(Spruijt et al., 2013). The 5hmC binding domains, as well as the
biological function, however, remain to be determined.
Kaiso-like proteins contain a BTB/POZ domain, which
facilitates interaction with different sets of co-repressors and
mediate transcriptional repression.
Kaiso was shown to recruit the NCoR complex to promoters
of target genes to introduce histone hypoacetylation, as well
as H3K9 methylation (Yoon et al., 2003). Moreover, Kaiso
was identified as component of an alternative MeCP1 complex
in NIH3T3 cells (Prokhortchouk et al., 2001). Zbtb38 was
found to interact with the co-repressors CtBPs (C-terminal
binding proteins), which include HDAC, methyltransferase,
and demethylase activities (Sasai et al., 2005; Zocchi and
Sassone-Corsi, 2012). Zbtb4 was shown to associate with the
Sin3A/HDAC complex to repress expression of p21CIP1 in
response to stimuli that activate p53 (Weber et al., 2008).
Kaiso-like proteins exhibit diverging expression patterns.
While Kaiso is ubiquitously expressed, Zenon, the rat homolog
of ZBTB38, is primarily transcribed in brain and neuroendocrine
tissues (Kiefer et al., 2005). For Zbtb4, in contrast, high expression
levels were identified in brain, lung, kidney, muscle, and heart
(Filion et al., 2006).
Kaiso-null mice (Table 3) are viable and fertile, with no
detectable changes in gene expression profiles or developmental
abnormalities. However, when crossed with tumor-susceptible
Apc(Min/+) mice, Kaiso-deficient animals showed resistance to
intestinal cancer (Prokhortchouk et al., 2006).
SRA Domain Protein Family
Recent studies implicate that yet another protein fold, the SRA
domain could read DNA (hydroxy)methylation marks in vitro
and in vivo (Unoki et al., 2004; Johnson et al., 2007; Woo
et al., 2007; Frauer et al., 2011a; Spruijt et al., 2013). In
mammals, two SRA domain-containing proteins (Figure 7),
Np95 (mouse homolog of human ICBP90, gene name UHRF1)
and Np97 (mouse homolog of human NIRF, gene name UHRF2),
have been characterized (Unoki et al., 2004; Woo et al.,
2007; Zhang et al., 2011). While Np95 was first discovered
during the generation process of antibodies against murine
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FIGURE 6 | Schematic representation of the Kaiso-like protein family. Shown are domain structures of mouse Kaiso-like proteins and the initial references.
Numbers represent amino acid positions. BTB/POZ, broad complex, tramtrack and bric a brac/poxvirus and zinc finger domain; ZF, zinc finger; CXXC, CXXC zinc
finger domain.
FIGURE 7 | Schematic representation of the SRA domain protein family. Shown are domain structures of mouse SRA domain proteins and the initial
references. Numbers represent amino acid positions. UBL, ubiquitin-like domain; TTD, tandem tudor domain; PHD, plant homeodomain; SRA, SET, and RING finger
associated domain; RING, really interesting new gene.
thymic lymphoma (Fujimori et al., 1998), NIRF was identified
through screenings for PCNP (PEST containing nuclear protein)
interaction partners (Mori et al., 2002).
Besides the eponymous SRA domain, ICBP90 contains at
least four additional functional motifs (Hashimoto et al., 2009):
an N-terminal ubiquitin-like domain (Ubl, or NIRF_N); a
tandem Tudor domain (TTD) that binds histone H3 tails di/tri-
methylated at lysine 9 (H3K9me2/3; Karagianni et al., 2008;
Papait et al., 2008; Rottach et al., 2010); a PHD, which binds
(un)modified histones; and a C-terminal RING, which exhibits
ubiquitin E3 ligase activity.
ICBP90 and Np95 play a critical role in epigenetic inheritance
and maintenance of DNA methylation (Bostick et al., 2007; Sharif
et al., 2007). Accordingly, ICBP90/Np95 was shown to colocalize
with PCNA during S phase and to interact with Dnmt3a, Dnmt3b
and several histone-modifying enzymes like HDAC1, as well as
histone methyltransferase G9a (Achour et al., 2009; Kim et al.,
2009; Meilinger et al., 2009). Moreover, besides its ability to
bind and flip out hemi-methylated DNA, the SRA domain of
ICBP90 was shown to target Dnmt1 to replicating pericentric
heterochromatin for maintenance methylation (Bostick et al.,
2007; Arita et al., 2008; Avvakumov et al., 2008; Hashimoto
et al., 2008; Papait et al., 2008). In addition, ICBP90 was
shown to bind histone H3K9me2/3 via its TTD, thus connecting
repressive histone marks with DNA methylation (Rottach et al.,
2010; Nady et al., 2011; Rothbart et al., 2012). The PHD of
ICBP90, on the other hand, was found associated with the
N-terminal tail of histone H3 (Papait et al., 2007; Hu et al., 2011;
Rajakumara et al., 2011; Wang et al., 2011; Arita et al., 2012;
Cheng et al., 2013). More recently, the SRA domain of Np95
was demonstrated to bind 5hmC and 5mC containing DNA
substrates with similar affinity in vitro (Frauer et al., 2011a).
Consistent with this, Np95 was identified as 5hmC reader in
mESCs and NPCs. In mouse brain tissue, however, association
with 5hmC remained undetected likely due to its low expression
levels. Although the structure of NIRF, the second member of
the SRA domain protein family, is closely related to ICBP90,
both proteins possess significantly different expression patterns.
While ICBP90 is mainly expressed in proliferating cells (Fujimori
et al., 1998), NIRF protein levels increase during differentiation
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(Pichler et al., 2011). NIRF binds hemi-methylated DNA and
H3K9me2/3 containing heterochromatin marks in a cooperative
manner, whereby localization and in vivo binding dynamics of
NIRF, were shown to require an intact TTD and depend on
H3K9me3 but not on DNA methylation (Pichler et al., 2011).
While Np95 was shown to bind 5hmC in mESCs and NPCs,
the interaction of Np97 and 5hmC was specific for NPCs.
Furthermore, Np97 exhibited higher binding affinity for 5hmC
than for 5mC in NPCs (Spruijt et al., 2013). Finally, Np97 was
proposed to promote repetitive oxidation of 5mC by Tet proteins,
since the levels of the oxidative cytosine derivatives 5hmC, 5fC
and 5caC were increased upon coexpression of Np97 and Tet1
in HEK293T cells (Spruijt et al., 2013). Consequently, Spruijt
et al. (2013), hypothesized that flipping of the modified base,
as previously described for Np95, may enhance the accessibility
of Tet enzymes to the hydroxymethylated base, whereby further
oxidation is promoted.
Furthermore, ectopic Np97 was unable to rescue DNA
methylation defects observed in Np95−/− ESCs. Neither DNA
methylation levels, nor pericentric heterochromatin localization
of Dnmt1 in S-phase could be restored upon overexpression of
Np97 arguing for functional differences between both proteins
(Pichler et al., 2011). NIRF was found to interact with cell cycle
proteins including cyclins, cyclin-dependent kinases (CDKs),
retinoblastoma protein (pRB), p53, PCNA, HDAC1, DNMTs, and
G9a (Mori et al., 2012). It was shown to ubiquitinate cyclins D1
and E1, and to induce G1 arrest. Accordingly, NIRF was proposed
to link the cell cycle regulatory network with the epigenetic
landscape (Mori et al., 2012).
While knockout of Np95 leads to developmental arrest shortly
after gastrulation and early gestational lethality (Sharif et al.,
2007), the phenotype of Np97 null mice has not been analyzed
(Li et al., 2013; Table 3).
ROLE OF 5mC WRITERS, READERS,
AND MODIFIERS IN DISEASE
Mutations in proteins involved in writing, reading, and
modifying the epigenetic landscape have been implicated in
various severe human disorders. Due to their high sequence
(Table 4) and functional similarity (Kumar et al., 1994; Hendrich
and Bird, 1998; Mori et al., 2002; Filion et al., 2006; Bostick et al.,
2007; Ito et al., 2010; Qin et al., 2011), we, hereafter, summarize
the state-of-the-art regarding the role of the human orthologs
of the aforementioned mouse Dnmts, Tets, and MBPs in human
diseases.
DNMT Proteins in Disease
Since Dnmt1 knockout is embryonic lethal in mice, it is
unlikely to expect a human disease linked to a DNMT1
catalytic domain mutation. But mutations in the regulatory
domain of DNMT1 were found (Table 5). Mutations in
the TS domain of DNMT1 cause neurodegeneration like
hereditary sensory autonomic neuropathy with dementia and
hearing loss (HSAN1E; Klein et al., 2011) and autosomal
TABLE 4 | Comparison of human proteins and their mouse orthologs.
Mouse protein Human protein Amino acid similarity (%)
Dnmt1 (1620 aa) DNMT1 (1632 aa) 76
Dnmt2 (415 aa) DNMT2 (391 aa) 77
Dnmt3a (908 aa) DNMT3A (912 aa) 96
Dnmt3b (860 aa) DNMT3B (853 aa) 80
Dnmt3l (421 aa) DNMT3L (387 aa) 56
Tet1 (2039 aa) TET1 (2136 aa) 50
Tet2 (1912 aa) TET2 (2002 aa) 55
Tet3 (1803 aa) TET3 (1795 aa) 89
Mecp2 (501 aa) MECP2 (498 aa) 94
Mbd1 (636 aa) MBD1 (605 aa) 68
Mbd2 (414 aa) MBD2 (411 aa) 94
Mbd3 (285 aa) MBD3 (291 aa) 92
Mbd4 (554 aa) MBD4 (580 aa) 58
Kaiso (671 aa) KAISO (672 aa) 84
Zbtb4 (982 aa) ZBTB4 (1013 aa) 85
Zbtb38 (1197 aa) ZBTB38 (1195 aa) 81
Np95 (782 aa) ICBP90 (806 aa) 72
Np97 (803 aa) NIRF (802 aa) 90
dominant cerebellar ataxia, deafness and narcolepsy (ADCA-
DN; Winkelmann et al., 2012). Mutations of Y495C, Y495H,
D490E-P491Y (Klein et al., 2011, 2013) in exon 20 cause
HSAN1E. Those mutations caused premature degradation
of mutant proteins, reduced methyltransferase activity and
impaired heterochromatin binding during G2 phase leading
to global hypomethylation and site-specific hypermethylation
(Klein et al., 2011). ADCA-DN is a polymorphic disorder first
described in 1995 in a Swedish pedigree. Unlike mutations in
HSAN1E located in exon 20, mutations in ADCA-DN including
A570V, G605A, and V606F were found in exon 21 of the DNMT1
gene.
Mutations in DNMT3A were found in de novo AML
and are associated with poor survival (Table 5; Ley et al.,
2011). The most frequent mutation occurred in amino acid
R882, however, frameshift, nonsense and splice site mutations
were also reported (Ley et al., 2011). Mutations of DNMT3A
are not only observed in AML patients, but also in MDS.
Similar to mutations leading to AML, amino acid R882 located
in the methyltransferase domain of DNMT3A is the most
common mutation site (Walter et al., 2011). Unlike in AML
and MDS, most mutations in overgrowth syndrome do not
directly affect the catalytic activity of DNMT3A, but interfere
with domain–domain interactions and histone binding, which
further affect the activity of DNMT3A (Tatton-Brown et al.,
2014).
ICF syndrome (immunodeficiency, chromosomal instability,
and facial anomalies), a human genetic disorder is caused by
DNMT3B mutations (Table 5; Hansen et al., 1999; Xu et al.,
1999). Several mutations were identified and most mutations
are located in the catalytic domain of DNMT3B and directly
affect the activity of DNMT3B (Xu et al., 1999). However,
mutations, which do not directly affect its catalytic activity were
also observed in ICF syndrome. Two mutations, A766P and
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TABLE 5 | Summary of disease-related DNMT and TET mutations.
Protein Disease Alteration Reference
DNMT1 Hereditary sensory autonomic neuropathy with dementia
and hearing loss (HSAN1E)
Y495C, Y495H, D490E-P491Y Klein et al., 2011, 2013
DNMT1 Autosomal dominant cerebellar ataxia, deafness and
narcolepsy (ADCA-DN)
A570V, G605A, and V606F Winkelmann et al., 2012
DNMT3A Acute myeloid leukemia (AML) myelodysplastic syndrome
(MDS)
R882 and frameshift, nonsense and splice site mutations Ley et al., 2011;
Walter et al., 2011
DNMT3A Overgrowth syndrome Mutations interfere with domain–domain interactions and
histone binding
Tatton-Brown et al., 2014
DNMT3B Immunodeficiency, centromeric region instability, facial
anomalies syndrome (ICF) syndrome
Mutations in catalytic domain Hansen et al., 1999;
Xu et al., 1999
TET1 AML Ten-eleven translocation that gives rise to a MLL-TET1
fusion
Lorsbach et al., 2003
TET2 AML, MDS, and myeloproliferative neoplasms Mutations mostly in catalytic domain Abdel-Wahab et al., 2009
R840Q displayed similar methylation activity than the wild-type
enzyme but lost the ability to interact with DNMT3L, which
further leads to loss of activity in vivo (Xie et al., 2006). Direct
or indirect loss of DNMT3B activity consequently decreased
satellite DNA methylation in ICF syndrome patients, indicating
that DNMT3B is involved in maintaining genome stability.
5mC, the product of DNMTs is related to tumorigenesis.
It was shown that the genome of cancer cells is globally
hypomethylated relative to their normal counterparts. Usually,
hypomethylation leads to gene activation. In cancer cells, the
activation of genes is caused by hypomethylation of nearby
CGIs, which are silenced in somatic tissues by DNA methylation
(Strichman-almashanu et al., 2002). Satellite sequences and
repetitive sequences such as LINE1, SINE, IAP, and Alu elements
are silenced mainly by DNA methylation in normal cells.
However, in tumor cells, hypomethylation of L1 promoter was
detected and the activation of L1 might promote chromosomal
rearrangements and genome instability (Suter et al., 2004).
Although the cancer genome is hypomethylated, several studies
showed that Dnmts are upregulated in cancer cells (Ahluwalia
et al., 2001; Lin et al., 2007; Roll et al., 2008), suggesting that
demethylation enzymes might be additionally involved in loss of
DNA methylation in cancer.
TET Proteins in Disease
MLL gene is located in 11q23 and is the most frequent cytogenetic
finding in AML. In AML, MLL is translocated to chromosome
10 as a fusion with the TET1 gene. The MLL-TET1 fusion
protein contains the AT hooks, subnuclear localization domains,
and the CXXC domain of MLL and the C-terminus of TET1
(Table 5; Lorsbach et al., 2003). The function of MLL-TET1
fusion protein is still unknown, but it was showed that TET1 is
involved in MLL-rearranged leukemia. TET1 is a direct target of
the MLL-fusion protein and is significantly upregulated in MLL-
rearranged leukemia, leading to a global increase 5hmC, thus
playing an oncogenic role (Huang et al., 2013).
In myeloproliferative neoplasms, mutations of TET2 but not
TET1 and TET3 were observed (Table 5; Abdel-Wahab et al.,
2009). Mutations of TET2 were also observed in AML with varied
frequency and most of them occurred in the catalytic domain of
TET2. In AML, TET2 mutations correlate with genomic 5hmC
level (Konstandin et al., 2011). TET2 is one of the most frequently
mutated genes in MDS. Mutations of TET2 were detected in
most of the bone marrow cells in MDS and these mutations
contribute to the malignant transformation of bone marrow
cells (Langemeijer et al., 2009), which consequently displayed
uniformly low levels of 5hmC in genomic DNA compared to
bone marrow samples from healthy controls (Ko et al., 2010).
Besides the hematopoietic malignancies, 5hmC levels are also
changed in solid tumors. 5hmC level were profoundly reduced in
glioma, colon cancer, breast cancer, and melanoma compared to
normal tissues (Haffner et al., 2011; Jin et al., 2011; Li and Liu,
2011; Xu W. et al., 2011; Kraus et al., 2012).
Unlike in cancer, in the hippocampus/parahippocampal gyrus
(HPG) of preclinical and later-stage Alzheimer’s disease patients,
significantly increased levels of TET1, 5mC, and 5hmC were
observed. In contrast, levels of 5fC and 5caC were significantly
decreased in the HPG of these patients (Bradley-Whitman and
Lovell, 2013). This indicates that DNA methylation might play an
important role in memory-related disease.
MBPs in Disease
As readers and translators of epigenetic information, alterations
in MBP sequences affect the precisely coordinated link between
DNA methylation, histone modification and higher order
chromatin structure.
Mutations in the X-linked MECP2 gene give rise to RTT
(Table 6), a late onset (6–18 months post-birth) debilitating
neurological disease that affects 1 in 10,000–15,000 female live
births (Hagberg et al., 1983; Amir et al., 1999). After a period of
normal development (6–18 months), RTT patients usually lose
speech and acquired motor skills (Hagberg et al., 1983). They
are aﬄicted with seizures, autism, loss of motor coordination,
abnormal breathing and develop stereotypical, repetitive hand
movements (Hagberg et al., 1983). After the initial regression,
however, conditions often stabilize and allow viability until
adulthood (Rett, 1966; Hagberg et al., 1983).
Although the first patients were described in 1966 by Andreas
Rett (Rett, 1966), more than 30 years passed before mutations
within the MECP2 gene located in Xq28 were identified as
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TABLE 6 | Summary of disease-related MBP alterations.
Protein Disease Alteration Reference
MECP2 Rett syndrome Causal MECP2 mutations of Rett syndrome are
summarized in: http://mecp2.chw.edu.au/mecp2/index.php
Amir et al., 1999
MBD1 Prostate cancer Upregulated Patra et al., 2003
MBD2 Breast cancer Upregulated Billard et al., 2002
MBD3 Glioblastoma Upregulated Schlegel et al., 2002
MBD4 Colorectal cancer
Endometrial cancer
Pancreas cancer
Frameshift mutation
Frameshift mutation
Frameshift mutation
Riccio et al., 1999
KAISO Colorectal cancer Upregulated Lopes et al., 2008
ZBTB4 Neuroblastoma Downregulated Weber et al., 2008
ICBP90 Non-small-cell lung cancer Upregulated Daskalos et al., 2011
NIRF Lung cancer Upregulated He et al., 2009
the cause of the neurological disorder (Amir et al., 1999). The
most frequent mutations observed in patients suffering from
RTT are missense mutations that cluster within the MBD (aa
78–162), as well as nonsense mutations primarily found within
the TRD (aa 207–310; Christodoulou et al., 2003). In Xenopus,
missense mutations R106W, R133C, F155S, and T158M were
shown to reduce the binding ability of Mecp2 to methylated
DNA (Ballestar et al., 2000). Studies in mouse cells showed
that the majority of MBD-related missense mutations affected
the heterochromatin binding and/or clustering ability of Mecp2
(Agarwal et al., 2011). By artificially targeting chromatin binding
deficient Rett mutants (R111G, R133L, and F155S) to constitutive
heterochromatic regions, however, Casas-Delucchi et al. (2012)
revealed that some of these mutations exclusively affect the
chromatin binding but not linking ability. Mutations within the
TRD have been shown to influence protein–protein interactions.
In knock-in mice bearing the common RTT mutation R306C,
neuronal activity fails to induce T308 phosphorylation, a PTM
required to suppress the interaction of Mecp2 with the co-
repressor complex NCoR. Accordingly, R306C mutations result
in persistent association of both proteins leading to decreased
induction of a subset of activity-related genes (Ebert et al.,
2013; Lyst et al., 2013). In addition to missense and nonsense
mutations, reading frame shifts and C-term deletions were shown
to give rise to RTT. Mice bearing a truncating mutation similar
to those found in RTT patients showed normally localized
Mecp2 proteins (Shahbazian et al., 2002). Histone H3, however,
was hyperacetylated indicating abnormal chromatin architecture
and misregulated gene expression (Shahbazian et al., 2002).
Moreover, Muotri et al. (2010) identified increased susceptibility
for L1 transposition and genome instability in RTT patients with
truncating mutations.
In addition to RTT, Mecp2 was implicated in other
neurological diseases, including Hirschsprung’s disease, autism
spectrum disorder, schizophrenia, Prader-Willi, and Angelman
syndromes (Carney et al., 2003; Shibayama et al., 2004; Nagarajan
et al., 2006; Loat et al., 2008; Ramocki et al., 2009; Zhou et al.,
2013).
More recently MBP have been associated with several types
of human cancers (Table 6). While Mecp2 was overexpressed in
estrogen receptor positive human breast cancer (Muller et al.,
2003), MBD1 mRNA and protein levels were increased in
FIGURE 8 | Writing, reading, and translating DNA modifications. Graphical summary of how DNA modification writers, readers, and translators can impact on
chromatin composition, structure (nucleosomes are represented as balls, DNA as line) as well as genome expression (arrow represents active promoters) and
stability.
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prostate cancer (Patra et al., 2003). Accordingly, Patra et al.
(2003) proposed MBD1 as the major cause of hypermethylated
chromatin regions in prostate cancer through the recruitment of
HDAC1/2 and subsequent histone deacetylation. MBD2 mRNA
level were shown to be significantly elevated in benign tumors
of the breast and correlated with tumor size of invasive ductal
carcinomas, the most common type of breast cancer (Billard
et al., 2002). Accordingly, upregulation of MBD2 was proposed
to be associated with breast cell proliferation (Billard et al., 2002).
Increased expression of MBD3 and MBD4 were associated with
malignant glioma of the brain, and the grade of malignancy
correlated with MBD3/4 expression level (Schlegel et al.,
2002). Furthermore, frameshift mutations of MBD4 have been
identified in colorectal, endometrial and pancreatic cancer with
microsatellite instability (Riccio et al., 1999). MBD4 mutations
consisted of 1- to 2-bp deletions or 1-bp insertions that caused
frameshifts and premature stop codons. The resultant truncated
MBD4 proteins were predicted to be non-functional, as they lack
the C-terminal catalytic domain, whereby genomic instability was
proposed to steadily increase (Riccio et al., 1999). As a regulator
of target genes of the canonical and non-canonical Wnt pathway,
Kaiso was shown to mediate silencing of tumor suppressor genes
CDKN2A and HIC1 in Wnt-driven human colon cancer cell
lines (Lopes et al., 2008). Kaiso depletion induced expression
of tumor suppressor genes without altering DNA methylation
levels (Lopes et al., 2008). As a result, colon cancer cells
became susceptible to cell cycle arrest and cell death induced
by chemotherapy (Lopes et al., 2008). Accordingly, Lopes et al.
(2008) suggested Kaiso as a methylation-dependent oncogene
that represses hypermethylated tumor suppressor genes. ZBTB4
expression was shown to be downregulated in advanced stages of
human neuroblastoma and multiple human solid tumors (Weber
et al., 2008). As a repressor of the P21CIP1 gene, an inhibitor of the
Cdk2 kinase, ZBTB4 usually blocks cell cycle arrest in response to
p53 activation (Weber et al., 2008). Consequently, loss of ZBTB4
inhibits apoptosis and favors long-term survival of affected cells
(Weber et al., 2008). In tumors, where many promoter-associated
CGIs are hypermethylated, maintenance of methylation plays a
major role. Accordingly, elevated levels of ICBP90 were shown to
control cell cycle through maintenance of promoter methylation
at CDK2A and RASSF1 in non-small-cell lung cancer (Daskalos
et al., 2011). Finally, decreased expression of let-7a miRNA in
lung cancer was shown to result in elevated NIRF and reduced
P21CIP1 protein level, thereby most likely contributing to lung
carcinogenesis (He et al., 2009).
CONCLUDING REMARKS
In summary, alterations in 5mC writers, readers, and modifiers
that affect their level, PTMs, ability to bind and/or modify DNA
and protein interactions are each and all potential mechanisms
contributing to altered chromatin composition and structure as
well as genome activity and stability (Figure 8) and contribute
to an overwhelming variety of human diseases. Despite intensive
research, genotype–phenotype connections have been generally
difficult to establish and subsequent studies are urgently needed
to elucidate potential strategies for diagnostic and therapeutic
applications.
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3 Aims of this study
Aberrant DNA methylation has been implicated in various severe human diseases, such as cancer and neuro-
logical disorders. To understand how 5-methylcytosine is regulated, we analyzed the interplay of proteins reading,
translating and erasing the repressive epigenetic mark.
In Chapter 1 (Binding of MBD proteins to DNA blocks Tet1 function thereby modulating transcriptional noise) we
analyzed:
• the impact of MBD proteins on the efficiency of Tet1 mediated 5mC oxidation
• the influence of the chronological DNA binding order of Tet and MBD proteins on the ability of MBDs to protect
5mC
• the effect of different MBD-DNA interaction modes on Tet1 activity and DNA binding ability
• the epigenetic composition of pericentric heterochromatin in a mouse model for Rett syndrome
• the correlation between pericentric 5hmC accumulation and major satellite expression
In Chapter 2 (L1 retrotransposition is activated by Ten-eleven-translocation protein 1 and repressed by methyl-
CpG binding proteins) we studied:
• the effect of Tet1 activity on promoter methylation levels, expression and retrotransposition of endogenous
L1 elements
• the influence of Tet1 activity on the retrotransposition efficiency of an engineered L1 element
• the impact of MBD proteins on Tet1-mediated demethylation and reactivation of endogenous L1 elements
Figure 1: Scheme summarizing the main aims of Chapter 1 and Chapter 2
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3 AIMS OF THIS STUDY
Similar to DNA, ribonucleic acids contain next to the four canonical bases a variety of post-synthetic nucleoside
modifications that affect their structural and functional properties. Recent data indicate that Tet enzymes catalyze
the formation of 5-hydroxymethylcytidine in RNA. To assess whether Tet proteins accumulate in the nucleolus to
modify ribosomal RNA directly at the place of synthesis, the general principles of protein targeting to this subnu-
clear compartment need to be determined.
In Chapter 3 (Principles of protein targeting to the nucleolus) we investigated:
• the molecular requirements, including charge, lengths and composition of peptides and proteins that are
necessary and sufficient to reach and accumulate inside of nucleoli
• the relative pH of the nucleolus compared to the surrounding nucleoplasm
• whether peptides and proteins that meet the sequence requirements for accumulation in nucleoli bind RNA
in vitro
In Chapter 4 (Visualization of the Nucleolus in Living Cells with Cell-Penetrating Fluorescent Peptides) we aimed
to
• develop a protocol for the selective labelling of nucleoli in living cells using fluorescently tagged cell-penetrating
peptides
Figure 2: Scheme summarizing the main aims of Chapter 3 and Chapter 4
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4 RESULTS
4 Results
4.1 Binding of MBD proteins to DNA blocks Tet1 function thereby modulating
transcriptional noise
A.K. Ludwig wrote the manuscript and prepared all of the figures (except for figures S4, S6, S10a (right) S10b,
S10c and S12a).
A.K. Ludwig performed and analyzed the experiments of figures 1a, 3a, S10b, S10c and S11 together with P. Zhang.
A.K. Ludwig performed and analyzed the experiments of figures S7 and S10a (left) together with F. Hastert.
A.K. Ludwig performed and analyzed the experiments for figures 1b, 3b, 6e, S2, S16c.
A.K. Ludwig imaged and analyzed the data of figures 5, 6b, S14 and S16d
A.K. Ludwig analyzed the data of figures 6c, 6d, S16a and S16b.
Content of figures:
Figures 1a and 3a: Radioactive and immunological assay to determine 5hmC levels in genomic DNA of tran-
siently transfected HEK cells. Figures S10b and S10c: Accumulation kinetics of Mbd2, Mecp2, MBD and IDTRD
to pericentric heterochromatin in C2C12 mouse myoblasts. Figure S11: Analysis of Tet1CD and MBD expression
levels in HEK versus C2C12 cells by flow cytometry analysis. Figure S7: Immunological assay to determine 5hmC
levels in genomic DNA of wild type and Mecp2 knockout MTF cells. Figures S10a (left), 1b and 3b: In situ stain-
ing and quantification of genomic 5hmC levels in transiently transfected C2C12 mouse myoblasts. Figure 6e:
RT-qPCR analysis of major satellite RNA transcript levels in transiently transfected C2C12 mouse myoblasts and
brain of wild type and Mecp2 y-/ mice, respectively. Figure S2: Western blot analysis of Tet1CD and MBD protein
levels of transiently transfected, FACS sorted HEK cells. Figure S16c: Immunostaining of transiently transfected
C2C12 mouse myoblasts for Mecp2 and 5hmC, respectively. Figure 5: Immunostaining and quantification of
Mecp2, 5mC and 5hmC levels in NeuN positive cells of wild type and Mecp2 knockout mouse pontes, respectively.
Figure 6b: Line intensity profiles of DNA and 5hmC distribution through pericentric heterochromatin in neurons
of wild type and Mecp2 y/- mouse pontes, respectively. Figure S14: Imaging and analysis of coronal cross sec-
tions of mouse brain immunostained for Tet1, NeuN and Mecp2. Figure S16d: Accumulation analysis of 5hmC
at chromocenters in neurons of wild type and Mecp2 y/- mouse pontes, respectively. Figures 6c,6d, S16a and
S16b: Detection and quantification of major satellite transcripts by Fluorescent In Situ Hybridization (FISH).
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ABSTRACT
Aberrant DNA methylation is a hallmark of vari-
ous human disorders, indicating that the spatial
and temporal regulation of methylation readers and
modifiers is imperative for development and dif-
ferentiation. In particular, the cross-regulation be-
tween 5-methylcytosine binders (MBD) and mod-
ifiers (Tet) has not been investigated. Here, we
show that binding of Mecp2 and Mbd2 to DNA pro-
tects 5-methylcytosine from Tet1-mediated oxidation.
The mechanism is not based on competition for 5-
methylcytosine binding but on Mecp2 and Mbd2 di-
rectly restricting Tet1 access to DNA. We demon-
strate that the efficiency of this process depends on
the number of bound MBDs per DNA molecule. Ac-
cordingly, we find 5-hydroxymethylcytosine enriched
at heterochromatin of Mecp2-deficient neurons of a
mouse model for Rett syndrome and Tet1-induced re-
expression of silenced major satellite repeats. These
data unveil fundamental regulatory mechanisms of
Tet enzymes and their potential pathophysiological
role in Rett syndrome. Importantly, it suggests that
Mecp2 and Mbd2 have an essential physiological role
as guardians of the epigenome.
INTRODUCTION
Methylation of DNA is generally accepted to be decisively
involved in regulating gene expression (1). In mammals, 5-
methylcytosine (5mC) accounts for 1% of all DNA bases
and is primarily found as symmetrical methylation of CpG
dinucleotides (2). A minor proportion of 5mC is localized
within so-called CpG islands at the 5′ ends of many genes,
including those, responsible for genomic imprinting and X-
inactivation (3). The vast majority of methylated cytosines,
however, are found in repetitive, endoparasitic sequences
(4), whose transcriptional activity must be repressed to pre-
vent translocations, gene disruption and chromosomal in-
stability (5,6). Themethylome is read and translated by con-
served families of proteins, such as the methyl-CpG binding
domain proteins (7). All members (of which the five best
studied ones are Mecp2, Mbd1, Mbd2, Mbd3 and Mbd4)
share a common protein motif, the methyl-CpG-binding
domain (MBD) (8), which enables all family members ex-
cept for Mbd3 to selectively bind to single methylated CpG
dinucleotides (9). Moreover, all MBD proteins with the ex-
ception of Mbd4 have been described to function in tran-
scriptional repression in part by recruiting silencing com-
plexes such as histone deacetylases (HDACs) (1,10).
Mecp2, the founding member of the MBD protein fam-
ily, is highly expressed in brain and was shown to medi-
ate silencing of neuronal genes by the recruitment of the
Sin3a–HDAC chromatin remodeling complex via its tran-
scriptional repression domain, abbreviated TRD (10,11). In
addition, Mecp2 was described to link methylated DNA
with the nuclear receptor corepressor (NCoR), as well as
the silencing mediator of retinoic acid and thyroid receptor
(SMRT) in a neuronal activity dependent manner (12,13).
Unlike its name suggests, Mecp2 binds preferentially, but
not exclusively to methylated DNA (9,14,15). In addition
to its core methyl-CpG binding domain (MBD), Mecp2
contains various non-sequence specific interaction sites for
double-stranded DNA, including the TRD domain and,
based on their relative location to the MBD and TRD, the
so-called intervening domain (ID), as well as the C-terminal
domain alpha (CTD alpha) (14). Upon binding to DNA,
the ID and TRD domains of Mecp2, which constitute a
large proportion of the extensively disordered protein, ac-
quire secondary structure and stabilize Mecp2-chromatin
complexes. Accordingly, deletion of these DNAbinding do-
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mains were shown to considerably increase the fraction of
unbound Mecp2 molecules within the cell nucleus (14,16).
Besides this, MBD-based binding affinity was described to
highly depend on the density of methylated CpG sites (15)
and, thus, might vary extensively among different cell types.
In mouse cells, Mecp2 was described to highly accumulate
at densely methylated pericentric heterochromatin (17). As
a consequence of homo- and hetero-interactions with itself
and Mbd2 (18), as well as its multivalent DNA and 5mC
binding ability, Mecp2 induces large-scale chromatin reor-
ganization (19) accompanied by dampening transcriptional
noise of highly methylated repetitive elements (20).
More recently, three mammalian enzymes (TET1-3)
named after the ten-eleven translocation (t(10;11)(q22;23))
identified in a few cases of acute myeloid and lympho-
cytic leukemia (21–23), were shown to catalyze the con-
version of 5mC to 5-hydroxymethylcytosine (5hmC), 5-
formylcytosine (5fC) and 5-carboxycytosine (5caC) in an
iterative, Fe(II)- and oxoglutarate dependent oxidation re-
action (23–25). This may either result in the erasure of
the repressing methylcytosine mark with the aid of deam-
inases and enzymes of the base excision repair system (26),
or the stable genomic integration of the oxidized cytosine
derivatives as additional epigenetic information (27). Con-
sequently, TET proteins have been proposed to play a key
role in the long sought mechanism of active DNA demethy-
lation (23), as well as in diversifying the epigenetic land-
scape, whose composition is dynamically regulated during
development and in disease (27).
DNA hypo- as well as hypermethylation as a conse-
quence ofmiss- or nonfunctioning 5mCwriters, readers and
modifiers, have been implicated in many malignancies in-
cluding neurological and autoimmune disorders and cancer
(28). Mutations in the X-linked MECP2 gene cause Rett-
syndrome (29,30), a debilitating neurological disease that,
at a molecular level, is characterized by increased expres-
sion and retrotransposition of repetitive elements (20,31).
By dissecting the interplay of 5mC readers and modifiers,
we test the hypothesis of whether the anomalous transcrip-
tional response observed in Rett patients is due to uncon-
fined access of TET proteins to their substrate 5mC. In ac-
cordance with this, our data unveil a molecular mechanism
by which Mecp2 and Mbd2 protect 5mC from Tet1 medi-
ated oxidation in vivo and in vitro and provide definite indi-
cations of aberrant Tet activity in a mouse model for Rett
syndrome, which lacks the aforementionedMBD-based de-
fense system.
MATERIALS AND METHODS
Plasmids
Mammalian expression constructs coding for GFP-tagged
mouse Mbd2-, mouse Mbd3- and rat Mecp2 full length
proteins, rat Mecp2 deletion mutants (Mecp2G.9: aa 163–
310 and Mecp2Y.5: aa 77–162), as well as for human
Mecp2 deletion mutant R111G were previously described
(8,18,19,32,33).
For construction of the mCherry-tagged catalytic ac-
tive (Tet1CD: aa 1365–2057) and inactive (Tet1CDmut:
aa 1365–2057, H1652Y, D1654A) domain of mouse Tet1,
Np95 was replaced from the mammalian expression vec-
tor pCAG-mCherry-Np95-IB (34) by Tet1CD (27) and
Tet1CDmut (35), respectively using AsiSI and NotI sites.
For the expression of GFP, the commercial vector
pEGFP-N1 (Clontech; Mountain View, CA, USA) was
used.
Insect expression constructs coding for GFP-tagged
mouse Mbd2- and rat Mecp2 full length proteins, as well as
for ratMecp2 deletionmutantsMecp2G.9 (aa 163–310) and
Mecp2Y.5 (aa 77–162) were previously described (18,32,36).
For construction of the His-tagged catalytic domain of
mouse Tet1, an N-terminal Histag, enterokinase- and AsiSI
cutting site were amplified (fwd primer: 5′-gcc cga att cat gag
cca tc-3′, rev primer: 5′-ccc ggc ggc cgc tta-3′) from an oligo
(gcc cga att cat gag cca tca tca tca tca tca tga cga cga cga caa
gag cga tcg cat gtc aac cag gag gga agc tta agc ggc cgc cgg g)
and inserted into the commercial transfer vector pFBDM
of the MultiBac Expression System (37) using EcoRI and
NotI sites. The catalytic active domain of mouse Tet1 (aa
1365–2057) was then cut from the mammalian expression
vector (27) and inserted into the modified pFBDM transfer
vector using AsiSI and NotI sites.
For the generation of the GFP- and mCherry-tagged
catalytic active domain of mouse Tet1, GFP- and cherry-
tagged Tet1CD, were cut from the mammalian expres-
sion vector pCAG-GFP-Tet1CD (27) and pCAG-cherry-
Tet1CD (described above), respectively and inserted into
the modified pFBDM transfer vector (described above) us-
ing BamHI and NotI sites.
Cell culture and transfection
C2C12 mouse myoblasts (38) were cultured using standard
conditions described previously (39).
C2C12 cells were grown to 70% confluence on 16 mm
glass cover slips in 6-well plates and transfected 3 hours post
seeding using poly-ethylenimine (PEI, 1 mg/ml in ddH2O,
pH 10; Sigma-Aldrich, St. Louis, MO, USA) (40).
HEK 293-EBNA cells (Invitrogen; Paisley PA4 9RF,
UK) were grown as previously described (41).
For the isolation of genomic DNA, HEK cells were
seeded in 6-well plates at a target density of 5 × 105
cells per well and transfected 24 hours post seeding using
poly-ethylenimine (PEI, 1mg/mL in ddH2O, pH 7; Sigma-
Aldrich, St. Louis, MO, USA).
For the production of GFP-tagged Tet1CD (27) and
Mecp2 (19) proteins, HEK cells were grown to 70% con-
fluence and transiently transfected using poly-ethylenimine
(PEI, 1mg/ml in ddH2O, pH 7; Sigma-Aldrich, St. Louis,
MO, USA).
Sf9 insect cells (Invitrogen, Paisley PA4 9RF, UK) used
for protein production were cultivated and transfected as
previously described (18).
V6.5 wild type and triple Tet-knockout mouse embry-
onic stem cells (42) were maintained under serum-free and
feeder-free conditions on Geltrex-coated flasks in N2B27
medium (50% neurobasal (Life Technologies, Carlsbad,
California, USA) and 50% DMEM/F12 medium (Life
Technologies, Carlsbad, California,USA) containing 2mM
L-glutamine (Life Technologies, Carlsbad, CA, USA), 0.1
mM !-mercaptoethanol, N2 supplement (Life Technolo-
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gies, Carlsbad, CA,USA), B27 serum-free supplement (Life
Technologies, Carlsbad, CA, USA), 100 U/ml Penicillin-
Streptomycin, 1000 U/ml LIF and 2i (1 "MPD032591 and
3 "M CHIR99021 (Axon Medchem, Groningen, Nether-
lands)).
Mouse tail fibroblast (MTF) lox/y andMTF -/y (Mecp2
knockout) (43) cells were cultured in Dulbecco’s modified
Eagle’s medium (DMEM) supplementedwith 10% fetal calf
serum. These cells are also heterozygous forMbd2.
Primary neurons were isolated from brain of adult
C57BL/6 mice. Whole brains were removed from mice un-
der sterile conditions, cut into small pieces, put into 10 ml
HBSS (Hank’s Balanced Salt Solution) and washed by cen-
trifugation (200 × g, 1 min). After centrifugation, HBSS
was discarded and the brain pellet resuspended in 5 ml
0.25% trypsin solution supplemented with 150 units DNa-
seI. After incubation for 20 min at 37◦C in a waterbath,
cells were centrifuged (200 × g, 1 min) again. Trypsin was
discarded and the pellet resupended in 5 ml FBS for 2
min at 37◦C. After centrifugation (200 × g, 1 min), FBS
was removed and the pellet resuspended in 5 ml Neu-
robasal medium (Thermo Fisher Scientific, Waltham, MA,
USA) supplemented with B-27 (Thermo Fisher Scientific,
Waltham,MA,USA). Next, the brain suspension was tritu-
rated by passing it through a 10ml serological plastic pipette
for 15 times and subsequently through a flamed-tip glass
Pasteur pipette for 15 times. Following centrifugation (400
× g, 1 min), the pellet was resuspended in 10 ml fresh neu-
robasal medium. Big parts were allowed to settle for around
30 s and the supernatant was distributed in dishes, set up
with laminin (Sigma, St. Louis,MO,USA) coated glass cov-
erslips. Cells were cultured for 10 days by replacing 50% of
the culture medium every two to three days before they were
used for immunostaining.
Mice
Dissected brains of male Mecp2 knockout mice (43) (∼
postnatal day 40) (WL.B6.129P2(C)-Mecp2tml.1Bird>/J;
Charles River Laboratories International, Inc., Wilming-
ton, MA 01887, USA) used for immunostainings were
kindly provided by AM Bischoff, lab of D. Richter (Uni-
versita¨tsmedizin Go¨ttingen, Germany).
Dissected brains of male Mecp2 knockout mice (43) (∼
postnatal day 40) (WL.B6.129P2(C)-Mecp2tml.1Bird>/J;
Charles River Laboratories International, Inc., Wilming-
ton, MA 01887, USA) used for RNA isolation were kindly
provided by the laboratory of Adrian Bird.
Brains of wild type mice (∼ postnatal day 40)
(C57BL/6N; Charles River Laboratories International,
Inc., Wilmington, MA 01887, USA) were used as control.
Protein preparation
GFP-tagged Tet1CD proteins (used in Supplementary Fig-
ure S9) were prepared from whole cell lysates of HEK cells
36 h post-transfection using 50 mM NaH2PO4; pH 7.5,
150 mM NaCl, 10 mM imidazole, 0.5% Tween-20, 0.5 mM
EDTA, 2 mM MgCl2, 0.5 mM CaCl2, 1 mM PMSF, 1
"g/"l DNaseI and 1×mammalian protease inhibitor cock-
tail (Sigma-Aldrich, St. Louis, MO, USA). Following cen-
trifugation, supernatant was added to pre-equilibrated (50
mM NaH2PO4; pH 7.5, 150 mM NaCl, 10 mM imida-
zole, 0.5 mM EDTA and 0.05% Tween-20) Ni-NTA beads
that were coupled to the GFP-binding protein (GFP-Trap,
ChromoTek, Planegg-Martinsried, Germany) (44,45) and
incubated for 2 h at 4◦C on a rotary shaker. To remove un-
bound proteins, beads were centrifuged and washed with
wash buffer (50 mM NaH2PO4; pH 7.5, 300 mM NaCl, 10
mM imidazole and 0.1%Tween-20). Elution was performed
using wash buffer containing 250 mM imidazole. Elution
buffer was exchanged to 20 mM Tris–HCl pH 7.5, 150 mM
NaCl, 0.5 mM EDTA, 1 mM DTT and 100 ng/"l BSA
using PD-10 desalting columns (GE Healthcare, Freiburg,
Germany).
GFP-taggedMecp2 R111G proteins were prepared from
whole cell lysates of HEK cells 24 h post-transfection us-
ing re-suspension buffer (32) containing 1 M NaCl and
protease inhibitors in following concentrations: AEBSF 1
mM (AppliChem, Darmstadt, Germany), E64 10 "M (Ap-
pliChem,Darmstadt,Germany), PepstatinA 1"M(Sigma-
Aldrich, St. Louis, MO, USA) and Aprotinin 2 ng/ml
(Sigma-Aldrich, St. Louis,MO,USA). Cells were disrupted
by syringe treatment (3 × 20 gauge, 3 × 21 gauge) followed
by incubation on ice for 10 min.
Proteins were eluted by the addition of 4 M MgCl2, pH
4.4 and subsequent incubation on ice for 10 min. Elution
buffer was exchanged to 1× PBS using Amicon Ultra cen-
trifugal filter units (Sigma-Aldrich, St. Louis, MO, USA).
All of the other GFP-, YFP- and mCherry-tagged
proteins were purified from Sf9 insect cells as previ-
ously described (18,32) with following exceptions: The re-
suspension buffer (32) was supplied with protease inhibitors
in concentrations as described above. For the purification
of Tet proteins, the sodium chloride (NaCl) concentration
of the re-suspension buffer was decreased to 0.5 M. Cells
were disrupted by syringe treatment (3 × 20 gauge, 3 × 21
gauge) followed by incubation on ice for 10 min. Proteins
were eluted by the addition of 4 MMgCl2, pH 4.4 and sub-
sequent incubation on ice for 10minutes. Elution buffer was
exchanged to 1× PBS using Amicon Ultra centrifugal filter
units (Sigma-Aldrich, St. Louis, MO, USA).
His-tagged proteins were purified from Sf9 insect cells
using TALON ion metal affinity chromatography (Clon-
tech Laboratories, Inc., CA, USA) according to the man-
ufacturer’s instructions with following changes. The re-
suspension buffer contained 50 mM NaH2PO4, 300 mM
NaCl and 10 mM imidazole, pH 8.0 and was supplied with
protease inhibitors as described above. The elution buffer
contained 50 mM NaH2PO4, 300 mM NaCl and 150 mM
imidazole, pH 8.0. Elution buffer was exchanged to 1× PBS
using Amicon Ultra centrifugal filter units (Sigma-Aldrich,
St. Louis, MO, USA).
Western blot analysis
HEK cells were lysed in re-suspension buffer (32) con-
taining 1 M NaCl for 20 min on ice and whole protein
lysates were blotted as described before (46) on a nitrocellu-
lose membrane (GE Healthcare, Mu¨nchen, Germany). Vi-
sualization of the immunoreactive bands was achieved by
ECL plus Western Blot Detection reagent (GE Healthcare,
Mu¨nchen, Germany). The following antibodies were used:
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monoclonal mouse anti GFP (Roche, Mannheim, Ger-
many), polyclonal rabbit anti PCNA (Santa Cruz Biotech-
nology, Heidelberg, Germany), monoclonal rat anti RFP
(47), Alexa488 conjugated goat anti mouse IgG (The Jack-
son Laboratory, Bar Harbor, USA), cy5 conjugated don-
key anti rabbit IgG (The Jackson Laboratory, Bar Harbor,
USA) and TexasRed conjugated donkey anti rat IgG (The
Jackson Laboratory, Bar Harbor, USA).
Genomic DNA preparation
For the preparation of genomic DNA (gDNA), sorted
HEK-EBNA, as well as MTF lox/y and -/y cells were pel-
leted (10 min, 2000 rpm, 4◦C) and incubated overnight at
50◦C in TNES buffer (10 mM Tris; pH 7.5, 400 mM NaCl,
10mMEDTA, 0.6%SDS) supplementedwith 1mg/mlPro-
teinase K (Carl Roth, Karlsruhe, Germany) (48). RNA was
removed by the addition of 0.6 mg/ml RNase A (Qiagen,
Hilden, Germany) for 30 min at 37◦C. gDNAwas extracted
by the addition of 6MNaCl at a final concentration of 1.25
M and vigorous shaking (48). After centrifugation (15 min,
13200 rpm, RT), gDNA was precipitated from the super-
natant by the addition of 100% ice cold ethanol followed
by incubation at –20◦C for 1 h and subsequent centrifuga-
tion (10 min, 13 200 rpm, 4◦C). After a washing step in 70%
ethanol, gDNA was air dried and solved in ddH2O. Iso-
lated gDNA fromHEK cells was fragmented (<2000 bp) by
sonication using the Biorupter TM UCD-200 (Diagenode,
SeraingOugre´e, Belgium). The concentration of gDNAwas
measured on a TECAN infinite M200 plate reader (Tecan
Group Ltd., Maennedorf, Switzerland).
RNA preparation
For sorted mouse C2C12 myoblasts, total RNA was
isolated using the RNeasy Mini Kit (Qiagen, Hilden,
Germany) according to the manufacturer’s instruction.
To remove traces of genomic DNA, RNA was treated
with RNase-free recombinant DNaseI (Macherey Nagel,
Dueren, Germany) for 90 min at 37◦C and further purified
with the Qiagen RNeasy Mini Kit. To assess the concen-
tration and purity of RNA, the ratio of absorbance at 260
and 280 nmwasmeasured on a TECAN infiniteM200 plate
reader (Tecan Group Ltd., Maennedorf, Switzerland).
For Mecp2 y/- and wild type mouse brain, total RNA
was isolated and treated with RNase-free DNaseI as previ-
ously described (49).
Flow cytometry
C2C12 mouse myoblasts transiently expressing mCherry-
tagged Tet1CD/Te1CDmut and GFP-tagged Mecp2 pro-
teins, as well as HEK-EBNA cells transiently co-expressing
high protein levels of mCherry-Tet1CD and GFP-tagged
MBD proteins (Mecp2, Mbd2, IDTRD and MBD, re-
spectively) were respectively trypsinized, re-suspended in
PBS and separated from untransfected cells by fluorescent-
activated cell sorting (FACS) on a S3e Cell Sorter (Bio-Rad
Laboratories, Hercules, CA, USA) equipped with 488 and
561 nm excitation lasers and 525 ± 30 and 586 ± 25 nm
emission filters, respectively. Sorted populations were either
processed for RNA- (C2C12 cells) or gDNA preparation
(HEK-EBNA cells), respectively.
Real-time quantitative reverse transcription-polymerase
chain reaction of major satellite repeats
For C2C12 mouse myoblasts, 20–200 ng of total RNAwere
used for cDNA synthesis using 200 units M-MuLV reverse
transcriptase (NEB, Frankfurt, Germany), 0.01 OD units
random primer of the Prime-It II Random Primer Labeling
Kit (Stratagene, La Jolla, CA, USA), 0.5 mM dNTPs (Carl
Roth, Karlsruhe, Germany) and 40 units recombinant ri-
bonuclease inhibitor RNaseOUT (Invitrogen, Paisley PA4
9RF, UK) in a total reaction volume of 20 "l. Cycles were
set to 10 min at 25◦C, 60 min at 42◦C and 20 min at 65◦C.
For Mecp2 y/- and wt mouse brain, cDNA was synthe-
sized as described previously (49) and kindly provided by
Congdi Song.
Equal amounts of cDNA (0.5 ng) were used for real-time
PCR with Platinum SYBR Green qPCR SuperMix-UDG
w/ROX (Invitrogen, Paisley PA4 9RF, UK) on a StepOne-
Plus Real-Time PCR System (Applied Biosystems, Darm-
stadt, Germany) according to the manufacturer’s instruc-
tion. UDG was inactivated for 2 min at 50◦C and cDNA
was denatured for 10 min at 95◦C. Cycle parameters were
set to 40 cycles of 15 s at 95◦C and 45 s at 60◦C. Specificity
of amplification products was confirmed by melting curve
analysis.
Gene expression level were normalized to Gapdh and
calculated using the comparative CT method (!!CT
method).
Primers for quantitative real-time PCR contained the fol-
lowing sequences: Gapdh forward: 5′-CCATACATACAG
GTT TCT CCA G-3′, Gapdh reverse: 5′-CTG GAA AGC
TGT GGCGTG ATGG-3′, MajSat forward (20): 5′-GGC
GAG AAA ACT GAA AAT CAC G-3′, MajSat reverse
(20): 5′-AGG TCC TTC AGT GTG CAT TTC-3′.
Radioactive beta-glucosyltransferase (BGT) assay
The radioactive BGT assaywas performed as described pre-
viously with following exceptions (50):
Reference DNA fragments (375 bp) containing 100%
hmC (except primer sites) were prepared by PCR, using
a 5-hydroxymethylcytosine dNTP Mix (Zymo Research,
Freiburg, Germany), and Taq DNA polymerase (Cardoso
Lab, Darmstadt, Germany). As template, gDNA isolated
from HEK-EBNA cells was used. Primers for PCR con-
tained the following sequences: 5′-ATC CCA CAC CTG
GCTCAGAGGG-3′ and 5′-GTCAGGGGTCAGGGA
CCC ACT TGA GGA-3′. Cycles were set to: 94◦C for 2
min, 40× (94◦C for 15 s, 62◦C for 30 s, 72◦C for 40 s), 72◦C
for 10 min.
PCR products were purified by gel electrophoresis fol-
lowed by silica column purification using the QIAquick
PCR Purification Kit (Qiagen, Hilden, Germany).
Reactions contained 50 mM potassium acetate, 20 mM
Tris acetate (pH 7.9), 10 mM magnesium acetate, 1 mM
DTT, 2.8 "M ‘cold’ UDP-glucose (Sigma Aldrich, St.
Louis,MO,USA), 86 nMUDP-[3H]glucose (glucose-6-3H;
60Ci/mmol; Hartmann Analytic GmbH), 1"g DNA sub-
strate and 75 nM recombinant !-glucosyltransferase in a
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total volume of 50 "l. Reactions were incubated for 1 h at
37◦C and terminated by heating at 65◦C for 10 min. DNA
was purified from the reaction mixture using the QIAquick
PCR Purification Kit (Qiagen, Hilden, Germany). Remain-
ing radioactivity was measured using a Liquid Scintilla-
tion Analyzer Tri-Carb 2800TR (PerkinElmer, Waltham,
Massachusetts, USA) with quench indicating parameter set
on tSIE/AEC (transformed spectral index of the external
standard/automatic efficiency control) in 2 ml of Rotiszint
Eco Plus scintillation liquid (Carl Roth, Karlsruhe, Ger-
many) in Snaptwist vials (Zinsser Analytic, Frankfurt, Ger-
many). Samples were measured for 1 min or until the 2#
value reached 2%.
In vitro oxidation and protection assay
Reference DNA fragments (375 bp) containing 100% 5mC
(except primer sites) were prepared by PCR, using 5-methyl-
dCTP (NEB, Frankfurt, Germany). Genomic DNA iso-
lated from HEK-EBNA cells was used as template with
primers: 5′-ATC CCA CAC CTG GCT CAG AGG G-
3′ and 5′-GTC AGG GGT CAG GGA CCC ACT TGA
GGA-3′, Q5® High-Fidelity DNA Polymerase (NEB,
Frankfurt, Germany) and the following cycling profile:
98◦C for 2 min, 40× (98◦C for 15 s, 62◦C for 30 s, 72◦C
for 60 s), 72◦C for 2 min. PCR products were purified
by gel electrophoresis followed by silica column purifica-
tion using the QIAquick PCR purification kit (Qiagen,
Hilden, Germany). For in vitro oxidation and protection
assays, DNA fragments were incubated with MBD- and
Tet1 proteins at 37◦C in Tet oxidation buffer (10 "M
Fe(NH4)2(SO4)2.6H2O, 100 mM NaCl, 50 mM HEPES
(pH 8), 1.2 mM adenosine triphosphate (ATP), 2.5 mM
dithiothreitol (DTT), 1 mM a-ketoglutarate (aKG) and 2
mM L-ascorbic acid). Following 120 min of Tet1 incuba-
tion, the reaction was stopped by the addition of 20 "g of
proteinase K at 50◦C for 2 h.
Slot blotting
gDNA samples and in vitro oxidation products were re-
spectively denatured at 99◦C for 10 min and placed quickly
on ice for 5 min. Denatured gDNA was mixed with ice-
cold 20× saline–sodium citrate (SSC) buffer at a final con-
centration of 4.8× SSC and blotted on a nitrocellulose
membrane (Bio-Rad Laboratories, Hercules, CA, USA),
which was pre-equilibrated in 20× SSC. After air-drying,
the membrane was blocked with 3% milk in PBST (PBS
containing 0.1% Tween) for 30 min at room temperature
(RT), followed by incubation with either mouse anti 5mC
(1:1000, Eurogentec, Seraing, Belgium) or rabbit anti 5hmC
(1:5000, Active Motif, La Hulpe, Belgium) antibodies for 1
h at RT. The membrane was washed 3× for 10 min with
PBST, before it was incubated with horseradish peroxidase
(HRP)-conjugated anti mouse IgG (1:5000, GE Health-
care, Freiburg, Germany) or anti rabbit IgG (1:5000, Sigma
Aldrich, St. Louis, MO, USA) antibody for 1 h at RT. Af-
ter three washing steps, remaining signals were detected
using Amersham ECL detection reagent (GE Healthcare,
Freiburg, Germany) and imaged on a Fuji LAS-1000 im-
ager (FUJI Film, Minato, Tokio, Japan).
Quantification of 5hmC using a methyl sensitive restriction
assay
ATTO550-labeled 42 bp-long, double-stranded oligonu-
cleotides (GGA TGA TGA CTC TTC TGG TCmC
GGA TGG TAG TTA AGT GTT GAG) (Eurofins MWG
Operon, Ebersberg, Germany) containing a central methy-
lated CpG site were diluted in Tet reaction buffer (50 mM
Tris–HCl; pH 7.5, 75 "M Fe(II), 2 mM sodium ascorbate,
1 mM di-sodium-ketoglutarate) (24,35). Following incuba-
tion with purified GFP-Tet1CD andMecp2-GFP, the reac-
tion was heat-inactivated for 2 min at 95◦C. Subsequently,
oligonucleotides were digested using MspI at 37◦C for 30
min. DNA was separated on a denaturing 17% polyacry-
lamide gel and imaged using the Typhoon TRIO Imager
(GE Healthcare, Freiburg, Germany). Quantification was
performed with ImageJ.
Competitive DNA binding assay
Gel mobility shift assays (EMSA) were performed as de-
scribed previously (http://www.nature.com/nmeth/journal/
v2/n7/abs/nmeth0705-557.html) with following modifica-
tions. GFP-tagged MBD and cherry-tagged Tet1CD pro-
teins were incubated with ATTO647N labeled 42 bp-
long, double-stranded oligonucleotides containing a sin-
gle methylated CpG dinucleotide (5′-CTC AAC AAC TAA
CTA CCA TmCGG ACC AGA AGC GTC ATC ATGG -
3′) in binding buffer composed of 20 mMHEPES pH 7.9, 1
mM EDTA, 3 mM MgCl2, 2 mM DTT, 4% glycerol and
0.1% Triton X100 for 1.5 h at 37◦C. Samples were sepa-
rated on a non-denaturing 4.5% polyacrylamide gel (30%,
29:1 acrylamide:bisacrylamide), which was pre-run for 2 h
at 4◦C. Fluorescent signals were detected using a Storm 860
Molecular Imager (GMI, Ramsey, Minnesota, USA) and
a TECAN infinite M200 plate reader (Tecan Group Ltd.,
Maennedorf, Switzerland), respectively.
Immunofluorescence staining of cells
Cells were fixed for 10 min in 4% formaldehyde and per-
meabilized for 20 min with 0.5% Triton X-100. For detec-
tion of genomic 5hmC, endogenous Tet1 proteins, as well
as NeuN, cells were incubated following formaldehyde fixa-
tion with ice-cold methanol for 5 min. After RNaseA treat-
ment (10 "g/ml) for 30 min at 37◦C, cells were washed and
blocked for 30 min in 0.2% fish skin gelatin (Sigma Aldrich,
St. Louis,MO,USA) at 37◦C.Genomic 5hmCwas detected
using a rabbit anti-5hmC antibody (1:250; Active Motif,
La Hulpe, Belgium) in conjunction with 25 U/ml DNa-
seI (Sigma Aldrich, St. Louis, MO, USA) for 70 min at
37◦C. Endogenous Tet1 and NeuN proteins were detected
using a rat anti Tet1 5D8 antibody (51) (1:4) and a mouse
anti NeuN (1:50, Merck Millipore, Darmstadt, Germany)
in conjunction with 25 U/ml DNaseI (Sigma Aldrich, St.
Louis,MO,USA) for 70min at 37◦C.To stopDNaseI diges-
tion, cells were washed with PBS containing 1 mM EDTA
and 0.01%Tween. Following incubation with the secondary
AMCAconjugated donkey anti rabbit IgG antibody (1:100;
The Jackson Laboratory, Bar Harbor, USA), or the cy3
conjugated anti mouse IgG (1:500; The Jackson Labora-
tory, Bar Harbor, USA) and Alexa488 conjugated donkey
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anti rat IgG antibody (1:500; The Jackson Laboratory, Bar
Harbor, USA) for 45 min at RT, cells were mounted in Vec-
tashield Medium (Vector Labs, Burlingame, CA, USA).
For immunofluorescence staining of Mecp2, fixed and
permeabilized cells were blocked for 30min in 0.2% fish skin
gelatin (Sigma Aldrich, St. Louis, MO, USA). The primary
rabbit anti Mecp2 antibody (32) (1:2) was applied for 1 h at
RT. After three washing steps using PBST containing 0.01%
Tween, the secondary donkey anti rabbit IgG cy3 (1:500,
The JacksonLaboratory, BarHarbor,USA)was applied for
45 min at RT. Following three washing steps in PBST con-
taining 0.01% Tween, DNA was counterstained for 10 min
with 1 "g/ml DAPI (Sigma, St. Louis, MO, USA), washed
in PBS and mounted in Vectashield Medium (Vector Labs,
Burlingame, CA, USA).
Immunofluorescence staining of tissues
Brains of Mecp2 wild type and knockout mice were fixed
for 24 h in 10% neutral-buffered formalin (Sigma, St. Louis,
MO, USA) at 4◦C. Fixed tissues were dehydrated (30 min
70% ethanol (Sigma, St. Louis, MO, USA), 45 min 70%
ethanol, 60 min 96% ethanol, 45 min 96% ethanol, 45 min
100% ethanol, 45 min 100% ethanol, 60 min xylol (Sigma,
St. Louis, MO, USA), 30 min xylol), embedded in paraf-
fin (60 min paraffin (Carl Roth, Karlsruhe, Germany), 45
min paraffin, 60 min paraffin) and sectioned at a thickness
of 6 "m. Following dewaxing in xylol (3 × 5 min) and re-
hydration (5 min 100% ethanol, 5 min 96% ethanol, 5 min
90% ethanol, 5 min 80% ethanol, 5 min 70% ethanol, 5
min ddH2O), brain sections were incubated for 30 min at
100◦C/1 bar overpressure in 10 mM sodium citrate buffer,
pH 6 (Carl Roth, Karlsruhe, Germany). Sections were en-
circled using a hydrophobic immuno-pen (Merck Milli-
pore, Darmstadt, Germany) and blocked for 30 min in
PBS containing 4% BSA. Primary antibodies (rabbit anti
5hmC (1:1000, Active Motif, La Hulpe, Belgium), mouse
anti Mecp2 8D11 (32) (1:2), mouse anti 5mC (1:100, Euro-
gentec, Seraing, Belgium), mouse anti NeuN (1:100, Merck
Millipore, Darmstadt, Germany) and rat anti Tet1 5D8 (51)
(1:2), respectively) were applied overnight in PBS supple-
mented with 1% BSA at 4◦C. After three washing steps
using PBS containing 0.1% Tween, secondary antibodies
(donkey anti rabbit IgG cy3 (1:500, The Jackson Labora-
tory, Bar Harbor, USA), donkey anti rat IgG cy3 (1:500,
The Jackson Laboratory, Bar Harbor, USA) and donkey
anti mouse IgG cy3 (1:500, The Jackson Laboratory, Bar
Harbor, USA)) were respectively applied for 1 h at RT.
Following three washing steps in PBS containing 0.1%
Tween, DNA was counterstained for 10 min with 1 "g/ml
DAPI (Sigma, St. Louis, MO, USA), washed in PBS and
mounted in VectashieldMedium (Vector Labs, Burlingame,
CA, USA).
Major satellite RNA FISH
For the detection of major satellite RNA transcripts,
cDNA probes were amplified and labeled from genomic
DNA of mouse myoblasts by PCR (major satellite fwd: 5′
AAAATGAGAAACATCCACTTG 3′, major satellite rev:
5′ CCATGATTTTCAGTTTTCTT 3′) and biotin dUTP.
Brain sections were prepared as described for immunoflu-
orescence staining of tissues. Following rehydration in wa-
ter, sections were hybridized for 1 h at RT and 12 h at 4◦C.
After three washing steps in water, slides were incubated for
1 h at RT with Alexa-488 conjugated streptavidin (1:500,
Invitrogen, Paisley PA4 9RF, UK). To remove unbound
Streptavidin, slides were washed in water before DNA was
counterstained for 10 min with 1 "g/ml DAPI (Sigma, St.
Louis, MO, USA). Brain sections were rinsed in PBS and
mounted in VectashieldMedium (Vector Labs, Burlingame,
CA, USA). All reagents used for RNA FISH were supple-
mented with 1x ProtectRNA RNase inhibitor (Sigma, St.
Louis,MO,USA).As control, equivalent slides were treated
in parallel with RNase A before signal detection.
Microscopy
Images of transiently transfected, anti 5hmC stainedC2C12
mouse myoblasts were acquired using the Operetta auto-
mated imaging system with a 20× long/0.45 NA objec-
tive (PerkinElmer, UK), a xenon fiber-optic as light source,
360–400, 460–490 and 560–580 nm excitation- and 410–
480, 500–550 and 590–640 emission filters, respectively.
Representative images of the same cells were acquired us-
ing a Leica TCS SP5 II confocal laser scanning micro-
scope (LeicaMicrosystems,Wetzlar, Germany) with a Plan-
Apochromatic 100×/1.44 NA oil objective and 405, 488
and 561 nm excitation lasers.
For the analysis of Mecp2-, 5mC-, 5hmC-, NeuN- and
Tet1 levels, colocalization studies of Mecp2 and 5hmC, as
well as for the detection of major satellite RNA FISH sig-
nals in Mecp2 y/- and wild-type mouse brain, 3D z-stacks
were acquired using the Operetta automated imaging sys-
tem with a 2× long/0.08 and 20× long/0.45 NA objec-
tive (PerkinElmer, UK), a xenon fiber optic as light source,
360–400, 460–490 and 560–580 nm excitation- and 410–480,
500–550 and 590–640 emission filters, respectively.
Image analysis and quantification
Fluorescence intensity histogram quantification of images
acquired on the Operetta automated imaging system (Fig-
ures 1B and 3B) was performed using the Harmony 3.5.1
software (PerkinElmer, UK). Nuclei were detected based
on Tet1CD signals and further selected pursuant to mor-
phology properties (area and roundness). For each nucleus,
mean intensities for Tet1CD- and MBD proteins (Mecp2,
IDTRD, MBD, Mbd2 and Mbd3, respectively), as well as
for 5hmC were calculated. After background subtraction,
nuclei were binned according to (i) Tet1CD signal (sub-
group) and (ii) to MBD signal (sub-subgroup). For each
independent experiment, mean 5hmC level were averaged
per sub-subgroup and normalized to highest 5hmC level of
Tet1CD + GFP transfected cells. To automate this proce-
dure, a routine was written in the programming language
R.
For calculation of mean Mecp2-, 5mC- and 5hmC level
at pericentric heterochromatin of Mecp2 y/- and wild-type
mouse brain (Figure 5), mid-optical sections of the 5mC
channel were used to generate chromocenter (CC) masks.
Therefore, images were processed using a median filter and
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thresholded in three successive steps using the basic algo-
rithm. For the generation of binary chromocenter masks,
all pixels below the final threshold were set to 0 and all pix-
els above the final threshold were set to 1. Total Mecp2-
, 5mC- and 5hmC- signals overlapping with the chromo-
center mask were calculated and divided by the total num-
ber of pixels corresponding to the area of chromocenters.
To automate this procedure, a routine was written in the
programming language python (http://code.google.com/p/
priithon/).
To determine the accumulation of 5hmC at pericentric
heterochromatin in neurons of Mecp2 y/- and wild type
mouse pontes (Supplementary Figure S16D), mean 5hmC
signals at chromocenters were divided by mean 5hmC sig-
nals within the nucleoplasm. Therefore, binary chromocen-
ter masks were generated as described above. Nucleoplasm
masks were prepared by subtracting a second chromocen-
ter mask with larger surface area from a nuclear mask. For
this purpose, chromocenter masks were generated as de-
scribed above, except that mid-optical sections of the 5mC
channel were filtered only once. Binary nuclear masks were
prepared by filtering and thresholding the DAPI channel
as described earlier. To further improve the nuclear mask,
holes were filled using the fill holes algorithm and back-
ground was removed via the watershed algorithm. To cal-
culate mean 5hmC signals at both, chromocenters and nu-
cleoplasm, total 5hmC signals overlappingwith either of the
two masks, were divided by the total number of pixels cor-
responding to the area of chromocenter- and nucleoplasm
masks, respectively. To automate this procedure, a routine
was written in the programming language python.
Colocalization of 5hmC and chromocenters in neurons
of Mecp2 y/- and wild type mouse brain (Figure 6A) was
assessed by the H-coefficient (52) as previously described
(53) and by line profiles generated with ImageJ (http://rsb.
info.nih.gov/ij/).
RNA level of major satellite DNA in neurons of Mecp2
y/- and wild type mouse brain (Figure 6B) were calcu-
lated manually by measuring nuclear RNA FISH signals
along a line through pericentric heterochromatin (50 pixel
in length) using ImageJ (http://rsb.info.nih.gov/ij/) (Supple-
mentary Figure S16A).
For quantification of mean nuclear Tet1 level in wild type
and Mecp2 y/- brain (Supplementary Figure S14), binary
nuclearmaskswere generated as described above. Total Tet1
signals overlapping with the nuclear mask were calculated
and divided by the total number of pixels corresponding to
the nuclear area. To automate this procedure, a routine was
written in the programming language python.
RNA-seq library preparation
Total RNA was isolated from wild type and triple Tet-
knockout mouse embryonic stem cells (V6.5) in biological
quadruplicates using the nucleospin triprep kit (Macherey
Nagel, Du¨ren, Germany). 50 ng RNA was reverse tran-
scribed. cDNA was pre-amplified as described elsewhere
(54). One ng of cDNA was used as input for tagmentation
by the Nextera XT Sample Preparation Kit (Illumina, San
Diego, CA, USA), where a second amplification round was
performed for 12 cycles. For each sample, 2.5 ng of final li-
brary were pooled.
RNA-seq and data analysis
One hundred base pairs single end reads were sequenced
on an Illumina HighSeq 1500. Libraries were barcoded and
mixed before sequencing. The resulting reads were mapped
to the Mouse genome build mm10 using STAR version
STAR 2.5.1b (55) with the specific settings:
–outFilterMultimapNmax 100 –
outFilterMismatchNmax 4 –winAnchorMultimapNmax
→ 100. The junction annotation was taken from ensembl
GRCm38.75 and the index was created as recommended
using the option –sjdbOverhang→ 99.
The resulting bam-files were then processed us-
ing TEtranscript (56) to obtain read count tables
for transcripts and transposons, using the TE an-
notation as provided by the authors of TEtranscript
(http://labshare.cshl.edu/shares/mhammelllab/www-data/
TEToolkit/TE GTF/mm10rmskT E.gtf.gz). Normaliza-
tion and differential expression analysis was done using
DESeq2 (57).
Statistical analyses
For Figures 1A and 3A, Tet1CDmut +GFP andmock were
excluded from statistical tests as the mean values were at
the background level. Homogeneity of variance was tested
beforehand with Levene’s test (using the median). The Lev-
ene’s test did not indicate heterogeneous variances (P> 0.1)
between the groups. Hence, we conducted repeated mea-
sures ANOVA for the three replicates in both experiments,
which showed highly significant results (F4,8 = 46.1, P <
0.001 and F4,8 = 22.7, P< 0.001). Therefore, post-hoc pair-
wise t tests with false discovery rate correction (58) were per-
formed.
For Figures 1B and 3B and Supplementary Figure S4,
we performed Welch’s ANOVA which gave a highly signif-
icant result (F6,97 = 331.4, P < 0.001), since the variances
were heterogeneous (Levene’s test: P < 0.001). Then, we
performed post-hoc pairwise t tests with non-pooled stan-
dard deviations and false discovery rate correction.
For Figure 3B (lower row), since the variances were not
significantly different (Levene’s test: P = 0.19), we com-
pared the means with a t test.
For Figures 2, 3C and 6E, we performed independent
two-sample Student’s t-test.
For Figures 5 and 6A and 6C, as well as Supplementary
Figures S14 and S16, we performed aWilcoxon signed-rank
test.
All statistical tests were conducted with R (https://www.
r-project.org/).
RESULTS AND DISCUSSION
Mecp2 and Mbd2 protect 5-methylcytosine from Tet1 medi-
ated oxidation in a concentration dependent manner
Considering that MBD and Tet proteins share a com-
mon substrate, we aimed at clarifying whether binding of
MBD proteins to methylated DNA protects epigenetically
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Figure 1. Impact of methyl-CpG binding domain proteins on the efficiency of Tet1 mediated 5mC oxidation. (A) Radioactive (top) and immunological
(bottom) assay to determine 5hmC levels in genomic DNA (gDNA) of transiently transfected HEK cells. Schemes (left) illustrate the workflow and mode
of 5hmC detection. Histograms (right) show relative 5hmC levels of three independent experiments +SD. Tet1CD +Mecp2 and Tet1CD +Mbd2 differed
significantly (**P < 0.01; post-hoc pairwise t test) from Tet1CD (see methods for details). gDNA quantities were monitored by methylene blue staining.
Tet1CD corresponds to Tet1 catalytic domain and Tet1CDmut is the catalytic domain of Tet1 containing two point mutations that abolish binding of the
co-factor Fe2+ (see also Supplementary Figure S2). Full blots are shown in Supplementary Figure S1. (B) In situ staining and quantification of genomic
5hmC levels in transiently transfected C2C12 mouse myoblasts. Images were acquired on an automated high throughput imaging system with a 20×, 0.45
NA objective. Gradient heat maps show relative 5hmC ( = cyan) signals as a function of increasing Tet1CD ( = magenta) and MBD ( = green) protein
expression levels depicted by the green and magenta gradient bars. Shown are mean values of five (Tet1CD + GFP, n = 12 798), four (Tet1CD + Mbd2,
n = 2598) or two (Tet1CD + Mecp2, n = 4760; Tet1CD + Mbd3, n = 6449) independent experiments, respectively. For statistical tests, 5hmC signals of
cells with high Tet1CD and high Mecp2/Mbd2/Mbd3 protein levels (framed in grey) were used. Tet1CD + Mecp2 and Tet1CD + Mbd2 differed highly
significantly (***P< 0.001; post-hoc pairwise t test) from Tet1CD+GFP. No significant difference was detected for Tet1CD+Mbd3 (P= 0.34). Confocal
images of mid optical sections of the same samples represent transiently transfected C2C12 mouse myoblasts (Tet1CD = magenta; GFP/MBD proteins
= green) immunostained for 5hmC (5hmC = cyan). Scale bar, 5 "m.
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silenced regions from Tet- mediated DNA demethylation.
To this end, we either radioactively (Figure 1A, top), or im-
munologically (Figure 1A, bottom and Supplementary Fig-
ure S1) labeled and subsequently quantified global 5hmC
levels in genomic DNA of FACS sorted HEK cells express-
ing comparable levels of the catalytic active (Tet1CD) and
inactive domain (Tet1CDmut) of Tet1 alone, or in combi-
nation with Mecp2 and Mbd2, respectively (Figure 1A and
Supplementary Figure S2). When compared to mock and
Tet1CDmut transfected cells, both, the radioactive (Figure
1A, top), as well as the immunological (Figure 1A, bottom)
assay revealed increased 5hmC levels in genomic DNA of
cells expressing the catalytic active domain of Tet1 alone.
Coexpression ofMecp2 orMbd2, however, significantly de-
creased global 5hmC levels by at least 50%, demonstrat-
ing reduced Tet1 effectiveness in the presence of substrate-
competitive proteins.
Further single-cell analysis (Supplementary Figure S3) of
transiently transfected mouse myoblasts (Figure 1B) and
HEK cells (Supplementary Figure S4) immunostained for
5hmC revealed a correlation between Tet1CD protein and
5hmC levels in a subpopulation of cells containing low
Mecp2 (Figure 1B, bottom, left and Supplementary Figure
S4, bottom, left) and Mbd2 (Figure 1B, bottom, right and
Supplementary Figure S4, top, right) protein amounts, re-
spectively. The remainder cells of the population, charac-
terized by high expression levels of the Mbd2 and Mecp2
proteins, in contrast, showed no longer any correlation be-
tween Tet1CD protein levels and the occurrence of its ox-
idation product. Instead, 5hmC levels anti-correlated with
increasing levels ofMecp2 (Figure 1B, bottom, left and Sup-
plementary Figure S4, bottom, left) and Mbd2 (Figure 1B,
bottom, right and Supplementary Figure S4, top, right), re-
spectively, indicating that protection of 5mC from Tet1 cat-
alyzed oxidation highly depends on the MBD protein con-
centration. In contrast to Mecp2 and Mbd2, even the high-
est expression levels of GFP (Figure 1B, top, left and Sup-
plementary Figure S4, top, left) and Mbd3 (Figure 1B, top,
right) proved insufficient to repress Tet1 activity. As both
proteins are not capable of binding to (methylated) DNA
(for Mbd3, see Supplementary Figure S5A), this suggests
that direct interaction with (methylated) DNA is a prereq-
uisite for the effective conservation of 5mC.
To determine, whether the levels of mCherry-Tet1CD ob-
tained through overexpression in mouse myoblasts and hu-
man embryonic kidney cells are within the physiological
range of endogenous Tet1 in primary mouse neurons and
mouse embryonic stem cells (ESCs), we stained all of the
four cell types for Tet1 and quantified the resulting im-
munofluorescent signals (Supplementary Figure S6). To al-
low a direct comparison to the Tet1 expression levels plot-
ted in Figure 1B and Supplementary Figure S4, transiently
transfected mouse myoblasts and HEK cells were binned
according to the ectopic Tet1CD signal (e.g. group 1 of Sup-
plementary Figure S6 corresponds to the first column of
all heatmaps in Figure 1B and Supplementary Figure S4,
respectively). We found that bins 1 and 2 of mouse my-
oblasts, as well as bin 1 of HEK cells express (combined ec-
topic+endogenous) Tet1 levels comparable to mouse ESCs.
As shown previously, the level of overexpressed Mecp2 in
mouse myoblasts is in the range of endogenous physiolog-
ical Mecp2 levels per mouse neuronal cell nucleus (36,59).
Accordingly, cells expressing low Tet1CD protein levels do
not create an artificial phenotype and, thus, reflect the situ-
ation in vivo.
Finally, we immunologically quantified 5hmC levels in
genomic DNA of Mecp2 lox/y and -/y mouse tail fibrob-
lasts (MTF). Compared to the floxed control group (lox/y),
we detected increased 5hmC levels in the corresponding
Mecp2 knockout cell line (-/y), indicating that Mecp2 re-
presses the formation of 5hmC in vivo (Supplementary Fig-
ure S7).
Prior binding of Mecp2 and Mbd2 to 5-methylcytosine en-
hances blocking of Tet1 catalyzed 5-hydroxymethylcytosine
formation in vitro
As described above, Tet1 mediated 5hmC formation is im-
paired by Mecp2 and Mbd2 in vivo. To gain a deeper un-
derstanding of the protective mechanism, we next sought to
determine, whether the chronological order of DNA bind-
ing by MBD and Tet1 proteins would influence the extent
of 5mC protection. Since at the cellular level the chronolog-
ical access of MBD- and Tet1CD proteins to DNA is diffi-
cult to control, we further investigated its influence on 5mC
protection in in vitro experiments. Therefore, various con-
ceivable binding scenarios were systematically mimicked on
a molecular level. Briefly, same molar ratios of Tet1CD and
MBD proteins were incubated simultaneously or consecu-
tively with a PCR fragment containing multiple methylated
cytosines. Following 2 h of Tet1CD incubation, DNA was
blotted on a membrane to then immunologically detect the
amount of remaining unoxidized 5mC, as ameasure of 5mC
protection by MBD proteins (Figure 2A and Supplemen-
tary Figure S8).
Altogether, 5mC levels were comparatively high in any of
the samples containing, in addition to Tet1CD, Mecp2 and
Mbd2 (Figure 2B and C), respectively, indicating restricted
Tet1CD activity in the presence of 5mC binding proteins,
which is in accordance with our in vivo data (Figure 1). In
more detail, when compared to the fully unprotected con-
trol group (DNA + Tet1CD) (Figure 2B and C, first col-
umn), 5mC levels were increased by a factor of 1.9 (Mecp2)
and 1.6 (Mbd2) in samples allowing simultaneous access of
Tet1CDandMBDproteins to their common substrate 5mC
(Figure 2B and C, second column). Incubation of MBD
proteins with the methylated DNA prior to the addition
of Tet1CD enzymes, yielded 5mC signals 3.9 (Mecp2) and
2.1 (Mbd2) fold higher relative to control samples without
MBD proteins (Figure 2B and C, third column). Delayed
addition of methylated DNA to pre-incubated Tet1CD and
MBDproteins resulted in relative 5mC levels of 2.1 (Mecp2)
and 1.3 (Mbd2) (Figure 2B and C, fourth column). Ac-
cordingly, among all tested conditions, early incubation of
MBD proteins with methylated DNA before the addition
of Tet1CD enzymes revealed the highest 5mC signals and,
thus, the best possible protection against Tet1CD catalyzed
oxidation (Figure 2B and C, third column).
As Mecp2 can bind to a single methylated CpG site
(mCpG), we further tested whether the protection against
Tet oxidation could take place on single mCpG containing
substrates. Therefore, we measured the degree of protection
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Figure 2. Influence of the chronological DNA binding order on the pro-
tecting ability of MBD proteins. Quantification of remaining 5mC levels
in 20 pmol of double-stranded DNA containing multiple 5mC nucleotides
after simultaneous or successive incubation with 20 pmol of Tet1CD (cat-
alytic domain) and 20 pmol of MBD proteins by slot blot. (A) Experimen-
tal setup illustrating the incubation order and time of proteins and oligos
prior slot blotting. (B and C) Histograms show relative 5mC levels of 5mC
containing PCR product after incubation with (B) Tet1CD and Mecp2 (n
= 4) and (C) Tet1CD andMbd2 (n= 4). Shown aremean values + SD. Sig-
nificant differences were detected for pre-incubation of Mecp2 and Mbd2
with DNA (*P< 0.05; ns= non significant; post-hoc pairwise t tests). Full
blots are shown in Supplementary Figure S8.
over time using a methyl sensitive restriction endonuclease
assay (35). Consistent with our previous results, single 5mC
containing, double-stranded oligonucleotides that were pre-
incubated with Mecp2 lost the least amount of 5mC. Even
after 2.5-h treatment with Tet1CD, the presence of Mecp2
(previously incubated with DNA) protected 80% of 5mC
from oxidation versus only 20% of 5mC surviving in the ab-
sence of Mecp2 (Supplementary Figure S9).
On this basis, we conclude that binding of MBD pro-
teins to DNA, especially prior binding provides the great-
est contribution towards preserving the methylation status
of CpG dinucleotides. Alternatively, protein-protein inter-
actions, which could have formed most effectively by pre-
incubation of Tet1CDandMBDproteins, do not play a role
in protecting DNA from Tet1CD driven oxidation.
Direct binding to DNA is sufficient to effectively prevent 5mC
oxidation by Tet1
As indicated earlier, Mecp2 contains various different inter-
action sites for DNA. While the IDTRD domain of Mecp2
was shown to bind both, methylated and unmethylated
DNA with similar affinity (9,10,15), the MBD domain of
Mecp2 has a preference for methylated CpG dinucleotides
(14,60).
To test whether and which of the above-mentioned bind-
ing mode is responsible for the conservation of 5mC, we
tested the protecting ability of both Mecp2 subdomains us-
ing the battery of assays employed before (Figure 1 and Fig-
ure 2). Quantification of 5hmC levels in genomic DNA of
humanHEK cells revealed that both subdomains ofMecp2
avert Tet1CD mediated 5mC oxidation to a similar extent,
indicating that the adverse impact on Tet1CD activity does
not directly correlate with 5mC affinity (Figure 3A). To fur-
ther test this conclusion, we measured the protective effect
of full length Mecp2 proteins carrying an R111G mutation
in theirMBDdomain.Whilemutation of arginine 111 abol-
ishes binding to 5mC in vitro and to methylated heterochro-
matin in vivo (61), the mutant protein is still able to interact
with unmethylated DNA in a sequence unspecific manner.
Accordingly, it shifts 5mC containing DNA in the absence,
but less efficiently in the presence of poly dI:dC competi-
tor DNA (Supplementary Figure S5B). As cells expressing
this mutant Mecp2 variant also exhibited low 5hmC levels
(Supplementary Figure S10A left), we deduce that sequence
unspecificDNA interactions, considerably contribute to de-
fending 5mC from Tet1CDmediated oxidation. Additional
5mC recognition by a functional MBD, as demonstrated
by wild type Mecp2, improved the protecting ability only
marginally (Supplementary Figure S10A left). Indeed, we
found that two proteins specifically binding major satellite
DNA sequences independent ofmethylation, the polydactyl
zinc fingerMaSat (62), as well as the transcription activator-
like effector protein msTALE (63), repressed the formation
of 5hmC in situ (Supplementary Figure S10A, right). Thus,
5mC recognition by the MBD is unlikely to per se play a
major role in the protective mechanism.
To validate and extend these results, we immunostained
and quantified genomic 5hmC levels in single C2C12mouse
myoblasts (Figure 3B) and HEK cells (Supplementary Fig-
ure S4). Similar to C2C12 and HEK cells coexpressing
Mecp2 and Mbd2 (Figure 1B and Supplementary Fig-
ure S4), genomic 5hmC content correlated with Tet1CD
protein levels in a subpopulation of cells containing low
IDTRD protein amounts (Figure 3B, top, left and Supple-
mentary Figure S4, bottom, middle; rows 3 and 4 from top
to bottom). Cells, characterized by high expression levels of
IDTRD proteins, in contrast, showed no longer any cor-
relation between Tet1CD protein levels and its oxidation
product. Instead, 5hmC levels anti-correlated with increas-
ing levels of IDTRD (Figure 3B, top, left and Supplemen-
tary Figure S4, bottom, middle; rows 1 and 2 from top to
bottom). In C2C12 cells, the MBD domain of Mecp2 re-
pressed merely the catalytic activity of a small number of
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Figure 3. Effect of different DNA binding modes on Tet1 activity. (A) Radioactive (top) and immunological (bottom) assay to determine 5hmC levels
in genomic DNA (gDNA) of transiently transfected HEK cells. Histograms show relative 5hmC levels of three independent experiments + SD. Tet1CD
+ IDTRD and Tet1CD + MBD differed significantly (**P < 0.01; post-hoc pairwise t tests) from Tet1CD + GFP. gDNA quantities were monitored by
methylene blue staining. Tet1CD corresponds to Tet1 catalytic domain and IDTRD and MBD correspond to the subdomains of Mecp2 (Supplementary
Figure S2). Full blots are shown in Supplementary Figure S8. (B) In situ staining and quantification of genomic 5hmC levels in transiently transfected
C2C12 mouse myoblasts. Images were acquired on an automated high throughput imaging system with a 20×, 0.45 NA objective. Gradient heat maps
show relative 5hmC ( = cyan) signals as a function of Tet1CD ( = magenta) and Mecp2 subdomain ( = green) levels depicted by the green and magenta
gradient bars. Shown are mean values of two (Tet1CD+IDTRD, n = 6495; Tet1CD + MBD, n = 1800) independent experiments. (B, upper row) For
statistical tests, 5hmC signals of cells with high Tet1CD and high IDTRD/MBD protein levels (framed in gray) were used. Tet1CD + IDTRD differed
highly significantly (***P < 0.001; post-hoc pairwise t tests) from Tet1CD + GFP (see Figure 1B). Weakly significant difference was detected for Tet1CD
+ MBD (*P < 0.05; post-hoc pairwise t tests). (B, lower row). For statistical tests, 5hmC signals of cells with low Tet1CD and high MBD protein levels
were used. From these, we selected the values framed in black. Highly significant differences were detected between both groups (***P < 0.001; t test).
Confocal images of mid optical sections of the same samples represent transiently transfected C2C12 mouse myoblasts (Tet1CD = magenta; GFP/MBD
proteins = green) immunostained for 5hmC (5hmC = cyan). Scale bar, 5 "m. (C) Quantification of remaining 5mC levels in double-stranded methylated
DNA after simultaneous or successive incubation with Tet1CD proteins and Mecp2 subdomains by slot blot. Scheme illustrates the incubation order and
time of proteins and methylated DNA prior slot blotting. Histograms show relative 5mC signals after incubation with Tet1CD and IDTRD (n= 4), as well
as Tet1CD and MBD (n = 5), respectively. Shown are mean values + SD. Significant differences were detected for pre-incubation of IDTRD with DNA
and for simultaneous incubation of IDTRD, Tet1CD and DNA (*P< 0.05; ns= non significant; post-hoc pairwise t tests). For MBD, a similar trend was
detected, however, without statistical significance.
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Tet1CD molecules (Figure 3B, top, right (columns 1 and 2
from left to right) and Figure 3B, bottom). In the presence
of high Tet1CD protein amounts, even the highest MBD
protein concentrations failed to repress the formation of
5hmC by Tet1CD (Figure 3B, top, right (columns 3 and
4 from left to right)). In HEK cells, which expressed ec-
topic proteins at a substantially higher level per cell than
the previously analyzedC2C12 cells (Supplementary Figure
S11 and Supplementary Figure S6), however, MBD protein
levels were sufficient to avert the catalytic activity of low
to high Tet1CD protein levels (Supplementary Figure S4,
bottom, right). Accordingly, we conclude that the extent of
5mC protection substantially depends on the concentration
ofMBD and IDTRDmolecules per cell as it determines the
coverage of DNA in a sequence-unspecific manner (see also
Figure 4).
Similar to the MBD domain of Mecp2, Mbd2 has been
shown to preferentially bind 5mC (64,65). In contrast,
though, Mbd2 was more efficient than theMBD in protect-
ing 5mC from oxidation (Figures 1 and 3). To test whether
binding kinetics in vivo may contribute to 5mC protection,
we performed fluorescence recovery after photobleaching
(FRAP) experiments. Whereas the MBD showed fast re-
covery at pericentric heterochromatin with halftimes of 2
s, Mbd2 recovered 15-fold slower after photobleaching (30
s) (Supplementary Figure S10B and S10C). Hence, we pro-
pose that long retention times of Mbd2 at methylated cy-
tosines improve the efficiency of 5mC protection. However,
since the IDTRD subdomain depicted similar fast recovery
kinetics (2 s) like the MBD domain (Supplementary Figure
S10B and 10C) but was more efficient in protecting 5mC,
we deduce that additional sequence-unspecific DNA bind-
ing parameters (e.g. stoichiometry) must play a role.
Finally, in vitro 5mC oxidation studies using a PCR frag-
ment containing multiple methylated cytosines showed that
similar to Mecp2 and Mbd2, prior binding of MBD and
IDTRD to DNA additionally strengthens the conservation
of 5mC (Figure 3C and Supplementary Figure S8).
In summary, these data highlight the complexity of the
MBD based 5mC protection mechanism, which achieves
best performance through prior and long lasting coverage
of DNA in a sequence-unspecific manner. It also differs
from previous reports (66) suggesting that 5mC binding per
se is critical to protect from oxidation.
Binding of Mecp2 to DNA impairs the DNA binding ability
of Tet1CD in vitro
Tet-mediated oxidation of 5mC was recently described as a
complex, multistep process, initiated by the binding of Tet
proteins to DNA via hydrophobic interactions, followed by
recognition of 5mC in CpG context, base flipping and oxi-
dation (67,68).
To investigate how prior binding of MBD proteins to
DNA protects 5mC from Tet catalyzed oxidation (Figures
1-3), we next analyzed which of the above-mentioned step
is affected. To this end, we tested the DNA binding abil-
ity of Tet proteins, considered as the first step towards 5mC
oxidation, in the presence of low and high concentrations
of 5mC specific (MBD, Figure 4B and Supplementary Fig-
ure S12B), as well as sequence-unspecific (IDTRD, Figure
4C and Supplementary Figure S12B) Mecp2 DNA binding
domains by electrophoretic mobility shift assays (EMSAs)
(Figure 4 and Supplementary Figure S12A).
To validate that both Mecp2 subdomains bind to DNA
under the given reaction conditions, we initially verified
their efficiency to form complexes with short double-
stranded (ds), single 5mC-containing DNA in the ab-
sence of Tet1CD proteins (Figure 4A–C, first and second
row). While incubation of DNA with low substoichiomet-
ric MBD (Figure 4B, first row) and IDTRD (Figure 4C,
first row) protein concentrations, resulted in a single, slow
migrating band, increasing protein amounts (Figure 4B-C,
second row) gave rise to an additional highmolecular super-
shift, originating from additive accumulation of proteins to
an already bound DNA molecule. Hence, our data prove
the suitability of the present reaction conditions. Further-
more, it indicates that at high protein levels, where most of
the unbound DNA substrate is depleted, multiple binding
of either Mecp2 subdomain to the same DNA fragment is
promoted (Figure 4A–C, compare first and second rows).
As the ratio of high molecular weight versus low molecu-
lar weight shifted DNA in the IDTRD is higher than with
the MBD, we conclude that the IDTRD of Mecp2 is more
efficient in fully covering DNA molecules than the MBD
(Figure 4B and C, second row).
Addition of Tet1CD molecules (Supplementary Fig-
ure S12B) to single 5mC containing dsDNA, which was
pre-incubated with low protein amounts of the MBD or
IDTRD, respectively, resulted in two discrete prominent
DNA shifts (Figure 4A–C, third row). While the fast mi-
gratingDNAco-localizedwithMBD (Figure 4B, third row)
and IDTRD (Figure 4C, third row) protein signals, respec-
tively, the highmolecularDNAband coincidedwith protein
signals for the catalytic domain of Tet1 (Figure 4B and C,
third row). Consequently, our data indicate that in the pres-
ence of low competitive protein concentrations and excess
availability of uncovered DNA substrate, Tet1CD binds to
DNA without compromising efficiency (Figure 4B and C,
third row). Pre-incubation of dsDNA with a higher num-
ber of IDTRD molecules, in contrast, greatly diminished
Tet1CD signals (arrowhead), which instead strongly colo-
calized with signals derived from IDTRD proteins (arrow,
Figure 4C, fourth row). Thus, we conclude that under the
present reaction conditions, under which most of the DNA
substrate is covered by IDTRD molecules (Figure 4C, sec-
ond row), binding of Tet1 proteins to their common sub-
strate is almost entirely averted. Similar to the IDTRD,
however, as a result of lower DNA coverage, less signifi-
cant, higher protein level of MBD (arrow) reduced the for-
mation of Tet1-DNA complexes (arrowhead) (Figure 4B,
fourth row). Similar results were obtained with equimolar
amounts of MBD/IDTRD and Tet1CD proteins (Supple-
mentary Figure S13).
In summary, these data demonstrate that the amount
of free Tet1CD enzyme highly correlates with the number
of bound methyl-CpG binding domain proteins per DNA
molecule. Hence, we conclude that binding of MBD pro-
teins to DNA protects 5mC from oxidation by restricting
access of Tet1CD enzymes to DNA, whereby any further
steps of the oxidation procedure are inhibited. Besides this,
we deduce that the efficiency of Tet DNA binding inhibi-
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tion, which is proportional to DNA coverage byMBD pro-
teins, may differ from cell type to cell type, as the binding
mode ofMBD proteins is strongly affected by DNAmethy-
lation density and binding partners (14).
The Tet oxidation product 5hmC is enriched in neurons of a
mouse model for Rett syndrome
As we found that Mecp2 represses Tet1-mediated 5mC ox-
idation in vivo (Figure 1) and in vitro (Figure 2), we next
tested whether the previously reported transcriptional in-
crease of repetitive elements in Mecp2 knockout brain (20),
may be considered as pathophysiological consequence of
unconfined Tet activity. To address this hypothesis, we ana-
lyzed genomic 5mC- and 5hmC levels in the pons (Supple-
mentary Figures S14A and S15) of a mouse model for Rett
syndrome (Mecp2−/ytm1.1Bird), which was previously identi-
fied as brain region partially responsible for the devastating
breathing disturbances observed in Rett patients (69). Since
in wild type brainMecp2 was primarily found at pericentric
heterochromatin of neurons (Figure 5A and Supplementary
Figure S14B and C), we consequently focused our analysis
to these chromatin regions, which in mouse cells assemble
into higher order aggregates known as chromocenters (CC)
(Supplementary Figure S15).
While knockout of Mecp2 had little effect on the distri-
bution of pericentric 5mC levels (Figure 5B), the amount
of the Tet oxidation product 5hmC was significantly in-
creased at chromocenters ofMecp2 deficient neurons of the
pons (Figure 5C), which is in agreement with previous data
(66). Using LC–MS it has been shown in different brain re-
gions, that 4.5% of all cytosines are methylated and 5mC
levels do not change between regions. Moreover, 5hmC lev-
els were shown to vary between 0.3% and 0.6%, with an av-
erage 0.45%, i.e. 10 times lower than 5mC (70). Using sim-
ilar methods, Wu and colleagues showed that the distribu-
tion of 5hmC, but not of 5mC, varies between tissues. They,
furthermore, showed that in Tet1 knockdown ES cells, al-
though the 5hmC decreased to less than half of the control
cells, 5mC did not change (71), which is similar to our re-
sults. As we measured a change of 40% for 5hmC in Mecp2
knockout relative to wild type neurons, we would expect
maximally 4% change of 5mC levels in a pure population
of neuronal cells. According to Mu¨nzel et al. (70) the max-
imally expected change of 4% lies within the experimental
error rate (±5% for 5mC and 5hmC) and is, therefore, most
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likely not detectable as our results indicate. Importantly, it
should be noted that the increase in 5hmC was not due to
enhanced Tet1 expression as wild type and Mecp2 deficient
neurons had comparable Tet1 levels (Supplementary Figure
S14D and E).
In conclusion, our data demonstrate on the subcellular
level that knockout of Mecp2 results in increased neuronal
5hmC levels.We cannot exclude that other secondary effects
may contribute to the increase of 5hmC at chromocenters in
vivo. However, expression ofMecp2 in cells that do not nor-
mally express endogenous Mecp2 (mouse myoblasts, Fig-
ure 1B), decreases Tet-mediated oxidation of 5mC. The only
difference between both sets of cells is the presence or not
ofMecp2. Hence, according to our cell data (Figure 1A and
B), unconfined access of Tet1 proteins to pericentric hete-
rochromatin, which is occupied when Mecp2 is present, is
very likely the dominant mechanism that allows 5hmC ac-
cumulation at pericentric heterochromatin.
Previous data showed that both, Mecp2 protein and
5hmC levels are high in neurons. To address this apparent
contradictory coexistence, we furthermore analyzed the ex-
pression of Tet1 in different cell types and found high lev-
els of the 5mC oxygenase Tet1 in NeuN positive compared
to surrounding glial cells (Supplementary Figure S14A–
C). Furthermore, we found the degree of colocalization be-
tween pericentric heterochromatin and 5hmC considerably
increased as a consequence of Mecp2 depletion. While in
wild-type brain, 5hmC is anti-correlated with DNA dense
chromocenters, this is not the case for Mecp2 deficient neu-
rons (Figure 6A, top). Similar results were obtained from
line intensity plots of 5hmC distribution through pericen-
tric heterochromatin (Figure 6B), as well as accumulation
studies of 5hmC at chromocenters (Supplementary Figure
S16D). Accordingly, 5hmC is indeed abundant in neurons
of wild-type mice, however, only at sites of low Mecp2 ac-
cumulation. Therefore, Mecp2 has a local protective effect
at pericentric heterochromatin.
In the absence ofMecp2, Tet1 reactivates expression of major
satellite repeats
Next, we tested whether hypomethylation of chromocen-
ters (Figures 5 and 6A, B), which were previously described
to be rich in major satellite repeats (72), leads to reacti-
vation of these epigenetically silenced elements. Hence, we
labeled and subsequently quantified (Supplementary Fig-
ure S16A and B) their RNA transcript levels by fluores-
cence in situ hybridization (FISH) in single cells of Mecp2
knockout mouse cerebella (Figure 6C). Compared to wild
type, mean major satellite RNA FISH signals were signifi-
cantly increased in nuclei of Mecp2 deficient cells (Figure
6C). Moreover, line intensity profiles of RNA FISH lev-
els across chromocenters of the same nuclei, showed ac-
cumulation of major satellite transcripts directly at and in
close proximity to pericentric heterochromatin (Figure 6D).
To ensure that the observed transcriptional increase of ma-
jor satellite DNA is not limited to the analyzed brain re-
gion, we additionally confirmed its elevated expression lev-
els in wholeMecp2 y/- mouse brain by reverse transcription
quantitative polymerase chain reaction (RT-qPCR) (Fig-
ure 6E, right). Moreover, we made use of C2C12 mouse
myoblasts, which show no detectable levels of Mecp2 and
Mbd2 (Supplementary Figure S16C, top; (19)) and, thus,
allowed us to directly test the effect of Tet proteins on
the expression of DNA repeats. Hence, mouse myoblasts
ectopically expressing the catalytic active domain of Tet1
were sorted by flow cytometry and the transcriptional lev-
els of major satellite repeats were quantified by RT-qPCR.
When compared to mock treated cells, major satellite RNA
transcripts were increased in mouse myoblasts, congenitally
lacking Mecp2 (Supplementary Figure S16C, top) and ec-
topically expressing Tet1CD (Figure 6E, left). Coexpression
of Mecp2, however, abolished Tet1CD-mediated reactiva-
tion of major satellite repeats and reduced major satellite
transcription by half when compared to mock treated cells
(Figure 6E, left). While transcription level of major satel-
lite repeats almost doubled upon ectopic expression of the
catalytically active Tet1 domain, overexpression of the inac-
tive variant resulted in an increase of only 40% (Figure 6E,
left). Accordingly, we conclude that the induction of major
satellite expression requires at least in part the catalytic ac-
tivity of Tet1 and, thus, results from increased 5hmC levels.
As overexpression of both, the catalytically active and inac-
tive domain of Tet1 leads to decondensation of pericentric
heterochromatin (Zhang et al., submitted), we furthermore
deduce that the 40% increase of major satellite expression in
cells expressing mutant Tet1CD, might be partially caused
by reorganization of chromatin to a more open and, thus,
accessible state.
Finally, we analyzed expression of satellite elements in
triple Tet-knockout (KO) and wild type (wt) mouse embry-
onic stem cells (ESC) by RNA-seq. The median log2-fold
change was -0.99, indicating that the expression of most ge-
nomic satellite sequences is down-regulated upon Tet1/2/3
depletion (Figure 6F). Taken together, our data demon-
strate that in the absence of Mecp2, Tet1 reactivates the ex-
pression of epigenetically silenced (major) satellite repeats,
which in turn might compromise genome stability (73,74).
Therefore, we suggest that unrestricted Tet activity may be
part of a pathogenic cascade in Rett syndrome, which is
initiated by Mecp2 gene mutations that reduce or abolish
DNA binding.
In the present study, we demonstrate that prior binding of
methyl-CpG binding domain proteins Mecp2 andMbd2 to
DNA protects 5mC from Tet1CD mediated oxidation in a
concentration dependent manner, thereby regulating chro-
matin composition (Figure 7A).
←−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
Expression levels are relative to Tet1CD transfected cells (left), or wild type mouse brain (right). Shown are average values from≥ two biological replicates
each measured from one (left), or two (right) independent cDNA synthesis reactions, respectively. Error bars represent ± SD. P values were calculated
by an independent two-sample student’s t-test (*P < 0.05, **P = 0.01, ***P < 0.001). (F) Violin-plot of the log2-fold changes of the triple Tet-knockout
(KO) relative to wild type (wt) mouse embryonic stem cells (ESC (v6.5)) for all genes and all satellites. Negative values indicate a down-regulation in the
knockout cells relative to the wild type, positive values an up-regulation. Significant elements are marked in color. The red line is at zero, i.e. the expected
value if expression were identical in the wild type and knockout. Triple Tet-knockout: P = 4.84 × 10−2; genes: P = 5 × 10−15.
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Figure 7. Mecp2 and Mbd2 preserve chromatin composition and thus genomic integrity by insulating 5mC from Tet1 activity. Scheme summarizing the
main conclusions drawn from our studies. (A) We show that Mecp2 and Mbd2 protect 5mC from Tet1-mediated oxidation in a concentration dependent
manner in vivo and in vitro. (B) The protection mechanism is not based on competition for 5mC per se but rather on sequence unspecific coverage of DNA
and correlates with the respective MBD protein dwell time on DNA. (A) As a biological consequence, we measured increased 5hmC level in neurons of a
mouse model for Rett syndrome with concomitant reactivation of epigenetically silenced pericentric DNA repeats.
The underlying molecular mechanism relies on compet-
itive, sequence unspecific coverage of DNA and is affected
by the respective MBD protein dwell time on DNA (Fig-
ure 7B). Accordingly, Tet binding to its substrate and, con-
sequently, 5mC modification are inhibited and chromatin
composition maintained. Hence, we infer that Tet1 activity
is likely to vary according to tissue and cell specific distri-
bution of methylated CpG sites, as it influences the bind-
ing affinity ofMBDproteins (15). Furthermore, we propose
that the quantity of methyl-CpG binding domainmolecules
per cell must be precisely regulated to accurately control
Tet1 activity. Indeed, either duplication of theMECP2 gene
with increased respective protein level or mutant MECP2
proteins with impaired DNA binding, are both observed in
Rett patients (61,75).
As a biological consequence, we measured increased
5hmC at pericentric heterochromatin in neurons of Mecp2
deficient mice with concomitant reactivation of epigeneti-
cally silenced major satellite repeats (Figure 7A). Compen-
satory effects by Mbd2 cannot come into play as its ex-
pression levels are significantly reduced in Mecp2 knock-
out brain (49). As Tet1 reactivates transcription of major
satellite repeats in the absence of Mecp2 and Mbd2 pro-
teins, we conclude that the transcriptional noise increase in
Rett animal models (20) is likely to result, at least in part,
from unconfined Tet activity and, thus, provide a potential
Tet-induced pathophysiological pathway in Rett syndrome.
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Since almost allmature, postmitotitc neuronswere shown
to express abundant levels ofmethyltransferasesDnmt1 and
Dnmt3a (76,77), we propose that stabilization or reversion
of Rett symptoms upon delivery of Mecp2 (78) results from
re-methylation and subsequent binding and protection of
5mC by the exogenous wild type Mecp2 protein.
In summary, these data provide mechanistic insights into
the regulation of Tet1 activity by methyl-CpG binding do-
main proteins and argue for a role of the MBD proteins as
guardians of the epigenome.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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 Supplementary Figures 
 
 
 
Supplementary Figure 1. Full slot blots used for the quantification of 5hmC in genomic DNA 
(gDNA) of transiently transfected HEK cells (Figure 1a, bottom). (left) anti 5hmC. (right) 
Methylene blue staining. 
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Supplementary Figure 2. Western blot analysis of Tet1CD and MBD protein levels of transiently 
transfected, FACS sorted HEK cells 
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 (a) Representative schemes of proteins that were used for in vitro and in vivo studies. Tet1CD 
corresponds to the Tet1 catalytic domain (aa 1365-2057) and Tet1CDmut is the catalytically inactive 
domain of Tet1 (aa 1365-2057) containing two point mutations (H1652Y, D1654A) that abolish binding 
of the co-factor Fe2+. Magenta colored star=mCherry; green colored star=GFP; yellow colored 
star=YFP. Cys=cysteine rich region; DSBH=double stranded beta helix; MBD=methyl CpG binding 
domain; TRD=transcriptional repression domain. (b) Shown are GFP or YFP-tagged Mecp2, IDTRD, 
MBD and Mbd2 (green, anti GFP), as well as, mCherry-tagged Tet1CD and Tet1CDmut (magenta, 
anti RED) proteins of transiently transfected HEK cells after enrichment for double-transfected cells by 
Fluorescent Activated Cell Sorting (FACS). Proliferating cell nuclear antigen (PCNA) was used as a 
loading control. Tet1CD expression levels are similar in cells coexpressing MBD proteins and 
comparatively low in cells coexpressing GFP. Accordingly, decreased genomic 5hmC levels observed 
in cells coexpressing MBD proteins (Fig. 1 and Fig. 3) are not due to lower Tet1CD expression levels. 
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 Supplementary Figure 3. Summary of the different steps used for quantification and 
normalization of genomic 5hmC levels in transiently transfected C2C12 mouse myoblasts 
(1) Cell nuclei segmentation according to Tet1 signals. (2) Nuclei area and roundness calculation. (3) 
Selection of cell populations based on morphology properties. (4) Calculation of mean Tet1CD-, MBD- 
and 5hmC intensities. (5) Normalization of mean hmC signals to background. (6) Sort cells according 
to Tet1 signals. (7) Bin cells based on mean Tet1 intensities. (8) Sort cells within subgroups (7) 
according to mean MBD intensities. (9) Bin cells within subgroups (7) based on MBD intensities. (10) 
Average mean 5hmC intensities of each sub-subgroup (9). (11) Remove outliers. (12) Normalize 
mean 5hmC signals of each sub-subgroup (10) to highest 5hmC level of Tet1CD + GFP transfected 
cells and plot in form of a heat map as a function of Tet1CD- and MBD protein expression levels. 
 
 
 
 
Supplementary Figure 4. Effect of methyl-CpG binding domain proteins on Tet1CD activity in 
human embryonic kidney cells 
In situ staining and quantification of genomic 5hmC levels in transiently transfected human embryonic 
kidney (HEK) cells. Images were acquired on an automated high throughput imaging system with a 
20x, 0.45 NA objective. Gradient heat maps show relative 5hmC (=cyan) signals as a function of 
increasing Tet1CD (=magenta) and MBD (=green) protein expression levels depicted by the green 
and magenta gradient bars. Shown are mean values of three (Tet1CD+GFP, n=38840; 
Tet1CDmut+GFP, n=53761; Tet1CD+Mbd2, n=39572; Tet1CD+Mecp2, n=41568; Tet1CD+IDTRD, 
n=30919; Tet1CD+MBD, n=32957) independent experiments, respectively. For statistical tests, 5hmC 
signals of cells with high Tet1CD and high Mecp2/Mbd2/Mbd3 protein levels (framed in grey) were 
used. All samples differed highly significant (***; p < 0.001; post-hoc pairwise t test) from 
Tet1CD+GFP.  
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Supplementary Figure 5. Binding properties of Mecp2, Mbd3 and Mecp2R111G to methylated 
DNA. (a) Electrophoretic mobility shift assay (EMSA) of methylated DNA (red) with Mecp2 and Mbd3 
(green) in the absence (left) and presence (right) of poly di:dC. (b) Electrophoretic mobility shift assay 
(EMSA) of methylated DNA (red) with Mecp2 and Mecp2R111G (green) in the absence (left) and 
presence (right) of poly di:dC. 
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Supplementary Figure 6. Estimation of the level of mCherry-Tet1CD in transfected mouse 
myoblasts and human embryonic kidney cells. In situ staining and quantification of Tet1 in 
mCherry-Tet1CD transfected mouse myoblasts (n=2704) and human embryonic kidney cells 
(n=11025), as well as untransfected primary mouse neurons (n=102) and mouse embryonic stem 
cells (n=373). Images were acquired on an automated high throughput imaging system with a 20x, 
0.45 NA objective. Mouse myoblast and human embryonic kidney cells were binned (as in Figure 1b 
and 3b) according to the ectopic mCherry-Tet1CD expression levels. Box plots represent the total 
nuclear Tet1 signal (endogenous + ectopic), as well as the first and third quartiles. Whiskers extend to 
1.5 times the interquartile range. 
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Supplementary Figure 7. Genomic 5hmC level in the presence and absence of Mecp2 in mouse 
tail fibroblast (MTF) cells. Immunological assay to determine 5hmC levels in genomic DNA (gDNA) 
of wild type (lox/y) and Mecp2 knockout (-/y) MTF cells. gDNA quantities were monitored by 
methylene blue staining. 
 
 
 
 
4.1 Binding of MBD proteins to DNA blocks Tet1 function thereby modulating transcriptional noise
65
  
 
Supplementary Figure 8. Full slot blots used for the quantification of remaining 5mC in double-
stranded DNA after simultaneous or successive incubation with Tet1CD and MBD proteins 
(see Fig. 2 and Fig. 3c). (a) Experimental setup illustrating the incubation order and time of proteins 
and methylated PCR product prior slot blotting. To be able to assign each of the four groups to the 
individual slots of the slot blots, they were labeled as A, B, C and D, respectively. (b) One 
representative full slot blot for IDTRD, Mecp2, Mbd2 and MBD. Unmarked slots are unrelated to the 
figure. 
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Supplementary Figure 9. Influence of the chronological DNA binding order on the protecting 
ability of MBD proteins over time 
Quantification of remaining 5mC levels in single 5mC-containing oligos after simultaneous and 
successive incubation with Tet1CD- and Mecp2 proteins by MspI digest. (a) Experimental setup 
illustrating the incubation order and time of proteins and oligos prior MspI restriction digest. When 
Tet1 oxidizes 5mC in the context of CCGG, the cleavable MspI site becomes uncleavable. (b) 
Diagram shows relative 5mC levels of single 5mC containing oligos after incubation with Tet1CD and 
Mecp2 (n=2). Incubation of Tet1CD with methylated oligos in the absence of its cofactor α-
ketoglutarat was used as a negative control (grey line). Shown are mean values +/-SD.  
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Supplementary Figure 10. Contribution of direct and long-lasting 5mC binding to the 
protection of 5mC from Tet1CD catalyzed oxidation 
(a) In situ staining and quantification of genomic 5hmC levels in transiently transfected C2C12 mouse 
myoblasts. Shown are relative 5hmC (=cyan) signals as a function of Tet1CD (=magenta) level 
represented as gradient bars. (a, left) Error bars represent standard deviation. Mean values of two 
independent experiments are plotted (Tet1CD+GFP, n=2255; Tet1CD+Mecp2, n=2351; Tet1CD+ 
R111G, n=3244; n=number of cells). (a, right) Mean values of three independent experiments are 
plotted (Tet1CD+GFP, n=17741; Tet1CD+Mecp2, n=27130; Tet1CD+MaSat, n=15149; 
Tet1CD+msTALE, n=18593) (b) Accumulation kinetics of Mbd2, Mecp2, MBD and IDTRD to 
pericentric heterochromatin in C2C12 mouse myoblasts. (c) Plateau level of accumulation curves. 
Box plots show the median accumulation of MBD proteins to pericentric heterochromatin (IDTRD, 
n=14; MBD, n=19; Mbd2, n=6; Mecp2, n=10; n=number of cells), as well as the first and third 
quartiles. Whiskers extend to 1.5 times the interquartile range.  
 
 
4 RESULTS
68
  
 
Supplementary Figure 11. Expression levels of Tet1CD and MBD in HEK versus C2C12 cells 
Flow cytometry analysis of (a) HEK and (b) C2C12 cells ectopically coexpressing mCherry-tagged 
Tet1CD and the YFP-tagged MBD domain of Mecp2. Gate A: cells expressing high Tet1CD and low 
MBD protein levels. Gate B: cells expressing low Tet1CD and low MBD protein levels. Gate C: cells 
expressing high Tet1CD and high MBD protein levels. Gate D: Cells expressing low Tet1CD and high 
MBD protein levels. Two independent experiments were performed. Data of one representative 
experiment are shown. (c) Bar diagrams represent the number of cells expressing high Tet1CD and 
high MBD protein levels (Gate C). Shown are mean values and standard deviation of two independent 
experiments. 
 
4.1 Binding of MBD proteins to DNA blocks Tet1 function thereby modulating transcriptional noise
69
  
4 RESULTS
70
 Supplementary Figure 12. Preparation of various controls required for the implementation and 
interpretation of Electrophoretic Mobility Shift Assays 
(a) Schemes (top) illustrate the workflow of Electrophoretic Mobility Shift Assays (EMSA) fluorescent 
imager compared to a fluorescent plate reader. Both detection methods lead to the same result and 
are thus equally suitable for the analysis of EMSA. (b) Separation of purified, fluorescently tagged 
proteins via electrophoresis through a denaturing polyacrylamide gel visualized by Coomassie Brilliant 
Blue staining.  
 
 
 
 
Supplementary Figure 13. Impact of 5mC-specific and sequence-unspecific DNA binding 
proteins on the DNA binding ability of Tet1CD proteins 
Electrophoretic mobility shift assay (EMSA) to determine the binding ability of fluorescently tagged 
Tet1CD to double-stranded, single mC containing DNA (ATTO647 labeled) in the presence of 
equimolar amounts of (b) 5mC specific (fluorescently tagged MBD) and (c) sequence-unspecific 
(fluorescently tagged IDTRD) DNA binding domain proteins, respectively. (a) Experimental setup 
illustrating the amount, as well as the incubation order and time of proteins and DNA prior to EMSA. 
(b) Separation of MBD-Tet1CD-dsDNA (n=3), as well as (c) IDTRD-Tet1CD-dsDNA (n=3) complexes 
via electrophoresis through a native polyacrylamide gel visualized using a fluorescent plate reader 
(see also Suppl. Fig. 12). (b and c) Running direction is from left (- pole) to right (+ pole). Arrow 
points to MBD and IDTRD protein/DNA complexes. Arrowhead points to Tet1CD/DNA complexes. 
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Supplementary Figure 14. Selection of neural cells for the quantification of Tet1, Mecp2, 5mC 
and 5hmC levels in wild type and Mecp2 knockout mouse pontes. (a) Representative low (2x) 
and high (40x) magnification scan of a coronal cross section through mouse brain used for 
quantification of nuclear Tet1 protein levels in single neural cells within the red-shaded regions of wild 
type and Mecp2 y/- pons. Tet1 proteins were detected immunologically using a Tet1-specific antibody. 
Neuronal cells were selected according to morphology properties, which were determined on (b) 
equivalent cross sections stained for Neuronal nuclear antigen (NeuN). 5mC, 5hmC and (c) MeCP2 
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 levels were stained and quantified in a similar manner. (a-c) DNA was counterstained with DAPI. 
Scale bar, 5 µm. (d) Visual summary of the steps used for quantification of nuclear Tet1 protein levels 
in neural cells of wild type and Mecp2 knockout mouse pontes. (e) Quantification result of (d). Box 
plots represent the distribution of nuclear Tet1 levels in neurons of two individual (top) and combined 
(bottom) wild type and Mecp2 y/- mouse pontes (wt1 n=29, wt2 n=64, KO1 n=56, KO2 n=43; from left 
to right; n=number of cells), respectively. Plotted is the median, as well as the first and third quartiles. 
Whiskers extend to 1.5 times the interquartile range. P values were calculated by Wilcoxon signed-
rank test (ns = non significant). Mid-confocal optical sections represent NeuN positive cells of wild 
type and Mecp2 y/- mouse pontes immunostained for Tet1. DNA was counterstained with DAPI. Scale 
bar, 5 µm. 
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 Supplementary Figure 15. Visual summary of the steps used for quantification of Mecp2, 5mC 
and 5hmC levels at various different nuclear regions in neural cells of wild type and Mecp2 
knockout mouse pontes. (a) Representative summary illustrating the quantification of 5mC and 
5hmC levels at pericentric heterochromatin (chromocenter, CC), as well as the accumulation of 5hmC 
at chromocenters. DNA was counterstained with DAPI. For the quantification of Mecp2 levels, mouse 
pontes were immunostained for 5mC and Mecp2. 
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Supplementary Figure 16. Detection and quantification of major satellite transcripts via RNA 
FISH and RT qPCR, respectively. (a) Visual summary of the different steps used for quantification of 
Major Satellite RNA transcripts detected by RNA FISH. (b) Mid-optical sections of RNaseA treated 
and untreated neural cell nuclei hybridized with a probe specific for major satellite repeats. The lack of 
signal in RNaseA treated cells proves specificity of the probe for major satellite RNA. (c) Mid-optical 
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 sections of transiently transfected (Mecp2 and Tet1CD, shown in green) C2C12 mouse myoblasts 
immunostained for Mecp2 and 5hmC (shown in magenta), respectively. The lack of signal in 
untransfected cells verifies the absence of Mecp2 and 5hmC in C2C12 mouse myoblasts. (b,c) DNA 
was counterstained with DAPI. Scale bar, 5 µm. (d) Accumulation of 5hmC at chromocenters in 
neurons of two individual (top) and combined (bottom) wild type and Mecp2 y/- mouse pontes (wt1 
n=29, wt2 n=26, KO1 n=30, KO2 n=30; from left to right; n=number of cells), respectively. Plotted is 
the median, as well as the first and third quartiles. Whiskers extend to 1.5 times the interquartile 
range. P values were calculated by Wilcoxon signed-rank test (***; P < 0.001). 
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A.K. Ludwig revised the manuscript.
A.K. Ludwig prepared figures S1, S2, S7 and S10 and wrote the respective figure legends.
A.K. Ludwig performed and analyzed the experiments of figures 1d, 3b, S1, S2, S7 and S10.
A.K. Ludwig performed and analyzed the experiments of figures 1e and 3c together with P. Zhang.
Content of figures:
Figure S1: Flow cytometry analysis of HEK cells ectopically coexpressing mcherry-Tet1CD/CDmut and GFP-tagged
MBD proteins Figure S2: Quantification of chromatin condensation states in Tet1CD, Tet1CDmut and GFP express-
ing C2C12 cells. Figure S7: PCR analysis to validate the presence of pCEP4-LRE3-EGFP (EGFP with γ-globin intron)
and the absence of genomically integrated LRE3-EGFP (EGFP without γ-globin intron) in the retrotransposition re-
porter cell line. Figure S10: Luciferase reporter assay to analyze whether transcription from a methylated L1
promoter is activated by Tet1CD and repressed by Mecp2. Figure 1d and 3b: RT-qPCR analysis of L1 transcript
levels in transiently transfected HEK cells. Figure 1e and 3c: L1 copy number analysis of transiently transfected
HEK cells.
This chapter is accepted for publication in Nucleus.
80

L1 retrotransposition is activated by Ten-eleven-translocation protein
1 and repressed by methyl-CpG binding proteins
Peng Zhang1*, Anne K. Ludwig1*, Florian D. Hastert1, Cathia Rausch1, Anne Lehmkuhl1, Ines Hellmann2, Martha
Smets3, Heinrich Leonhardt3 and M. Cristina Cardoso1
1Department of Biology, Technical University Darmstadt, 64287 Darmstadt, Germany
2Anthropology and Human Genomics, Department Biology II, LMU Munich, Germany
3Human Biology and BioImaging, Department of Biology II, LMU Munich, Germany
*Equally contributing authors
One of the major functions of DNA methylation is the repression of transposable elements, such as the long-
interspersed nuclear element 1 (L1). The underlying mechanism(s), however, are unclear. Here, we addressed how
retrotransposon activation and mobilization are regulated by methyl-cytosine modifying ten-eleven-translocation
(Tet) proteins and how this is modulated by methyl-CpG binding domain (MBD) proteins. We show that Tet1 ac-
tivates both, endogenous and engineered L1 retrotransposons. Furthermore, we found that Mecp2 and Mbd2
repress Tet1-mediated activation of L1 by preventing 5hmC formation at the L1 promoter. Finally, we demon-
strate that the methyl-CpG binding domain, as well as the adjacent non-sequence specific DNA binding domain of
Mecp2 are each sufficient to mediate repression of Tet1-induced L1 mobilization. Our study reveals a mechanism
how L1 elements get activated in the absence of Mecp2 and suggests that Tet1 may contribute to Mecp2/Mbd2-
deficiency phenotypes, such as the Rett syndrome. We propose that the balance between methylation "reader"
and "eraser/writer" controls L1 retrotransposition.
Introduction
In humans, 17% of nuclear DNA consists of long in-
terspersed nuclear element 1 (LINE1 or L1). The ma-
jority of L1s, however, are retrotransposition defective
(RD-L1) due to 5’ truncations, internal rearrangements
or mutations. Only 80-100 copies of the half a mil-
lion human L1s are retrotransposition competent (RC-
L1) [1]. Full length L1 has a total length of about six kilo-
base pairs and contains a 5’ untranslated region (5’UTR)
with promoter activity in both, sense and antisense di-
rections, three open reading frames (ORFs) and a 3’UTR
that ends in an AATAAA polyadenylation signal. ORF1
encodes for a p40 protein with RNA-binding and chaper-
one activities [2], whereas ORF2 encodes for a protein
of 150 kDa in size with endonuclease and reverse tran-
scriptase activities [3]. In contrast to ORF1 and ORF2,
ORF0 is primate-specific and lies downstream the 5’UTR
in antisense direction. It has two splice donor sites that
can react with splice acceptors of downstream genomic
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sequences to generate fusion proteins [4]. During the L1
retrotransposition procedure, ORF1 and ORF2 proteins
bind to their own RNA in the cytosol to form a ribonucle-
oprotein particle (RNP), which facilitates the re-import
of L1 RNA to the nucleus. The majority of genomic L1
integrations follow a mechanism termed target primed
reverse transcription (TPRT) [5], which involves en-
donuclease and reverse transcriptase activity of ORF2p.
However, endonuclease independent L1 integration is
also observed in non-homologous end joining (NHEJ) and
p53 double deficient cells [6, 7]. Previous studies us-
ing engineered L1 elements showed that retrotranspo-
sition occurs not only in brain cells like neural progeni-
tor cells of rat hippocampus [8] and human fetal brain
[9], but also in non-brain cells such as embryonic stem
cells (ESC) [10]. Moreover, transgenic mice, harbor-
ing a fluorescently tagged human L1 under the con-
trol of its endogenous promoter showed only detectable
L1 retrotransposition activity in mouse germ cells and
brain. Furthermore, methylation level of L1 elements
differed in brain and skin [8], indicating that L1s are dif-
ferently regulated in tissues and cell types. Altogether,
these studies demonstrate that retrotransposition of L1
elements can occur in embryonic and importantly, also
in somatic cells and correlates with the L1 promoter
methylation status. Although host cells have multiple
mechanisms to restrict L1 retrotransposition [11–14],
sporadic insertions of a small number of RC-L1s accom-
panied by large chromosomal rearrangements can oc-
cur that lead to genomic instability [15]. Insertions of
L1 sequences into protein coding regions of the genome
can decrease RNA levels by inhibiting transcriptional
elongation [16]. In addition to its ability to propagate
itself, 3’ transductions of L1 occur in germ and cancer
cells, whereby unique sequences downstream of L1 ele-
ments can also be retrotransposed, if transcription con-
tinues beyond the L1 sequence [17]. Moreover, other
studies showed that L1 expression leads to high levels
of double strand breaks, as evidenced by the formation
of γH2AX foci and the recruitment of repair proteins in-
volved in the L1 retrotransposition process [18]. One
of the most important mechanisms repressing L1 retro-
transposition depends on DNA methylation. Methylation
of cytosines has been shown to recruit 5-methylcytosine
(5mC) binding domain (MBD) proteins. Mecp2, the
founding member of the MBD protein family, was sub-
sequently shown to modulate L1 retrotransposition in
a DNA methylation dependent manner [19, 20]. While
the transcriptional repression domain (TRD) of Mecp2
was shown to be sufficient for repressing L1 retrotrans-
position in a reporter assay system [20], the mecha-
nism(s) of L1 repression mediated by Mecp2 remain
unknown. Mecp2 and Mbd2, another family member
of the MBD protein family, specifically bind to methy-
lated CpG dinucleotides in DNA [21]. Hypomethylation
of the L1 promoter is associated with overexpression
of L1 transcripts [11], suggesting that a decrease in
DNA methylation might play a role in L1 retrotranspo-
sition. Ten-eleven-translocation (Tet) proteins convert
5-methylcytosine to 5-hydroxymethylcytosine (5hmC),
5-formylcytosine (5fC) and 5-carboxylcytosine (5caC) in
an iterative iron- and oxoglutarate dependent oxidation
reaction. These further modifications of methylated cy-
tosines are proposed to be one of the long sought mech-
anisms leading to loss of DNA methylation [22]. Tet1
and Tet2 depletion in ESCs has been shown to cause
loss of 5hmC in the 5’ region of L1 [23], but a connec-
tion to L1 regulation is lacking. In this study, we in-
vestigate whether and how Mbd and Tet proteins affect
L1 expression and mobilization in human cells. We de-
tected increased transcription and transposition of hu-
man endogenous L1 in the presence of Tet1 proteins and
showed that activation of L1 transposition depends on
the catalytic activity of Tet1. By the use of an L1 retro-
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transposition reporter assay, we additionally showed
that Tet1 proteins activate retrotransposition of engi-
neered L1. Moreover, we found that Mbd2, Mecp2, as
well as its methylcytosine binding and transcriptional
repression subdomains counteract Tet1-mediated reac-
tivation of L1 retrotransposons.
Materials and Methods
Plasmids, cell culture and transfection
Plasmids coding EGFP tagged MBDs were described in
previous publications [21, 24–26].
For construction of the mcherry-tagged catalytic active
(mcherry-Tet1CD: aa 1367-2007) and inactive (mcherry-
Tet1CDmut: aa 1367-2007, H1652Y, D1654A) domain of
mouse Tet1, Np95 was replaced from the mammalian
expression vector pCAG-mcherry-Np95-IB54 by Tet1CD
and Tet1CDmut28, respectively using AsiSI and NotI
sites.
The reporter plasmid pGL3-L1.3-Luc [20] coding for a
firefly luciferase under the control of the L1.3 promoter
was a generous gift of G. Schumann (Paul Ehrlich Insti-
tute, Langen, Germany).
HEK-EBNA cell line was purchased from Invitrogen (cata-
log #R620-07; Paisley PA4 9RF, UK). Cells were cultured
and transfected as previously described [27].
For genomic DNA (gDNA) extraction, HEK-EBNA cells
were transfected with mcherry-Tet1CD/CDmut and
EGFP-MBDs and flow cytometry sorted (Biorad S3
sorter, Bio-Rad Laboratories, USA) according to EGFP
and mcherry expression levels. 488 and 561 nm exci-
tation lasers and 525 ± 30 and 586 ± 25 nm emission
filters are used for EGFP and cherry detection.
For RNA preparation, HEK-EBNA cells were transfected
with mcherry-Tet1CD/CDmut and EGFP-MBDs encoding
plasmids, and the expression of mcherry and EGFP was
analyzed by flow cytometry. Cells with similar mcherry-
Tet1CD/CDmut expression were used for RNA prepara-
tion.
C2C12 mouse myoblast cell line [28] were cultured us-
ing the conditions described previously [29]. C2C12
cells were grown to 70% confluency on glass cover slips
and transfected with EGFP-Tet1CD/CDmut and EGFP ex-
pression constructs 24 hours post seeding using Lipofec-
tamine (Life Technologies, Carlsbad, CA, USA) according
to the manufacturer’s instructions.
Human AG01522D foreskin fibroblasts cells (obtained
from Coriell Cell Repository, Camden, NJ, USA) were cul-
tured in DMEM medium supplemented with 15% FCS.
The cells were transfected by electroporation as previ-
ously described [30].
Mouse tail fibroblasts (MTF) cells were a gift from A. Bird
(Wellcome Trust Centre for Cell Biology, Edinburgh, UK)
and were cultured using the conditions as previously
described [31].
Mouse neural stem cells were a gift from B. Hendrich
(Cambridge Stem Cell Institute, Cambridge, UK) and
cultured using the conditions as previously described
[32].
Human fibroblast cells (BJ-hTERT; ATCC CRL-4001) 60
were cultured in DMEM medium supplemented with
15% FCS. The cells were transfected by electropora-
tion as previously described [30].
V6.5 wt and Tet-TKO mouse embryonic stem cells [33]
were a gift from R. Jaenisch (Whitehead Institute for
Biomedical Research, Cambridge, USA) and were main-
tained under serum-free and feeder-free conditions
on Geltrex-coated flasks in N2B27 (50% neurobasal
medium (Life Technologies) and 50% DMEM/F12 (Life
Technologies) containing 2 mM L-glutamine (Life Tech-
nologies), 0.1 mM β-mercaptoethanol, N2 supplement
(Life Technologies), B27 serum-free supplement (Life
Technologies), 100 U/ml Penicillin-Streptomycin, 1000
U/ml LIF and 2i (1 µM PD032591 and 3 µM CHIR99021
4 RESULTS
84
(Axon Medchem, Netherlands)).
L1 retrotransposition reporter assay
HEK-EBNA cells were transfected with the pLRE3-EGFP
plasmid [9] (gift from J. V. Moran, U. Michigan Medical
School, USA). Two days after transfection, cells were cul-
tured in DMEM medium containing 2 µg/mL puromycin
(Invitrogen; Paisley PA4 9RF, UK) for resistance selec-
tion. 18 days later, single colonies were picked and pas-
saged in DMEM medium containing 2 µg/mL puromycin.
For retrotransposition reporter assays, cells were cul-
tured in DMEM medium without puromycin selection.
For fixed-cell analysis, the reporter cell line was grown
on glass cover slips and transfected with mcherry-
Tet1CD/CDmut and only mcherry using PEI. 24 hours and
48 hours after transfection, cells were fixed with 3.7%
formaldehyde (Carl Roth GmbH, Karlsruhe, Germany),
DNA was counterstained with DAPI (Invitrogen; Paisley
PA4 9RF, UK) and cells were mounted in Vectashield
antifade medium (Vector Laboratories, Burlingame, CA,
USA).
DAPI, EGFP and mcherry were imaged by high content
microscopy with 20x long/0.45 NA objective (Operetta,
PerkinElmer, UK), a xenon fiber optic as light source,
360-400, 460-490 and 560-580 nm excitation- and 410-
480, 500-550 and 590-640 emission filters, respectively.
And the intensities were analyzed using the Harmony
software (PerkinElmer, UK).
For flow cytometry analysis of the aforementioned
reporter cell line, cells either ectopically expressing
mcherry-Tet1CD/CDmut or mcherry or treated with 5-
azacytidine (5-aza-C, Sigma-Aldrich, St. Louis, MO, USA)
were grown in 6-well plates. 48 hours later, cells were
harvested and EGFP positive cells were counted by flow
cytometry.
RNA-Seq library preparation and data analysis
Total RNA was isolated from mouse embryonic stem
cells (V6.5) in biological quadruplicates using the nu-
cleospin triprep kit from Macherey-Nagel. 50 ng RNA
was reverse transcribed. cDNA was pre-amplified as de-
scribed elsewhere [34]. 1 ng of cDNA was used as input
for tagmentation by the Nextera XT Sample Prepara-
tion Kit (Illumina), where a second amplification round
was performed for 12 cycles. For each sample, 2.5 ng
of final library was pooled. The library pool was se-
quenced 1 x 100 bases on a Illumina HiSeq1500. The
average sequencing depth was 1.2 million reads per
replicate. Sequencing reads were demultiplexed from
the Nextera (i5 and i7) indices. Demultiplexed reads
were mapped to the Mouse genome build mm10 using
STAR version STAR 2.5.163 with the specific settings:
outFilterMultimapNmax 100, outFilterMismatchNmax 4,
winAnchorMultimapNmax 100. The junction annotation
was taken from ensembl GRCm38.75 and the index was
created as recommended using the option sjdbOver-
hang 99. The resulting bam-files were then processed
using TEtranscript [35] to obtain read count tables for
transcripts and transposons, using the TE annotation
as provided by the authors of TEtranscript (http://
labshare.cshl.edu/shares/mhammelllab/www-data/
TEToolkit/TE_GTF/mm10_rmsk_TE.gtf.gz). Normaliza-
tion and differential expression analysis was done using
DESeq265.
Quantitative PCR (q-PCR)
q-PCR was performed on a StepOnePlus Real-Time PCR
System (Applied Biosystems, Darmstadt, Germany) with
Platinum SYBR Green qPCR SuperMix-UDG w/ROX (Invit-
rogen, Paisley PA4 9RF, UK) according to the manufac-
turer’s instruction. The program used for the amplifi-
cation of all fragments consisted of 1) inactivation of
UDG for 2 min at 50◦C, 2) denaturation of DNA for 10
min at 98◦C, 3) 40 cycles of PCR (98◦C for 15 sec, 60◦C
for 1 min), followed by 4) dissociation (melting) curve
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analysis to confirm the specificity of the amplicon.
DNA glucosylation, MspI digestion and quantita-
tive PCR based 5hmC and 5mC detection (GluMs-
qPCR)
To detect 5hmC after Tet1 transfection, gDNA was ex-
tracted from HEK-EBNA cells as described previously
[36]. Concentration and purity of DNA was measured
on a TECAN infinite M200 plate reader (Tecan Group
Ltd., Maennedorf, Switzerland) by the absorbance at
260 nm and 280 nm. 1 µg of gDNA was treated with
or without 0.18 µM of T4 phage β-glucosyltransferase
(T4-BGT) [37] in a final volume of 50 µl supplemented
with 1x NEB cut smart buffer (NEB, Frankfurt, Germany)
and 1 mM of UDP-Glucose (Sigma-Aldrich, St. Louis,
MO, USA) for 18 hours at 37◦C. Then 0.5 µg of gluco-
sylated or mock treated DNA was used for digestion
with 100 units of MspI (NEB, Frankfurt, Germany) at
37◦C for 18 hours in a final volume of 20 µL, which
was followed by treatment with 20 µg of proteinase K
(PK, Carl Roth GmbH, Karlsruhe, Germany) for 30 min at
50◦C. Following proteolysis, PK enzymatic activity was
inactivated for 10 min at 98◦C. The MspI-resistant frac-
tion was amplified using qPCR with primers flanking the
MspI site (F: 5’- ATCCCACACCTGGCTCAGAGGG -3’ and R:
5’- GTCAGGGGTCAGGGACCCACTT -3’). After qPCR, the
relative amounts of 5hmC were analyzed as described
previously [38]. To detect 5mC at position 482 in L1
5’UTR before Tet1 transfection, the gDNA was treated
with or without T4-BGT as described above. Then, the
gDNA was further treated with MspI, HpaII (50 units,
NEB, Frankfurt, Germany) or mock for 18 hours at 37◦C.
The qPCR and data analysis were performed as above.
cDNA preparation and reverse transcription
quantitative real-time PCR (RT qPCR)
Total RNA was isolated using the RNeasy Mini Kit (Qia-
gen, Hilden, Germany) according to the manufacturer’s
instruction. To remove traces of genomic DNA, RNA was
treated with RNase-free recombinant DNaseI (Macherey
Nagel, Dueren, Germany) for 30 min at 37◦C and fur-
ther purified with the Qiagen RNeasy Mini Kit. To as-
sess the concentration and purity of RNA, the ratio of
absorbance at 260 nm and 280 nm was measured on
a TECAN infinite M200 plate reader. 500 ng of total
RNA were used for cDNA synthesis using 200 units M-
MuLV reverse transcriptase (NEB, Frankfurt, Germany),
0.01 OD units random primer from the Prime-It II Ran-
dom Primer Labeling Kit (Stratagene, La Jolla, California,
USA), 0.5 mM dNTPs (Carl Roth GmbH, Karlsruhe, Ger-
many) and 40 units recombinant ribonuclease inhibitor
RNaseOUT (Invitrogen, Paisley PA4 9RF, UK) in a total
reaction volume of 20 µL. Cycles were set to 5 min at
25◦C, 90 min at 50◦C and 15 min at 70◦C. For qPCR,
0.5 ng of cDNA were used for each reaction. Primers
for quantitative real-time PCR contained the following
sequences: Gapdh F: 5’- CAT GAG AAG TAT GAC AAC
AGC CT-3’, Gapdh R: 5’-AGT CCT TCC ACG ATA CCA AAG
T-3’ [39], hL1 5’ UTR F: 5’-GAA TGA TTT TGA CGA GCT
GAG AGA A-3’, hL1 5’ UTR R: 5’-GTC CTC CCG TAG CTC
AGA GTA ATT -3’ [9]. 5’ UTR expression level was nor-
malized to Gapdh and calculated using the comparative
CT method (∆∆CT method) [40].
L1 copy number analysis
To detect newly integrated L1 ORF2 sequences in
human embryonic kidney or human fibroblast cells,
qPCR was performed as described above. For each
reaction, 80 pg of gDNA were used. Primers con-
tained the following sequences: hL1 ORF2 F: 5’-
CAAACACCGCATATTCTCACTCA-3’, hL1 ORF2 R: 5’-
CTTCCTGTGTCCATGTGATCTCA-3’ [9]. Computational
estimates using the UCSC genome browser in sil-
ico PCR function (genome: human, assembly: De-
cember 2013 (GRCh38/hg38), target: genome as-
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sembly) indicated that at least 2734 endogenous hu-
man L1 elements could be detected using the hL1
ORF2 primer set. As control we used primers for
hL1 5’ UTR. This sequence is usually truncated dur-
ing the course of retrotransposition. Accordingly,
the number of hL1 5’ UTR sequences remains con-
stant. Primers contained following sequences: hL1
5’ UTR F: 5’-ACAGCTTTGAAGAGAGCAGTGGTT-3’, hL1
5’ UTR R: 5’-AGTCTGCCCGTTCTCAGATCT-3’ [9]. To de-
termine the content of L1 ORF2 sequences in mouse
embryonic stem cells (wild type and Tet1/Tet2/Tet3
TKO) and mouse fibroblast cells ectopically express-
ing mcherry or mcherry-Tet1CD, gDNA was isolated
and qPCR was performed as described above. For
each reaction, 80 pg of gDNA were used. Primers
contained the following sequences: mL1 ORF2 F:
5’-CTGGCGAGGATGTGGAGAA-3’, mL1 ORF2 R: 5’-
CCTGCAATCCCACCAACAAT-3’ [19]. Computational es-
timates using the UCSC genome browser in silico PCR
function (genome: mouse, assembly: December 2011
(GRCm38/mm10), target: genome assembly) indicated
that at least 1308 endogenous mouse L1 elements could
be detected using the mL1 ORF2 primer set. As con-
trol we used non-mobile genomic repetitive sequences:
5SRNA F: 5’-ACGGCCATACCACCCTGAA-3’; 5SRNA R: 5’-
GGTCTCCCATCCAAGTACTAACC-3’ [19]. To calculate the
relative copy number of genomic L1 ORF2, the compar-
ative CT method (∆∆CT method) was used. For HEK
cells, as well as for mouse and human fibroblast cells,
relative ORF2 content was further normalized to Tet1CD
expressing cells. For mouse ESCs, relative ORF2 content
of wild type cells was further normalized to the mean
relative ORF2 content of Tet-TKO cells.
Chromatin decondensation analysis
3D structured illumination microscopy images were ac-
quired as previously described [41]. To quantify the
grade of chromatin decondensation, binary nuclear
masks were generated. Therefore, images were pro-
cessed using a 3D median filter. Filtered images of the
DAPI channel were then thresholded using the basic al-
gorithm. Next, all DAPI pixels below the threshold were
set to 0 and all pixels above the threshold were set to
1. For further improvement of the nuclear masks, bi-
nary images were additionally processed using the "fill
holes" and "watershed" algorithms. Finally, the stan-
dard deviation of all DAPI histograms was calculated
automatically. To automate this procedure, a routine
was written in the programming language python.
Immunofluorescence staining
Human AG522D fibroblasts cells were fixed for 10 min-
utes in 4% formaldehyde in PBS and permeabilized for
20 minutes with 0.5% Triton X-100. For detection of
genomic 5hmC and γH2AX, the cells were further fixed
with ice-cold methanol for 5 minutes. After RNaseA
treatment (10 µg/mL) for 30 minutes at 37◦C, cells were
washed and blocked for 60 minutes in 0.2% fish skin
gelatin (Sigma Aldrich, St. Louis, MO, USA) at 37◦C.
Then 5hmC and γH2AX were detected using a rab-
bit anti-5hmC (1:250, catalog number: 39769, Active
Motif, La Hulpe, Belgium) and a mouse Anti-phospho-
Histone H2A.X (1:400, catalog number: 05-636, Merck,
Darmstadt, Germany), antibody in conjunction with 25
U/mL DNaseI (Sigma Aldrich, St. Louis, MO, USA) for 70
minutes at 37◦C. To stop DNaseI digestion, cells were
washed three time with PBS containing 1mM EDTA and
0.01% Tween. Following incubation with secondary an-
tibody mixture of AMCA donkey anti-rabbit IgG (1:100,
catalog number: 715-155-151, The Jackson Laboratory,
Bar Harbor, USA) and Alexa Fluor 488 goat anti-mouse
IgG (1:250, catalog number: A11029, Invitrogen In-
vitrogen, Paisley PA4 9RF, UK) for 50 minutes at RT.
After three time washing with PBS containing 0.01%
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Tween the cells were mounted in Vectashield Medium
(Vector Labs, Burlingame, CA, USA) and imaged with
high content screen microscopy with 20x long/0.45 NA
objective (Operetta, PerkinElmer, UK). The intensities
were further calculated using the Harmony software
(Operetta, PerkinElmer, UK) and blotted by RStudio
(https://www.rstudio.com).
L1 ORF1p proteins were detected in HEK using the poly-
clonal rabbit anti-L1 ORF1p antibody [42] as described
before [43]. As secondary antibody the AMCA donkey
anti-rabbit IgG was used (1:100, catalog number: 715-
155-151, The Jackson Laboratory, Bar Harbor, USA).
Luciferase reporter assay
Methylated pGL3-L1.3-Luc [20] reporter plasmids were
obtained by incubation with M.HpaII and controlled by
digestion with HpaII and MspI. Cells were seeded in
6-well dishes at 7x105 cells/well. Three hours post
seeding, cells were cotransfected with the unmethy-
lated or methylated reporter plasmid pGL3-L1.3-Luc
and effector constructs coding for Tet1CD/Tet1CDmut/
Mecp2/Tet1CD+Mecp2, respectively. Luciferase activity
was determined using the "Luciferase Assay System"
(Promega, Madison, Wisconsin, US) as described by the
manufacturer on a TECAN infinite M200 plate reader
(Tecan Group Ltd., Maennedorf, Switzerland). To control
for consistent transfection of methylated and unmethy-
lated reporter plasmids, the fluorescent signal emanat-
ing from the effector proteins was quantified in parallel
(GFP: excitation 475 nm, emission 520 nm; RFP: excita-
tion 585 nm, emission 630 nm) and was used for normal-
ization of the luciferase signal. In addition, fluorescent
signals were used to control for homogeneous expres-
sion of Tet1CD in single (Tet1CD) and double (Tet1CD +
Mecp2) transfected cells.
Results
Tet1 activates retrotransposition of endogenous
L1
Three steps are involved in L1 retrotransposition, com-
prising loss of DNA methylation in the L1 5’UTR, L1
transcription and L1 transposition (Fig 1A). 5hmC, which
is produced by Tet proteins, is thought to be an inter-
mediate modification during loss of DNA methylation
[44, 45], as well as a stable epigenetic mark, which
tunes a large number of CpG dinucleotides located
at poised enhancers and actively transcribed regions
[46, 47]. To test whether L1 retrotransposition is re-
activated by Tet-mediated 5mC to 5hmC conversion,
we transfected HEK-EBNA cells with the catalytically ac-
tive domain of Tet1 fused to mcherry (mcherry-Tet1CD),
which was previously shown to be sufficient to induce
genome-wide hydroxymethylation in vivo [48–50]. As
control, mcherry-Tet1CDmut, which lacked catalytic ac-
tivity due to two mutations in the Fe(II) binding sites
(H1652Y, D1654A) was used [48]. Since loss of DNA
methylation in the L1 5’UTR is the first step that makes
L1 retrotransposition possible, we performed GluMs-
qPCR (DNA glucosylation, MspI digestion and quan-
titative PCR based 5hmC detection, described in the
methods) to determine the methylation state of the L1
promoter. L1 has 20 mapped CpG sites within its 5’UTR.
Methylation of only a subset of CpG dinucleotides, such
as nucleotide position 482, were shown to correlate in-
versely with retrotransposition activity of L1 elements
[9]. Therefore, we chose CpG dinucleotide at position
482 to quantify the methylation status of the L1 pro-
moter (Fig 1B) before and after transfection. In un-
transfected cells, we observed using GluMs-qPCR that
around 60% of all CpG dinucleotides at position 482
were methylated upon Tet1CD expression, however,
5hmC levels at position 482 were increased compared
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Figure 1: Tet1 reactivates retrotransposition of endogenous L1. (A) Schematic overview of L1 retrotransposition. (B) Experi-
mental rationale of human L1 retrotransposition detection. (C) Relative 5hmC levels in L1 5’UTR (n=3, *p < 0.05, independent
two-sample studen’s t-test), (D) relative L1 transcription levels (n≥ 4; ns= non significant; ***p < 0.001, independent two-
sample student’s t-test) and (E) relative L1 ORF2 DNA content was checked 48 hours after Tet1CD, Tet1CDmut and mock
transfection (n=4, *p < 0.05, independent two-sample student’s t-test). (F) Scheme summarizing the effect of Tet1 on the
three steps of L1 retrotransposition. Black and red circles indicate 5mC and 5hmC nucleotides, respectively. Bars represent
the mean + standard deviation (SD). (G) Experimental rationale of mouse L1 retrotransposition detection. (H) Boxplot of the
log2-fold changes of the triple mouse embryonic stem cells Tet-knockout relative to wild-type (V6.5) for all genes and all L1 ele-
ments. Negative values indicate a down-regulation in the knock-out relative to the wild-type, positive values an up-regulation.
Significant elements are marked in color. The red line is at zero, i.e. the expected value if expression were identical in the wild
type and mutant. (I) Relative mouse L1 ORF2 content. Bars represent mean + SD. (n=3, *p< 0.05, independent two-sample
student’s t-test).
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to Tet1CDmut and mock transfected cells (Fig 1C), indi-
cating that Tet1 oxidizes 5mC in the L1 promoter. Conse-
quently, we aimed to determine, whether Tet1-mediated
5hmC formation of the L1 promoter leads to reactivation
of L1 transcription. Since RNA transcript levels might be
affected by several exogenous factors during cell sort-
ing [51], cells cotransfected with mcherry-Tet1CD and
EGFP, as well as mcherry-Tet1CDmut and EGFP were
analysed by flow cytometry and only cell populations
with comparable expression levels between samples
were chosen for RNA preparation (Fig S1). Reverse tran-
scription quantitative real-time PCR (RT qPCR) showed
that besides Tet1CD, ectopic expression of Tet1CDmut
leads to increased L1 transcription when compared to
mock transfected cells (Fig 1D), indicating that L1 tran-
scription does not depend on the catalytic activity of
Tet1 proteins. Previous studies showed that besides
DNA methylation, histone acetylation [52] and chro-
matin structure [53] affect L1 retrotransposition. In that
regard, we found chromatin decondensation caused
by Tet proteins in an oxygenase-independent manner
(Fig S2), which might contribute to the reactivation of
L1 transcription. Using high content imaging, we next
tested, whether the observed increase in L1 transcrip-
tion results in elevated L1 ORF1p levels. Therefore, HEK
cells ectopically expressing mcherry-Tet1CD, mcherry-
Tet1CDmut or mcherry were fixed and immunostained
for L1 ORF1p. While the catalytically active Tet1 vari-
ant increased mean protein levels of L1 ORF1 by 60%,
ORF1p levels were elevated by 20% in Tet1CDmut ex-
pressing cells (Fig S3). Accordingly, L1 ORF1p formation
requires, at least in part, the catalytic activity of Tet
proteins. Based on the knowledge that L1 elements mo-
bilize via an RNA intermediate using a "copy and paste"
mechanism and our observation that Tet1 proteins in-
crease L1 transcription, we next analyzed L1 copy num-
bers in genomic DNA (gDNA) of Tet1CD and Tet1CDmut
overexpressing cells, respectively. Since most of the
newly inserted L1 elements are 5’ truncated, we used
primers specific for the 5’UTR as a constant normaliza-
tion control and ORF2 primers as an indication of newly
inserted L1 elements to detect de novo transposition
events. Compared to Tet1CDmut and mock transfected
cells, genomic L1 ORF2 content was increased upon
Tet1CD overexpression (Fig 1E), indicating that L1 trans-
position depends on the oxygenase activity of Tet1. As
we observe that catalytically active and inactive Tet1
proteins generate similar L1 mRNA levels, but have dif-
ferent L1 transposition efficiencies, we suggest that the
Tet 1 catalytic activity may enhance L1 transposition
through a yet unknown mechanism. We found that the
global Tet1-mediated 5hmC increase leads to accumula-
tion of γH2AX (Fig S4). As L1 retrotransposition has been
shown to be proportional to the number of γH2AX foci
[54], we suggest that Tet1 induced formation of γH2AX
might enhance L1 integration. Since, on the other hand,
the catalytically inactive Tet1 does not produce 5hmC
and, accordingly, γH2AX was not increased (Fig S4), L1
transposition was thus not elevated. In summary, our
data demonstrate that Tet1 proteins induce loss of L1
promoter methylation and further activate L1 transcrip-
tion and transposition in human HEK cells (Fig 1F). As
ESCs depleted of Tet1 and Tet2 showed loss of 5hmC
in the 5’ region of L1 [23], we further tested, whether
loss of 5hmC affects L1 transcription and transposition.
To this end, we performed RNA-seq analysis and de-
termined L1 copy numbers using RNA and DNA from
Tet1/Tet2/Tet3 triple knockout ESCs (Tet-TKO), as well
as the corresponding wild type cells (V6.5 wt) (Fig 1G).
Although global gene expression did not change, L1 ex-
pression was significantly reduced in Tet-TKO cells (Fig
1H), indicating that Tet proteins regulate L1 transcrip-
tion. In agreement with this, L1 copy numbers were
decreased in Tet-TKO cells, indicating that Tet proteins
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modulate L1 transposition. The activity of L1 is tissue
and cell type dependent [8]. Low and high activity of
L1 retrotransposition was observed in fibroblasts and
neural stem cells, respectively, indicating that host cells
adopt a protection mechanism to prevent L1 retrotrans-
position. To test whether Tet proteins could activate L1
in both cells types, we analyzed L1 copy number in cells
expressing either mcherry-Tet1CD or mcherry. As shown
in Figure S5, genomic L1 ORF2 content was increased in
mouse neural stem cells, however, it was not changed
in both mouse and human fibroblasts upon Tet1 expres-
sion. These results indicate that although Tet proteins
can active L1 retrotransposition, cell type dependent
protection mechanisms also play a role in preventing L1
activity.
Tet1 activates retrotransposition of engineered
L1
To further validate Tet1 mediated L1 activation, we
made use of a cell culture based retrotransposition
assay, where the plasmid pLRE3-EGFP [9] was episo-
mally present in HEK-EBNA cells. The L1 cassette of the
pLRE3-EGFP construct contains a full-length human L1
element, with a sense oriented γ-globin intron, which
interrupts the antisense EGFP cassette in its 3’UTR re-
gion. Therefore, EGFP positive cells arise only when the
EGFP is transcribed from the L1 promoter, spliced, re-
verse transcribed and integrated into the genome [9]
(Fig S6A). Self-replicating, viral-based vectors are ca-
pable of long-term episomal persistence in mammalian
cells, in particular in HEK-EBNA cells. Two components
are needed for episomal maintenance, the latent origin
of replication (oriP) present in the vector and the trans-
activator protein EBNA-1 stably expressed in HEK-EBNA
transgenic cells [55, 56]. The episomal plasmid con-
tains a puromycin resistance gene to facilitate selection
of cells containing the episome. HEK-EBNA cells were
transfected with the pLRE3-EGFP construct and treated
with 2 µg/mL puromycin two days later. From three days
after transfection, EGFP expression was observed in a
small number of cells, indicating that HEK-EBNA cells are
suitable to detect engineered L1 retrotransposition from
the episome into the genome. Since we observed only
a small number of EGFP expressing cells, i.e., where
transposition took place, we wanted to test whether the
EGFP negative cells still contained the episomal plasmid
pLRE3-EGFP. To this end, PCR was performed on whole
cell lysates of sorted, EGFP negative cells using primers
for EGFP, which amplify both, spliced (genomically in-
tegrated copy) and unspliced (episomal copy) EGFP
versions. As shown in Figure S7, only unspliced EGFP
was amplified from EGFP negative cells, indicating that
pLRE3-EGFP is present in these cells. A spliced, genom-
ically integrated EGFP cassette (CMV promoter+EGFP),
however, could not be detected indicating that no retro-
transposition took place in these cells. After 15 days of
antibiotic selection, puromycin-resistant colonies con-
taining few EGFP positive cells formed (Fig S6B). An-
tibiotic resistance of a large number of EGFP negative
cells, however, indicated that the pLRE3-EGFP was epi-
somally present, but its ability to retrotranspose was
most likely silenced by DNA methylation (Fig S6B). To
test whether Tet1 can activate L1 transposition from
the silenced episome in these cells, we transfected
the reporter cell line with mcherry-Tet1CD, mcherry-
Tet1CDmut or mcherry, fixed them 24 and 48 hours
post transfection and further quantified the EGFP pos-
itive cells by high content screening microscopy. The
ratio of EGFP-positive cells in Tet1/mcherry-positive and
-negative cells was used to show L1 retrotransposition
events induced by Tet activity (Fig 2A). We observed an
increase in the number of EGFP-positive cells upon over-
expression of Tet1CD, compared to the overexpression
of Tet1CDmut and mcherry alone at 48 hours (Fig 2C).
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Figure 2: Tet1 reactivates retrotransposition of engineered L1. (A) Experimental rationale. The ratio of EGFP-positive cells in
Tet1/mcherry-positive and negative cells, was quantified to detect recent L1 retrotransposition events. (B-C) Relative increases
of retrotransposition events (B) 24 hours and (C) 48 hours after Tet1CD, Tet1CDmut and mcherry transfection. At least three in-
dependent experiments were performed and more than 250,000 cells for each group were analyzed and the bar represents the
mean + SD. Independent two-sample student’s t-test was performed between Tet1CD and Tet1CDmut or Tet1CD and mcherry
transfected cells. Only significant differences were indicated on the plots as two asterisks (p<0.005). (D) Representative im-
ages of the pLRE3-EGFP reporter cell line 48 hours after mcherry-Tet1CD/CDmut and mcherry transfection, respectively. Scale
bar: 100 µm.
24 hours after transfection no increase of EGFP posi-
tive cells was detected in the presence of Tet1CD (Fig
2B). Consistent with the reporter assay using fixed cells,
live-cell time lapse imaging analysis showed a large in-
crease in the amount of EGFP positive cells after 40
hours with Tet1CD transfection, but not with Tet1CDmut
and mcherry (Fig S8A, videos 1-3). This fits well the pre-
viously reported L1 de novo retrotransposition kinetics
[57]. To further validate the increase of L1 retrotrans-
position induced by Tet1CD, we used flow cytometry
analysis. The number of mcherry positive (+) and nega-
tive (-), as well as EGFP positive (+) cells was counted by
flow cytometry and the ratio between EGFP+/mcherry+
and EGFP+/mcherry- cells was calculated to show re-
cent L1 integrations. The results showed an increase of
EGFP positive cells in the presence of Tet1CD 48 hours
after transfection (Fig S8B). These data indicate that
the L1 promoter of the episomal plasmid was activated
by Tet1CD ultimately leading to transposition into the
host cell’s genome and expression of the EGFP gene. To
further verify that the activation of EGFP resulted from
L1 retrotransposition and not from silenced genomically
integrated copies, we cultured the reporter cell line in
the absence of puromycin. Four and 11 days later, the
cells were transfected with mcherry-Tet1CD plasmids
and two days after transfection the EGFP positive cell
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numbers were counted using flow cytometry. As shown
in Figure S9, EGFP positive cell numbers were decreased
in the absence of puromycin. Previous studies showed
that the episomal plasmids are easily lost during cell
generations [58]. In the absence of puromycin, the cells
without pLRE3-EGFP plasmid are able to survive, but
due to the lack of the episome no transposition can take
place and, hence, those cells do not express EGFP. These
results indicate that the activation of EGFP expression
upon Tet expression results from L1 retrotransposition
from the episome into the genome rather than from
genomically integrated EGFP cassette, since the latter
would be activated by Tet1CD in the absence or pres-
ence of puromycin. Increase of L1 retrotransposition
and the conversion of 5mC to 5hmC induced by Tet1
prompted us to test, whether the observed L1 reactiva-
tion arose from DNA methylation changes, so we made
use of the cytidine analogue 5-azacytidine (5-aza-C) to
induce DNA hypomethylation [59]. The stable cell line
was treated with either 5 µM or 50 µM of 5-aza-C and
48 hours later the number of EGFP positive cells was
quantified by flow cytometry analysis. Compared to un-
treated cells, the 5-aza-C treatment increased the num-
ber of EGFP positive cells in a dose dependent manner
(Fig S8C), indicating that decreased DNA methylation is
involved in the activation of L1. This effect is in line with
results from non-transformed cells that were treated
with 5-aza-C [60]. Since 5mC oxidation products such
as 5hmC are considered to be intermediates of DNA
demethylation, we suggest that the activation of L1 by
Tet1 is mainly dependent on its DNA demethylation ac-
tivity potentially involving subsequent repair processes.
Mecp2 and Mbd2 repress endogenous human L1
retrotransposition
As Mecp2 has been shown to regulate L1 retrotrans-
position in a methylation dependent manner [19, 20],
we wanted to test whether Tet1 mediated activation
of L1 can be counteracted by MBD proteins. To this
end, we analyzed the effects of co-expressed Tet1CD,
Tet1CDmut, Mecp2 and Tet1CD+Mecp2 on transcrip-
tion of a luciferase reporter plasmid driven by the in-
ternal L1.3 promoter (nucleotides 1-909) in response
to its methylation by HpaII methyltransferase [20, 61]
(Fig S10A and S10B). While in the absence of any ef-
fector protein, methylation of the L1.3 promoter led
to a weak transcriptional decrease, overexpression
of Tet1CD/Tet1CDmut resulted in similar transcription
rates for the methylated and unmethylated promoter
(Fig S10C). Ectopic expression of Mecp2, in contrast,
reduced transcription from the methylated promoter in
the absence and presence of Tet1CD (Fig S10C), indi-
cating that Mecp2 represses Tet1 mediated activation
of L1 transcription. Next, we co-expressed Tet1 with
Mbd2, Mecp2, or its subdomains MBD and IDTRD, re-
spectively in HEK-EBNA cells and analyzed 5hmC levels
at the endogenous L1 promoter by GluMS-qPCR. The re-
sults showed decreased 5hmC levels in the 5’UTR of L1
upon co-overexpression of MBDs together with Tet1CD
(Fig 3A), indicating that MBDs block Tet mediated 5mC
to 5hmC conversion in the 5’UTR of L1. The failure of
Tet binding to DNA in the presence of Mbd2, MeCP2,
as well as its subdomains MBD and IDTRD [50] might
thus be causative for the observed decrease of 5hmC
at the L1 5’UTR. Previous studies showed activation of
L1 retrotransposition in the absence of Mecp2 [19], and
our data indicate that this activation might be due to
Tet induced 5hmC formation. In accordance with the
decreased 5hmC levels, L1 mRNA levels and copy num-
bers were lower in cells co-expressing Tet1CD and MBDs
(Fig 3B and Fig 3C), indicating that MBDs can prevent
L1 transcription and transposition. In summary, the ac-
tivation of L1 by Tet1 can be prevented by the action of
MBD proteins.
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Figure 3: MBD proteins prevent Tet-mediated reactivation of endogenous L1. (A) Relative 5hmC in L1 5’UTR (n=3, *p <
0.05, independent two-sample student’s t-test), (B) relative L1 transcription levels (n=4; **p<0.01, independent two-sample
student’s t-test) and (C) relative L1 ORF2 DNA content were checked 48 hours after cotransfection with plasmids coding for
Tet1CD- and MBD proteins (n=3, *p < 0.05, independent two-sample student’s t-test). All of the three independent experiments
for IDTRD and Mbd2 showed decreased, but variable L1 copy number when compared to Tet1CD, giving rise to an apparent
non-significant difference. (D) Scheme illustrating the effect of Tet1- and MBD proteins on L1 retrotransposition. Black and red
circles indicate 5mC and 5hmC nucleotides, respectively. Bars represent the mean + SD.
Here, we show that Tet1 mediated formation of 5hmC
activates the L1 retrotransposition. Previous studies
have shown that the activation of endogenous L1 tran-
scription does not depend on Tet3 in mouse zygotes
[62], but the potential effect of Tet3 on L1 transposition
is still unknown. To further check the effect of Tets on L1
transposition, we took advantage of Tet1, Tet2 and Tet3
triple knockout ESCs, which do not express any Tets but
their corresponding wild type cells express high levels of
Tets, especially Tet1 and Tet2. We showed that the tran-
scription and transposition of mouse L1 is significantly
decreased in Tet1, Tet2 and Tet3 triple knockout mouse
ESCs as compared to the corresponding wild type cells,
indicating that Tets are involved in L1 retrotransposi-
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tion activation. Since 5hmC is not only involved in loss
of DNA methylation, but also a stable epigenetic mark
in mouse embryonic stem cells, we propose that both,
loss of DNA methylation and the 5hmC mark itself are
involved in L1 retrotransposition activation. Rett syn-
drome (RTT), a postnatal occurring neurological disor-
der with an incidence of 1 in 10,000 female births [63],
is mostly caused by mutations in the MBD and IDTRD
of Mecp2 [27, 64]. The increased L1 retrotransposition
events in RTT patients suggest that L1 activity is facili-
tated upon loss of Mecp2 function in human cells [19],
but the mechanism is still unknown. Here, we show
that L1 retrotransposition is activated by Tet1 and re-
pressed by MBD proteins. In the absence of Mecp2,
Tet proteins oxidize methylated DNA, which is usually
bound by Mecp2, leading to L1 element activation. Al-
though previous studies showed that Mecp2 binds to
5hmC enriched within active genes [65], we found, on
the other hand, that the MBD of Mecp2 does not bind to
5hmC [66]. Therefore, our data is not consistent with
sustained inhibition of L1 activation through binding of
Mecp2 to 5hmC. However, Mecp2 binds with high affin-
ity to DNA and this could explain the results of Mellen et
al [65]. Previous studies showed that transgenic mice
harboring either DNA binding-incompetent MBD or TRD
of Mecp2 is sufficient to cause RTT [64]. Here, we show
that MBD as well as the IDTRD of Mecp2 are also each
sufficient to mediate repression of L1 mobilization. In
addition to Mecp2, we show that Mbd2 can also re-
press human L1 retrotransposition, indicating that the
repression of L1 is not Mecp2 specific. Besides 5mC spe-
cific binding domains, such as the MBD of Mecp2, the
non sequence specific DNA binding domain IDTRD of
Mecp2 can also repress the L1 retrotransposition. When
compared to in vitro methylated L1 5’UTR using HpaII
methyltransferase [20], human endogenous L1 5’UTR
[60] might provide more binding sites to Mbd2. Thus,
four methylated CpG sites seem to be not enough for
the repression of L1 retrotransposition by Mbd2, but it
is enough for Mecp2 because of its sequence unspecific
strong DNA binding ability [67]. In summary, we show
that human L1 can be re-activated by Tet1 proteins and
this might lead to decreased genome stability [15] and
activation of proto-oncogenes in cancer [68]. Finally,
our data indicates that the Tet1 mediated activation of
L1 can be repressed by Mecp2 and Mbd2 revealing a
role of Mecp2 and Mbd2 as guardians of genome stabil-
ity by preventing retrotransposition.
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Supplementary Figures 
 
 
 
Figure S1 Flow cytometry analysis of cells ectopically coexpressing mcherry-Tet1CD/CDmut 
and GFP-tagged MBD proteins. Shown are cell populations expressing similar mcherry-
Tet1CD/CDmut levels that were used for RNA preparation.  
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Figure S2 Effect of Tet proteins on chromatin structure. (A) Quantification of chromatin 
condensation states. On a histogram, condensed chromatin (DAPI stained) is characterized 
by high DAPI intensities. Accordingly, cell nuclei containing condensed chromatin have a 
higher DAPI standard deviation than cells containing decondensed chromatin, which in turn is 
characterized by low DAPI intensities. (B) 3D structured illumination microscopy images of 
fixed and DAPI stained mouse C2C12 myoblasts 24 hours post transfection with GFP-
Tet1CD, GFP-Tet1CDmut and GFP. Scale bar 5 µm. (C) DAPI standard deviation values of 
mouse myoblasts 24 hours post transfection with GFP-Tet1CD, GFP-Tet1CDmut and GFP as 
negative control. Shown are mean values of two independent experiments and the 
corresponding 95% confidence interval. Independent two-sample student’s t-test was 
performed (***: p < 0.001, ns: non significant).  
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Figure S3 Tet1 increases L1 ORF1p levels. (A) Schematic overview of the automated 
analysis procedure performed with the Harmony 3.5.1 software (PerkinElmer). Shown are 
representative confocal images of HEK293T cells cotransfected with EGFP and mcherry-
Tet1CD and immunostained for L1 ORF1p. For calculation of the sum fluorescence EGFP, 
mcherry-Tet1CD and L1 ORF1p intensity, the nucleoplasm was identified according to the 
mcherry-Tet1CD signal and the cytoplasm was identified (in mcherry-Tet1CD positive cells) 
according to the EGFP signal. Subsequently, the total fluorescence intensity of the 
nucleoplasm was subtracted from the total fluorescence intensity of the cytoplasm (= sum 
cytoplasmic fluorescence intensity). Same analysis was performed for HEK293T cells 
coexpressing EGFP and mcherry-Tet1CDmut, or mcherry. (B) Boxplots of three independent 
biological repeats with at least 45000 cells per condition. Tet1CD overexpression increases 
L1 ORF1p levels significantly more than ectopic expression of Tet1-CDmut or mcherry. 
Independent two-sample student’s t-test was performed (***: p < 0.001). 
4.2 L1 retrotransposition is activated by Ten-eleven-translocation protein 1 and repressed by methyl-CpG binding proteins
105
 
Figure S4 Catalytic activity of Tet1 induces γH2AX formation.  The human AG cells were 
transfected with mcherry tagged Tet1CD or Tet1CDmut and 24 hours after transfection, the 
cells were used for immunostaining with γH2AX and 5hmC antibody. The results showed that 
5hmC levels are increased with increase expression of Tet1CD but not Tet1CDmut. 
Accordingly, the γH2AX signal is also increased with Tet1CD but not Tet1CDmut. Two 
independent experiments were performed.  
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Figure S5 Tet proteins activate L1 retrotransposition in mouse neural stem cells but not 
mouse and human fibroblast cells. Mouse neural stem cells, mouse tail fibroblast and human 
skin fibroblast cells were transfected with mcherry-Tet1CD or mcherry. 48 hours after 
transfection, mcherry positive cells were separated from untransfected cells using flow 
cytometry. Genomic L1 ORF2 content was checked using quantitative PCR. The relative 
amount of ORF2 to 5’UTR and ORF2 to 5S RNA was used to show the copy number 
changes for human and mouse cells, respectively. The results showed that Tet1 proteins 
increase genomic L1 ORF2 content in mouse neural stem cells, but not in mouse and human 
fibroblast cells. Shown are mean values of at least three independent experiments and the 
corresponding standard deviation. Independent two-sample student’s t-test was performed  
(*p < 0.05, ns: non significant).  
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Figure S6 Generation of reporter cell line expressing pLRE3-EGFP (A) The human L1 
retrotransposition cassette of the pLRE3-EGFP plasmid. (B) The process of reporter cell 
generation. The HEK-EBNA cells were transfected with pLRE3-EGFP plasmid. Two days 
after transfection, cells were treated with 2 µg/mL puromycin for resistance selection. Lower 
row shows the representative images of EGFP expression and corresponding bright field. 
Scale bar: 100 µm. Upper row shows the hypothesis that the episomal L1 promoter gets 
methylated during persisting cultivation. Cartoon cells illustrate expression of EGFP and 
episomal presence of pLRE3-EGFP. Grey and black circles attached to chromosomes 
represent unmethylated and methylated pLRE3-EGFP plasmid, respectively. Green dots on 
chromosomes represent the integrated EGFP cassette, which includes the CMV promoter 
and the EGFP coding sequence. 
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Figure S7 PCR analysis to validate the presence of pCEP4-LRE3-EGFP (EGFP with γ-globin 
intron) and the absence of genomically integrated LRE3-EGFP (EGFP without γ-globin intron) 
in the retrotransposition reporter cell line. Three days after transfection with pCEP4-LRE3-
EGFP, HEK-EBNA cells were treated with 2 µg/mL puromycin. One day after puromycin 
selection, EGFP negative cells were separated from EGFP positive cells using flow cytometry. 
EGFP negative, EGFP positive and untransfected (negative control) cells were boiled for 20 
minutes at 99°C in ddH2O. Cell lysates containing 20,000 cells were used as template for the 
amplification of EGFP (CMV fwd: 5’ CGTGGATAGCGGTTTGAC 3’, EGFP rev: 5’ 
TCTTTGCTCAGGGCGGACTG 3’) to determine if the globin intron had been removed by 
splicing during the retrotransposition process. As positive controls, pEGFP-N1 (EGFP without 
γ-globin intron) and pCEP4-LRE3-EGFP (EGFP with γ-globin intron) were used. To control 
for the presence of genomic DNA, we amplified exon 12 of human TET1 (TET1 fwd: 5’ 
GAACTCGAGCCAACCAACACAACATCAGC 3’, TET1 rev: 5’ 
GAATTCGAAAATACACTGCACTAGCAAAGG 3’. The spliced EGFP variant could only be 
detected in EGFP positive, but not in EGFP negative cells (red square). 
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Figure S8 Tet1 reactivates engineered L1. (A) Detection of L1 retrotransposition events by 
time lapse imaging. Reporter cell line was grown in 96-well plates and transfected with 
mcherry-Tet1CD/CDmut or mcherry only. 16 hours post transfection, EGFP and mcherry (+/- 
Tet1CD/CDmut) expression levels were detected over a period of 76 hours in time intervals of 
four hours at 37°C with 5% CO2. Representative images of each time point were compiled in 
form of a video. Mean intensities of EGFP and mcherry expressing cells were calculated 
using the Harmony software and plotted by RStudio. Two individual experiments were 
performed and mean values are shown. (B) Detection of engineered L1 retrotransposition 
events in reporter cell line containing pLRE3-EGFP 48 hours after mcherry-Tet1CD/CDmut 
and mcherry transfection. The number of mcherry positive (+) and negative (-), as well as 
EGFP positive (+) cells was counted by flow cytometry and the ratio between 
EGFP+/mcherry+ and EGFP+/mcherry- cells was calculated to determine the quantity of 
recent L1 integrations. Independent two-sample student’s t-test was performed between 
Tet1CD and Tet1CDmut or Tet1CD and mcherry transfected cells (***: p< 0.001). Three 
individual experiments were performed and the bar represents the mean + SD. At least 
120,000 cells were analyzed for each group. (C) Detection of engineered L1 
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retrotransposition events in pLRE3-EGFP containing, 5-aza-C treated cells by flow cytometry. 
Two individual experiments were performed and the bar represents the mean + SD. At least 
2,500 cells were analyzed in each time point.  
 
 
	
Figure S9 EGFP expression results from de novo retrotransposed L1 elements and not from 
genomically silenced previously integrated EGFP in the reporter cell line. The reporter cell 
line was cultured in the absence or presence of 2 µg/uL puromycin. Four and 11 days later, 
the cells were transfected with mcherry-Tet1CD plasmids and two days after mcherry-Tet1CD 
transfection, the number of EGFP positive (+) cells was counted by flow cytometry and the 
percentage of EGFP positive cells was used to determine the quantity of recent L1 
integrations. At least three independent experiments were performed and each experiment 
around 100,000 cells were analyzed. The bar represents the mean + SD. Independent two-
sample student’s t-test was performed (***: p< 0.001, ns: non significant). 
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Figure S10 Transcription from a methylated L1 promoter is activated by Tet1CD and 
repressed by Mecp2. (A) Scheme illustrating the workflow and sites (nucleotides 36, 101, 304 
and 481) in the L1.3-5’UTR methylated by M.HpaII methyltransferase. (B) HpaII and MspI 
digestion to control for efficient methylation of the pGL3-L1.3-Luc plasmid. While HpaII 
digestion is impaired by methylation, MspI cuts both, methylated and unmethylated DNA. (C) 
HEK cells were co-transfected with unmethylated (UM) or HpaII-methylated (M) reporter L1.3-
Luc and expression constructs coding for Tet1CD, Tet1CDmut, Mecp2 and Tet1CD+Mecp2, 
respectively. Relative luciferase activity of the unmethylated reporter was set to 1. Bars 
represent mean luciferase activities of three independent experiments + SD and p values are 
indicated.  
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Video 1 Time-lapse fluorescence microscopy of the L1 retrotransposition reporter cell line 
upon Tet1CD expression. EGFP (left, green) indicates L1 retrotransposition events. mcherry-
Tet1CD protein is shown in red (right). Multiple fields of view are shown stitched together and 
time is indicated at the top. Scale bar: 100 µm.  
 
Video 2 Time-lapse fluorescence microscopy of the L1 retrotransposition reporter cell line 
upon Tet1CDmut expression. EGFP (left, green) indicates L1 retrotransposition events. 
mcherry-Tet1CDmut protein is shown in red (right). Multiple fields of view are shown stitched 
together and time is indicated at the top. Scale bar: 100 µm.		
Video 3 Time-lapse fluorescence microscopy of the L1 retrotransposition reporter cell line 
upon mcherry expression. EGFP (left, green) indicates L1 retrotransposition events. mcherry 
protein is shown in red (right). Multiple fields of view are shown stitched together and time is 
indicated at the top. Scale bar: 100 µm.		
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The nucleolus is the hallmark of nuclear compartmentalization and has been shown to exert multiple roles in cellular
metabolism besides its main function as the place of rRNA synthesis and assembly of ribosomes. Nucleolar proteins
dynamically localize and accumulate in this nuclear compartment relative to the surrounding nucleoplasm. In this
study, we have assessed the molecular requirements that are necessary and sufﬁcient for the localization and
accumulation of peptides and proteins inside the nucleoli of living cells. The data showed that positively charged
peptide entities composed of arginines alone and with an isoelectric point at and above 12.6 are necessary and
sufﬁcient for mediating signiﬁcant nucleolar accumulation. A threshold of 6 arginines is necessary for peptides to
accumulate in nucleoli, but already 4 arginines are sufﬁcient when fused within 15 amino acid residues of a nuclear
localization signal of a protein. Using a pH sensitive dye, we found that the nucleolar compartment is particularly acidic
when compared to the surrounding nucleoplasm and, hence, provides the ideal electrochemical environment to bind
poly-arginine containing proteins. In fact, we found that oligo-arginine peptides and GFP fusions bind RNA in vitro.
Consistent with RNA being the main binding partner for arginines in the nucleolus, we found that the same principles
apply to cells from insects to man, indicating that this mechanism is highly conserved throughout evolution.
Introduction
Proteins inside the highly compartmentalized cell nucleus
often localize in correlation with their function to discrete subnu-
clear regions also referred to as subnuclear bodies.1,2 These
nuclear substructures were identified as sites where specific bio-
chemical reactions take place, e.g., DNA replication foci, or as
sites of storage and modification for different proteins like in
Cajal bodies and nuclear speckles.3,4 The localization of proteins
in the nucleus is often mediated by specialized signals, targeting
or interaction motifs of different length and can change over
time, cell cycle and with external stimuli.5-8 The most prominent
subnuclear structure is the nucleolus, which appears as a dark
region in phase contrast microscopy due to its high density.9-11
The nucleolus is the place of transcription and storage of the
rDNA as well as the assembly and maturation site for ribosomes
and, in translationally active cells, filled with pre-ribosomal par-
ticles and components. The nucleolar structure is very dynamic
and forms around rDNA loci.12,13 It has further substructures,
which are connected to the different steps in ribosome biogenesis
and can be best identified by antibody labeling or electron
microscopy. The fibrillar centers (FC) harbor the rDNA in the
nucleolar center and are surrounded by the dense fibrillar compo-
nents (DFC) containing the nascent rRNA transcripts. The gran-
ular component (GC) is filled with pre ribosomal particles
composed of rRNA and proteins, extends into the nucleus and is
surrounded by chromatin.11,14,15
An early study has shown that the nuclear import of sev-
eral proteins is mediated by short sequences of 6–10 basic
amino acid (aa) termed nuclear localization sequences (NLS),
some of which also serve as nucleolar targeting sequence
(NoLS).16 Another nucleolar targeting sequence (NoLS) was
described in 1990 and contains a minimum of 5 basic aa,
often lysines and arginines.17 The recent systematic analysis
of 46 NoLS sequences for their amino acid composition and
sequence features has shown greater sequence diversity
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including bipartite sequences as well as overlap with NLS.
The study determined also a high content of basic amino
acids (48%) and a predominant location in the termini of
proteins.18 Proteins smaller than 60 kDa or up to a diameter
of 9 nm can passively diffuse into the nucleus19 but this pro-
cess becomes more and more inefficient with increasing size
(reviewed in20,21). The nucleus is separated from the cyto-
plasm by a membrane system and involves an active import
mechanism.22 In contrast, the localization of proteins to the
nucleolus has never been shown to involve active transport
mechanisms. Nuclear proteins without nucleolar function are
often less concentrated or completely excluded from the
nucleoli while nucleolar proteins are highly enriched in this
nuclear compartment. The localization or exclusion of pro-
teins from the nucleolus is subject to dramatic changes upon
cellular stimuli, stress and complete reorganization during cell
cycle progression.23-25
In a previous study, we have shown that a reporter protein
traverses nucleoli rapidly with less obstruction compared to
nucleoplasmic regions rich in chromatin.26 In that study, we
described a structural feature of the nucleolus with channel like
regions void of nucleic acids and proteins that facilitates a fast
movement of non-nucleolar proteins through this compart-
ment. Contrastingly, the neighboring densely packed structures
in the nucleolus reduce the available space for the localization
of non-nucleolar proteins.26 Still it is unclear, what are the
essential properties or requirements of proteins and peptides to
accumulate in the nucleoli and what are the features of these
molecules that prevent nucleolar accumulation. The systematic
identification of NoLS sequences by an artificial neural network
trained with confirmed NoLS sequences has found thousands
of potential sequences that could serve to mediate nucleolar tar-
geting. Several previously unknown NoLS have been experi-
mentally confirmed thereafter.18,27 However, a considerably
false positive prediction rate especially among sequences from
nuclear proteins raises the question of how NLS and NoLS can
be distinguished. The difference in the composition of a stan-
dard NLS and the peptides that accumulate in nucleoli is
rather subtle, with the NLS being a few basic charged amino
acids shorter than, e.g., the nucleolar marker peptide of 10
arginines described by us.16,28 This observation led to the fol-
lowing 2 questions: (a) what are the specific requirements in
amino acid composition for peptides and proteins to localize to
the nucleoli and (b) what are the key differences between
NoLS and NLS sequences?
In this study, we systematically investigated the molecular
properties of peptides and proteins that result in different distri-
bution levels between nucleoplasm and nucleolus. For this pur-
pose, we tested and analyzed the distribution of a series of
fluorescently labeled short peptides with different charge and iso-
electric properties between the cytoplasm, nucleoplasm and their
accumulation in the nucleolus. The same peptide sequences were
genetically fused to the 50 end of the open reading frame coding
for the tracer protein GFP, with no intracellular binding sites, to
test the effect of the same short peptide sequences on the localiza-
tion of proteins.
Materials and Methods
Peptides, plasmids and cell lines
All peptides were synthesized from L-amino acids except deca-
arginine (R10), which was made as 2 versions one from L- and
one from D-amino acids by Peptide Specialty Laboratories
GmbH (Heidelberg, Germany). The peptides were coupled
directly to fluorescein at the N-terminus, contain a C-terminal
amide-group and were purified by HPLC. The TAT peptide was
synthetized with D-amino acids and conjugated with TAMRA as
described.29 It can be excluded that different amounts of fluores-
cent labeling on the different peptides play a role in the intracel-
lular distribution, since the in vitro synthesis of peptides coupled
to a resin material allows only in line addition of amino acids
and the fluorophore. The pI values of the peptides and proteins
were calculated using the ProtParam tool on http://web.expasy.
org/protparam/.
The GFP based mammalian expression constructs were gener-
ated by using oligonucleotides encoding the respective poly-D,
poly-G and poly-R sequences (supplementary Table 1). The oli-
gos with overhanging 30 and 50 AgeI sites were annealed and
ligated into the AgeI site of an NLS-GFP construct based on the
pEVRF vector.30 This vector is identical to the one described
before for the CMV-driven expression of GFP-tagged PCNA.31
In addition, the pEGFP-C1 vector (Clontech, Heidelberg, Ger-
many) without a NLS sequence was used.
Human HeLa and HEK 293-EBNA cells, as well as mouse
C2C12 myoblasts were cultured as described before.32,33 Pac2
zebrafish cells were grown at 28C in Leibovitz L-15 medium
supplemented with 15% fetal calf serum in presence of 1%
penicillin-streptomycin. Sf9 insect cells were maintained in EX-
CELL TM 420 Insect Serum Free (SAFC) medium with L-gluta-
mine (Biosciences) and 10% fetal calf serum and cultured with
shaking at 100 rpm and 28C. The L40ccua yeast strain used for
the current study has the following genetic background: (MATa
his3_200 trp1–901 leu2–3,112 LYS2::(lexAop)4-HIS3 ura3::
(lexAop)8- lacZ ADE2::(lexAop)8-URA3 GAL4 gal80 can1
cyh2).34 Yeast cells were grown at 30C in yeast extract/peptone/
dextrose (YPD) and were supplemented with 2% glucose as a car-
bon source.
Live cell peptide loading and transfections
All peptide experiments were performed exclusively with liv-
ing cells plated on 8-well Ibidi chambers. The different poly-
lysine (poly-K) and poly-arginine (poly-R) peptides were scratch
loaded into living cells. For the scratch loading of peptides we
used syringes and scratched over the chamber bottom in different
directions.35,36 The size of the peptides permitted passive diffu-
sion into the cells and nuclei after delivery. After the scratch load-
ing the cells were allowed to recover for about half an hour at
37C before exchanging the medium to remove unloaded pepti-
des. Microscopy and image acquisition was started immediately
after the procedures described above to circumvent peptide short-
ening by proteases and, hence, mislocalization. Peptide concen-
trations from 10 to 100 mm were initially tested and no apparent
changes in cell viability were observed during the course of the
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experiments. As low concentrations of 20 mM were sufficient for
quantitative imaging, these conditions were used for the subse-
quent quantification. Scratch loaded cells did not show dramatic
differences in the level of intracellular fluorescence, likely because
the peptide concentration in the medium was the same in all
cases. Only cells with normal cellular physiology comparable to
non-scratch loaded cells were imaged. The criteria for the selec-
tion of cells that repaired after scratch loading were: i) cells are
completely attached and stretched out on the chamber bottom
surface; ii) no membrane lesions or leakage of cytoplasmic con-
stituents visible in phase contrast; iii) round or oval shaped nuclei
with smooth outline and nucleoli visible in phase contrast.
The transfection of cells with plasmid constructs was per-
formed using the CaPO4-DNA co-precipitation protocol as
described before,37 except for HEK 293-EBNA cells, which were
transfected using poly-ethylenimine (1 mg/mL in ddH2O, pH 7;
Sigma-Aldrich, St. Louis, MO, USA) as described before.38
Cell fixation and antibody staining
Cells grown on glass coverslips for 24 h were incubated with
10 mM FITC-R10 for 1 h. After washing with 1xPBS, cells were
fixed in 3.7% formaldehyde in PBS for 10 min and permeabi-
lized with 0.25% Triton X100 in PBS for 10 min. Immunostain-
ing with anti-B23 mouse monoclonal antibody (clone FC82291;
Sigma) was followed by detection with donkey anti-mouse IgG
antibody conjugated with TexasRed (Jackson). Coverslips were
mounted with Moviol (Sigma).
Microscopy, image acquisition and analysis
Live cell microscopy was performed with a Zeiss
LSM510Meta confocal setup mounted on an Axiovert 200 M
inverted microscope using a 63x phase contrast plan-apochromat
oil objective NA1.4. The microscope was placed in an incubation
chamber heated to 37C to maintain the cell incubation condi-
tions (Okolab, Italy). For the measurements of plasmid trans-
fected cells, a Leica TCS SP confocal microscope was used. For
all acquisition settings the main beam splitter was HFT UV/488/
543/633. FITC was excited with the 488 nm line of an argon
laser and fluorescence detected with a band-pass filter 500–
530 nm. Phase contrast or differential interference contrast
images were recorded simultaneously with FITC fluorescence in
the transmission channel. The live-cell DNA dye DRAQ5 was
used and imaged as described.32
Cells loaded with peptides were chosen for imaging by having
low but easily detectable intracellular fluorescence intensity. The
same criteria were applied to cells transfected with plasmid con-
structs. Imaging of live cells was performed using as much as pos-
sible similar settings per instrument.
The SNARF 4F cell-permeant dye (Sigma) was loaded into
cells by incubating for 30 min at a final concentration of 5 mM
in growth medium. Fluorescence was excited at 561 nm and
emission detected at 587 nm and 640 nm.
For image analysis, the nuclei were identified in the corre-
sponding phase contrast images by means of the nuclear mem-
brane delineation and nucleoli correspond to the dark dense
structures inside the cell nucleus. Identification of nucleoli was
confirmed in earlier experiments using a nucleolar marker for liv-
ing cells.28 The selection of regions (cytoplasm, nucleus, nucleo-
lus) and measurements of mean signal intensity were performed
in ImageJ. Measurements of mean fluorescence intensities were
performed by excluding non-interest areas from the measure-
ment, e.g. the nucleoli areas excluded from nucleoplasm and, cor-
respondingly, for all other regions intensities were determined. In
each experiment the average was calculated for 10 cells for each
peptide and protein. Data were normalized to 1.0 (100%) with
respect to the nucleoplasmic fluorescence (excluding the nucleoli)
to directly illustrate the relative accumulation of fluorescence in
the nucleoli. Cytoplasmic fluorescence levels were normalized
correspondingly (excluding nucleus and nucleoli). Data analysis
and statistical tests were performed and displayed with Origin 7
software.
The complete list of predicted nucleolar localization sequences
was downloaded from http://www.compbio.dundee.ac.uk/www-
nod/ and analyzed for mean length, mean numbers of amino
acids and frequencies in Excel and Origin 7.
Protein preparation
GFP and NLS-R7-GFP were prepared from HEK cells 48 h
post transfection using an ice-cold buffer composed of 20 mM
Tris-HCl, 1.5 mM MgCl2, 0.2 mM EDTA, 1 M NaCl and
0.4% NP40. After homogenization by mechanical shearing
through a 23 gauge syringe, lysates were incubated for 10 min on
ice. Following centrifugation (14,000 rpm for 12 min at 4C)
supernatants were incubated for one hour with GFP binding pro-
tein (GBP) coupled to sepharose beads at 4C on a rotary shaker
as described.39 GBP bound proteins were washed 3 times with
ice-cold HEPES buffer (140 mM NaCl, 2.5 mM KCl, 5 mM
HEPES, 5 mM glycine, pH 7.4) and used for the in vitro RNA
pull-down assay. All buffers were supplemented with 1 mM of
protease inhibitor PMSF (Carl Roth, Karlsruhe, Germany).
RNA preparation
Total RNA was isolated from HEK cells using the RNeasy
Mini Kit (Qiagen, Hilden, Germany) according to the man-
ufacturer’s instructions. To remove traces of genomic DNA,
RNA was treated with RNase-free, recombinant DNaseI
(Macherey Nagel, Dueren, Germany) for 30 min at 37C and
further purified with the Qiagen RNeasy Mini Kit. To assess the
concentration and purity of RNA, the ratio of absorbance at
260 nm and 280 nm was measured on a TECAN infinite M200
plate reader (Tecan Group Ltd., Maennedorf, Switzerland). To
further verify RNA quality, total RNA was denatured for 5
minutes at 99C, separated on a 1.5% Tris-acetate-EDTA/aga-
rose gel supplemented with 0.05 mL/mL Roti-Safe GelStain
(Carl Roth, Karlsruhe, Germany) by electrophoresis and imaged
on an Amersham Imager 600 (GE Healthcare, Freiburg,
Germany).
In vitro RNA binding assays
For RNA slot blots, total RNA was mixed with RNase-free
ddH2O at a final concentration of 500 ng/mL and blotted on
pre-equilibrated (5 min methanol, 5 min 20x saline sodium
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citrate) PVDF membranes (0.45 mm pore size; Pall GmbH,
Dreieich, Germany). After air-drying, membranes were blocked
for 30 min with 5% milk in PBS supplemented with 1x Pro-
tectRNA RNase inhibitor (Sigma-Aldrich, St. Louis, MO, USA)
and incubated for 1 h with either TAT, D-R10, or L-R10 (all
fluorescently labeled), respectively, on a rotary shaker. Following
three washing steps (5 min each) with HEPES buffer, remaining
fluorescent signals were detected on an Amersham Imager 600
(GE Healthcare, Freiburg, Germany). Quantities of blotted
RNA were monitored in parallel by methylene blue (0.02%)
staining (Carl Roth, Karlsruhe, Germany) in 0.3 M sodium ace-
tate (Merck, Darmstadt, Germany) pH 5.5.
For the pulldown assay, immobilized GFP and NLS-R7-GFP,
respectively, were incubated with equal amounts (3.4 mg) of total
RNA in 20 mL HEPES buffer for 1.5 h at 4C on a rotary
shaker. After three washing steps with HEPES buffer, RNA was
labeled with 3.3 mg/mL propidium iodide (Sigma-Aldrich, St.
Louis, MO, USA). Following three washing steps in HEPES
buffer, remaining fluorescent signals were measured on a
TECAN infinite M200 plate reader (Tecan Group Ltd., Maen-
nedorf, Switzerland) using excitation/emission at 488/555 nm
and 515/617 nm for GFP and propidium iodide, respectively.
To control for the amount of GFP and NLS-R7-GFP, fluores-
cent signals of propidium iodide were normalized to GFP signals.
In addition, the same beads were imaged in an UltraVIEW VoX
spinning disc confocal system (PerkinElmer), mounted on a
Nikon TI microscope. Images were taken with a 20x/0.7 NA
objective. GFP and propidium iodide or TAMRA were imaged
with 488 and 561 nm laser excitation and 527 § 55 and 612 §
70 nm emission filters, respectively.
Results
Short specific sequence motifs in proteins are well known to
play a key role in localizing proteins to specific cellular and sub-
cellular compartments. We have shown earlier that short peptides
of 10 arginines with a strong basic charge have the potential to
accumulate inside the nucleoli of living cells and can be used to
label this subnuclear compartment.28 Now, we wished to investi-
gate the specific molecular requirements of peptides and proteins
that are necessary and sufficient to reach and accumulate inside
of the nucleolus.
Therefore, our first aim was to determine the properties of
charge, length and composition of basic charged peptides neces-
sary for nucleolar targeting and accumulation. We used short
synthetic peptides labeled with FITC for visualization, which
were scratch loaded into living C2C12 mouse myoblast cells.
The peptides, either composed of arginines (R) or lysines (K)
with a length varying from 5 to 12 amino acids, were allowed to
enter the cells and distribute in the cytoplasm and nucleus. The
observation of the cells by confocal microscopy started after a
recovery time of 30 min after scratching loading. For each pep-
tide at least 10 cells were selected and imaged with respect to sim-
ilar intracellular fluorescence intensity levels. The microscopic
observation of the cells shows for all peptides a homogeneous
distribution in the cytoplasm, where only vesicular structures
were free of labeled peptides. Similarly, in the nucleoplasm the
peptides distributed without enriching at any foci. All L-amino
acid peptides tested here, K5 to K12 and R5 to R12 accumulated
predominantly in the nucleus compared to the cytoplasm, as
shown by the fluorescence intensity in mouse C2C12 cells
(Fig. 1A and B). The peptides R6 to R12 clearly showed higher
fluorescence intensity in areas inside the cell nucleus, which were
identified as nucleoli correlating with the dark dense structures
visible in the phase contrast images (Fig. 1A). The peptide R5
did not accumulate in nucleoli (Fig. 1A), which was also the case
for all poly-K peptides (Fig. 1B). This indicates that charge alone
is not the only determinant but rather the isoelectric properties,
which differ between K and R polymers. To quantitatively ana-
lyze the intensity and distribution patterns, we determined for 10
cells the mean fluorescence intensity in the cytoplasm, nucleus
(excluding nucleoli) and in the nucleoli. The regions for fluores-
cence intensity measurements were chosen with reference to the
phase contrast images and overlayed with the fluorescence image
as shown in Figure 1C. Data were normalized to the nucleoplas-
mic levels to reflect the accumulation potential of molecules in
the nucleolus over the nucleoplasmic levels (Fig. 1C). The
numerical values are given in supplementary Tables 2 and 3.
The comparison of the mean fluorescence intensity shows, for
all poly-K peptides, an average cytoplasmic level of 0.74 fold less
compared to the nucleoplasm. For poly-R peptides the cyto-
plasmic level is on average 0.68 fold less than in the nucleoplasm
(Fig. 1A, B and supplementary Table 2). These data already
demonstrate that poly-R peptides have the potential for stronger
accumulation in the nucleus than poly-K peptides. Although all
peptides tested are small enough to passively diffuse in and out of
the nucleus and should distribute evenly, all of them accumulate
in the nucleoplasm.
Strikingly, only the peptides R6 to R12 show a further visible
accumulation inside nucleoli with an average of 1.16-fold over
the nucleoplasmic level (Fig. 1C). The statistical analysis with a
non-parametric Kruskal-Wallis ANOVA test shows significance
for the accumulation of R6 to R12 in the nucleolus. The poly-K
peptides show only slightly higher level in the nucleoli with val-
ues between 1.02 and 1.06 fold over the nucleoplasm. An
increase of the peptide length from R6 to R12 and thus the posi-
tive charge and isoelectric properties does not linearly increase
the nucleolar accumulation level of the peptides. The highest
level of nucleolar accumulation was found for the R9 peptide
with 1.22 fold over the nucleoplasmic level, while the mean accu-
mulation of R11 and R12 rather decreases slightly to 1.12 and
1.14-fold respectively (Fig. 1A, B and supplementary Table 2).
This suggests that there is a saturation/plateau level at and above
9 arginine residues.
From yeast to human cells, main features of the nucleolus
structure and function are conserved as it forms around clus-
ters of rRNA genes and is the sites of ribosome biogenesis. We
were now interested if the nucleolar localization and accumu-
lation of proteins and peptides is similarly conserved. There-
fore, we tested the nucleolar accumulation potential of the
R10 peptide in cultured cells of different species. We scratch
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loaded the FITC labeled R10
into cells from yeast
(S. cerevisiae), insects (D. mela-
nogaster), fish (D. rerio), mouse
(M. musculus) and human (H.
sapiens) cells and analyzed the
localization of the peptides by
confocal microscopy (Fig. 1D).
In yeast cells the nucleus and
nucleolus are more difficult to
identify and clear accumulations
in the cells are not as visible as
for the cells of higher eukar-
yotes. Regions with less peptide
inside the yeast cells could cor-
respond to the vacuole. In the
cells from insect, fish, mouse
and human, on the other hand,
the nucleoli are visible in the
phase contrast images and show
clearly an accumulation of the
R10 peptide compared to the
nucleus and cytoplasm of the
cells (Fig. 1D). To clarify the
localization of the FITC-R10 in
yeast we performed a co-label-
ing of yeast cells with the live
cell DNA dye DRAQ5.32 In
this experiment the yeast
nucleus is visible as intense
labeled round compartment in
the cells. In some cells we could
identify a crescent shaped
region in the periphery of the
nucleus with higher FITC-R10
intensity compared to the
nuclear interior and the cyto-
plasm. A corresponding fluores-
cence intensity linescan analysis
confirms an accumulation of
the peptide in a crescent shaped
region in the nuclear periphery
(Fig. 1E). Early studies on the
composition of yeast nuclei
have shown that, depending on
the orientation a round or cres-
cent shaped peripheral nuclear
compartment harbors the nucle-
olus.40-42 All cell types of multi-
cellular organisms tested here
show a similar enrichment of
the labeled poly-R peptides in
the nucleoli. Some yeast cells
show a similar accumulation in the nuclear periphery. The
accumulation of peptides like R10 inside nucleoli is, thus, evo-
lutionary conserved at least from insects to humans. Notably,
HeLa cells in metaphase having no cell nucleus and with the
nucleoli disassembled lack also the nucleolar accumulation of
peptides found in interphase cells. Thus, the accumulation of
Figure 1. Distribution of poly-(R)and poly-(K)peptides in living cells. Intracellular distribution of poly-R pepti-
des in (A) and poly-K peptides (B) in living C2C12 mouse cells. In each panel, the ﬂuorescence image is on top
of the corresponding phase contrast image. Nucleoli are clearly visible as dark round structures within the
nuclei in the phase contrast images. The bar diagrams in (C) show the quantiﬁcation of the poly-K and poly-R
peptide mean ﬂuorescence in cytoplasm, nucleoplasm and nucleoli averaged for 10 cells from 2 independent
experiments. The nucleoplasmic values were used for normalization. Areas for quantiﬁcation were deﬁned as
described in methods and overlayed with ﬂuorescence images as shown. Intracellular distribution of R10 pep-
tide in living cells of different species as indicated is shown in (D). In (E) living yeast cells were further stained
with DRAQ5 for better visualization of the nucleus and a line intensity proﬁle in arbitrary units (a.u.) of both
DNA and peptide is shown. The intracellular distribution of (D) and L-R10 peptides in living C2C12 cells and
the corresponding quantiﬁcation of mean ﬂuorescence intensities is shown in (F). Scalebars: 5 mm.
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poly-R peptides is directly linked to the structure and function
of the nucleolus (supplementary Fig. 1D).
All amino acids incorporated into proteins by translation in
living organisms are L-enantiomers and only post-translational
enzymatic reactions in various organisms convert some to D-
amino acids.43,44 Besides that, free D-amino acids were discovered
only in brain tissue.45 We argue that a poly D-arginine peptide
may not exhibit the specific binding to the same cellular target
components, e.g., proteins or nucleic acids, as the L-enantiomer.
In contrast, the peptide charge and isoelectric properties are not
altered when composed of D-amino acids. This phenomenon is
exploited in mirror image phage displays used in the search for
therapeutic peptides with novel targets and improved proper-
ties.46,47 The latter exploits the stability of the D-amino acid pep-
tides to proteolytic degradation. Hence, we compared the
distribution of FITC-R10 composed of D and L amino acids
(Fig. 1F). Inside living cells both D- and L-R10 peptides distrib-
ute homogenously in the cytoplasm and accumulated in the
nucleoli. The main difference in the distribution is that D-R10
had a much lower concentration in the nucleoplasm compared to
the L-R10, therefore the measurement of relative accumulation of
D-R10 over the nucleoplasmic level appears much stronger
(Fig. 1F). However, the absolute detected fluorescence intensities
were comparable between both types of peptides using the same
microscopic detection settings. This finding indicates either a
binding of the L-peptide to a nucleoplasmic component, which is
not the case for the D-peptide, and/or the lack of degradation of
the D-R10. Interestingly though, the mean intensity of fluores-
cence in the nucleoli is at similar levels for both types of peptides.
Next, we tested the role of various peptides in the targeting of
proteins inside the cell nucleus. We used peptides fused to the
neutral tracer protein GFP to determine localization patterns.
For this purpose, we used GFP already fused to a NLS sequence
(SV40 T antigen derived; PKKKRKV48) and added downstream
further basic, acidic and neutral peptides of different lengths fol-
lowed by the enhanced GFP coding sequence. The different GFP
fusions were expressed in C2C12 mouse myoblast cells (Fig. 2A)
and in human HeLa cells (supplementary Fig. 1) and imaged
with a confocal microscope. We also tested the distribution of an
uncoupled GFP and the NLS-GFP alone as comparison and as
controls for cytoplasmic and nucleoplasmic localization with no
expected nucleolar localization and accumulation.
The microscopic images of the GFP versions in Figure 2A
show for the GFP without NLS a homogeneous distribution
throughout the cell with similar levels in cytoplasm and
nucleus with significant reduction in the nucleoli (p D 0.01 see
supplementary Table 2). The slightly lower mean intensity in
the cytoplasm is the result of membranous compartments
devoid of GFP protein (Fig. 2A
and C; supplementary Table 2).
The homogeneous distribution
between nucleus and cytoplasm
is the result of passive diffusion
into the nucleus. Molecules with
a diameter of up to »9 nm are
capable of entering the cell
nucleus by passive diffusion,
which has been measured for
fluorescent molecules the size of
GFP to occur within a few
minutes.19,49 The NLS coupled
GFP, though, shows more than
2-fold accumulation in the
nucleus over the cytoplasmic
level but with a similar reduction
in the nucleoli, visible as round
elevated objects in the DIC
images. This distribution pattern
is similar for all NLS-GFP var-
iants with additional acidic
(aspartate) and neutral (glycine)
amino acid series (Fig. 2A and
C). The nucleolar level of the
different proteins in Figure 2A is
significantly reduced in the range
of 0.7 to 0.5-fold compared to
the nucleoplasmic level as deter-
mined by measuring the mean
fluorescence intensity (Fig. 2C
and supplementary Table 2).
Figure 2. Intracellular distribution of peptide tagged GFP tracer proteins in living cells. (A) Representative
microscopic images of live C2C12 cells transfected with GFP, NLS-GFP and a fusion of NLS-GFP with 8 glycines
(8G) as example for the addition of neutral amino acids is shown in the ﬁrst panel. The second panel shows
images of cells with fusions of an increasing number of aspartates as examples for acidic amino acid fusions
to NLS-GFP. The GFP ﬂuorescence is depicted in the upper row with the corresponding differential interfer-
ence contrast (DIC) images below. (B) Microscopic Images of the distribution of the NLS-GFP fused to 4 to 7
additional arginines. The graphs in (C) represent the mean distribution of the GFP constructs depicted in (A)
and (B) in cytoplasm and nucleoli in relation to the nucleoplasm for an average of 10 cells from 2 indepen-
dent experiments. Scalebars: 5 mm.
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Contrastingly, all NLS-GFP versions coupled to poly-R pepti-
des from R4 to R7 show a clear accumulation in the nucleoli
around 2 to 3-fold over the nucleoplasmic level. The nucleolar
accumulation is lowest for NLS-R4-GFP at 1.7-fold and
increases with the growing number of arginine residues up to
2.7-fold for NLS-R7-GFP (Fig. 2B and C and supplementary
Table 2). Interestingly, the comparison of the data for peptides
and proteins shows that in contrast to the FITC-R5 peptide, we
see already for the R4 fused to NLS-GFP a nucleolar accumula-
tion. This may reflect the proteolytic degradation of the L-amino
acids containing peptides versus the more stable corresponding
GFP fusion proteins. On the other hand, the additional arginine
within the NLS sequence could account for this apparent
difference.
Noteworthy, peptides without nucleolar accumulation like K5
and R5 show no reduced concentration inside nucleoli. Already
in an earlier study testing functional peptides not accumulating
in nucleoli, we observed a similar homogenous nuclear and
nucleolar distribution of a fluorophore labeled peptide.50 These
observations exemplify the dense structure of the nucleoli result-
ing in a size dependent sieving effect for molecules without
potential for accumulation therein. Larger molecules like GFP
(with dimensions of around 2.4 £ 4.2 nm)51 are significantly
excluded compared to much smaller peptides. Interestingly, the
R5 to R7 coupled NLS-GFP molecules show in addition an even
higher efficiency of nuclear import with levels up to 10-fold over
the cytoplasm compared to NLS-GFP alone (Fig. 2B, C and
supplementary Table 2). This observation shows that the addi-
tion of arginine residues to a minimal NLS increases the effi-
ciency of nuclear import largely exceeding the passive leakage
efflux of small protein molecules through nuclear pores. Alterna-
tively, their active retention in the
nucleus by binding, e.g., to the
nucleolus, prevents their exit from
the nucleus.
The data presented here so far
demonstrate that peptides and pro-
teins with a strong positive charge
and high isoelectric point have the
potential to accumulate in the
nucleolus of live cells. The thresh-
old for strong nucleolar accumula-
tion in peptides is R6, while in
proteins bearing an NLS (with one
additional R) already 4 additional
consecutive arginines are sufficient.
In addition, the nuclear import is
enhanced by the addition of at
least 5 arginine residues in proxim-
ity to a minimal NLS. We con-
clude that the charge and
isoelectric properties of the pepti-
des and protein domains responsi-
ble for nucleolar accumulation is
key in this process because first,
the difference between nuclear
import and nucleolar accumulation has never been shown to rely
on an active mechanism. Second, even peptides synthesized with
D-amino acids show nucleolar accumulation, which may fail to
specifically bind to the same cellular targets as their L-enantiomer
counterparts.
The evidence for a charge and isoelectric point dependency for
peptide and protein accumulation in nucleoli led us to postulate
the presence of an electrochemical component. Electrochemical
interactions that would accumulate positively charged basic pep-
tides should be mediated by highly abundant or strong negatively
charged acidic nucleolar components. These have to be confined
to nucleoli as are the accumulated basic peptides and proteins.
Such molecules could be nucleic acids, which are highly abun-
dant in the nucleoli in form of rRNA. Therefore, we wanted to
determine the pH distribution inside the nucleus in living cells.
We used the live cell permeable fluorescent dye SNARF-4F,
which has 2 pH dependent ratiometric emission peaks at around
587 and 640 nm. The calculation of the ratio of the fluorescence
intensity at the 2 emission peaks gives information on the pH of
subcellular structures. The ratiometric images of HeLa cells show
in the fluorescence channel view as well as in the intensity ratio
view different cellular structures highlighted (Fig. 3A top row).
The magnified image detail shows structures at the nuclear
periphery and in the center of the nucleus highlighted as more
acidic (Fig. 3A bottom row). Although the cytoplasm is generally
considered to have a neutral pH, the more acidic regions in the
cytoplasm do most likely represent parts of the Golgi network
and organelles like peroxisomes.52 The central nuclear region
with more acidic pH is reminiscent of the nucleoli in HeLa cells
shown in the phase contrast images in Figure 1D as well as the
DIC images in Figure 2 and in supplementary Figure 1. Almost
Figure 3. Intracellular pH landscape by ratiometric ﬂuorescence microscopy toward the generation of an
intracellular pH landscape. The ﬁgure in (A) displays ﬂuorescence microscopy images of the pH sensitive
dye SNARF-4F in live HeLa cells (color). The green channel shows the emission at 587 and the red channel
the emission of the dye at 640 nm during excitation with the same wavelength. The resulting intensity ratio
image (gray scale) shows ratiometric differences between the intensities of the 2 ﬂuorescence emission
peaks of the dye due to pH variations in subcellular structures. The ﬂuorescence color scale and the ratio
scale in gray indicate the relative range from more acidic to more basic pH. Panel (B) illustrates a map of the
intracellular pH landscape by measuring the pH in various cellular compartments and substructures like
nucleoplasm and nucleolus (modiﬁed from53). Scalebars: 5 mm.
320 Volume 6 Issue 4Nucleus
4 RESULTS
126
every cell in the overview image has the nucleoli highlighted as
more acidic compared to the nucleoplasmic surrounding
(Fig. 3A top row). Although precise measurements of subcellular
pH values are not possible with the SNARF-4F dye, it allows us
to conclude that the nucleolar environment is more acidic than
the neutral pH of the nucleoplasm. The subcellular pH landscape
was measured in various studies before and is reviewed in.53
Figure 3B summarizes the reviewed data and was adapted to
now incorporate the differentiated neutral pH of the nucleo-
plasm and more acidic pH of the nucleolus obtained from our
measurements.
Next, we wanted to test whether the peptides and proteins
with the sequence requirements sufficient to accumulate in
nucleoli do bind RNA. To test our hypothesis, we purified total
RNA (Fig. 4A) and performed slot blot analysis (Fig. 4B). We
blotted increasing amounts of total RNA on a PVDF mem-
brane followed by incubation with either fluorescently labeled
L-R10, or D-R10, respectively (Fig. 4B). The fluorescently
tagged D- and L-R10 were only detected on slots spotted with
RNA (Fig. 4B, rows 4 and 6) but not in control slots without
RNA (Fig. 4B, rows 3 and 5). As
a loading control, membranes
were stained in parallel with
methylene blue (Fig. 4B, rows 1
and 2). To test the RNA binding
of basic peptides fused to GFP,
we performed an in vitro RNA
pulldown assay using NLS-R7-
GFP immobilized to sepharose
beads via the GFP binding pro-
tein (GBP)39 (Fig. 4C, scheme).
This assay allowed us to observe
(Fig. 4C, confocal image) and
quantify (Fig. 4C, bar plot), the
binding of RNA to NLS-R7-
GFP. The accumulation of pepti-
des in nucleoli is a common fea-
ture of arginine-rich cell
penetrating peptides (CPPs).54
Consistently, we found that the
TAT peptide, one of the best
known CPPs derived from HIV-
1 TAT protein,55 also binds to
RNA (supplementary Fig. 2).
Defining experimentally the
requirements of nucleolar peptide
and protein accumulation has
shown that several arginines in
sequence are required. At least 6
arginine residues in a peptide and
4 arginines in combination with
an NLS provide sufficient local-
ized surface charge for nucleolar
accumulation. Importantly,
charge alone cannot explain the
difference between poly-R and
poly-K, which may additionally rely on the higher number of
functional amino groups in arginines vs. lysines. Now we asked,
how our findings relate to NoLS sequences found in the human
proteome? A previous comprehensive study of nucleolar targeting
sequences has systematically evaluated 46 nucleolar targeting
sequences curated from the literature. Based on this analysis an
algorithm was developed to predict nucleolar targeting based on
peptide amino acid composition. The algorithm was then run
against the International Protein Index database (IPI 3.4) and
predicted >10,000 putative nucleolar targeting sequences. We
have used this list to perform further analysis of the amino acid
composition of predicted nucleolar targeting sequences. An over-
all statistics shows that the predicted NoLS have an average
length of 27 amino acids with a most frequent length of 20
amino acids. The vast majority (83%) of predicted NoLS sequen-
ces has a length of 30 amino acids or less. For these NoLS the
mean ratio of the number of basic (lysine, arginine and histidine)
versus the total number of amino acids is 0.34. The shortest and
most frequently predicted NoLS sequences of 20 amino acids
therefore contain on average at least 7 basic amino acids. The 15
Figure 4. Analyses of RNA binding to poly-(R)peptides and GFP fusions. (A) Total RNA used for in vitro RNA
binding assays separated by size showing the absence of genomic DNA contamination, as well as character-
istic bands for the 28S and 18S rRNA, which are primarily synthesized and localized in nucleoli. The slot blot
in (B) (representative from 2 independent experiments), rows 1 and 2, show a methylene blue stained PDVF
membrane in the absence (1) and presence (2) of different amounts of total RNA (0.5 mg and 1 mg) and
were used as a loading control. The rest of the blot shows the binding of ﬂuorescently tagged L-R10 (3 and
4) and D-R10 (5 and 6) in the absence (3 and 5) and presence (4 and 6) of total RNA. Slots lacking RNA (rows
5 and 6) do not show binding of L- and D-R10, respectively. In contrast, slots probed with increasing amounts
of RNA show increasing L- and D-R10 binding. (C) In vitro RNA pulldown assay using NLS-R7-GFP immobilized
to sepharose beads via the GFP binding protein (GBP) (scheme). RNA was stained using propidium iodide (PI)
and GFP alone was used as a negative control. RNA binding was measured on a ﬂuorescent plate reader (bar
plot) and imaged by confocal microscopy (microscopic images). Plots represent the average plus standard
deviation of 2 independent experiments. Scalebar: 100 mm.
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amino acids sequence contain-
ing NLS-R4 from the GFP cou-
pled construct tested here has a
ratio of 0.66 and contains 10
basic amino acids. A statistical
analysis of the individual num-
ber of the amino acids for the
2001 predicted NoLS of 20
amino acid length most fre-
quently contain at least 3
lysines, 3 arginines, one histi-
dine, 2 cysteines, 2 prolines,
and further each one aspartate,
glutamate, glycine, alanine,
threonine, valine, leucine,
asparagine, glutamine. A pep-
tide with the amino acid com-
position KKKRRRDE-
GATVLNQ would have a pKi
value of 11.00, which is compa-
rable to the FITC-K11 peptide
tested in this study, which did
not show significant nucleolar
accumulation. But the combi-
nation of 4 arginines with an
adjacent but separated NLS
within 15 residues, as in NLS-
R4-GFP, proved effective.
To gain a systematic over-
view over the peptide and pro-
tein localization dependent on
charge, isoelectric properties
and amino acid sequence com-
position, we created gradient
charts depicting the pI values
along with the respective
nuclear and nucleolar accumu-
lation as well as peptide compo-
sition maps (Fig. 5). The chart
for peptide and total protein pI
values shows a clear difference
between all poly-K peptides (pI
10.6–11.04) exhibiting no
nucleolar accumulation and the
poly-R peptides with more basic
pI values between 12.6 and
13.04 (Fig. 5A). Although the
pI values of the R5 and R6 pep-
tides differ only slightly with
12.6 and 12.7 respectively, the
charge driven threshold for nucleolar accumulation of peptides is
found between these values (Fig. 5A). When comparing the pI
values of proteins it becomes apparent that the total protein pI
does not represent specific charged targeting sequences or
domains appropriately. All poly-R fused NLS-GFP versions with
nucleolar accumulation range between pI 7.77 and 8.83, which
is much less basic than any of the poly-R peptides. The pI value
of GFP of 6.09 has a strong influence on the calculation of pI val-
ues for the fusion proteins with relatively short additions of basic
amino acids (Fig. 5A). Therefore, we also plotted the pI of the
peptides tested and the protein N-terminal domains containing
the NLS and the fused poly-R and poly-D sequences (Fig. 5B).
Figure 5. Chart of peptide and protein pI values, intracellular distribution and sequence composition. (A) Dis-
play of the pI value of FITC labeled peptides and full-length proteins coupled to different peptides along a con-
tinuous pI scale. Representative images illustrating the intracellular and intranuclear distribution are indicated
along the scale. (B) Subsets of the pI scale with the values exclusively for the charged amino acid domains in
the proteins and peptides tested combined with an illustrative representation of the domains. For the proteins
the domain considered starts with the nuclear localization signal (NLS) and continues through the different
motifs of charged amino acids (poly-R and poly-D) introduced into the GFP open reading frame. The peptides
tested consist exclusively of basic amino acids. The clustering of the charged amino acids is displayed as color
bars in the box adjacent to the respective ﬂuorophore FITC or GFP. A legend for the charged amino acids is
given above. Representative images for the distribution inside the cells and nuclei are displayed on the right
for the respective peptide or protein. Scalebar: 5 mm.
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This representation shows that the pI values of the FITC-5R,
which shows homogeneous nuclear distribution, and the NLS-
4R, which shows nucleolar accumulation are virtually the same.
The main difference between these sequences is the distribution
of the charge over just 5 residues (5R) or 15 residues (NLS-4R)
resulting in a different surface charge density. Therefore, we rea-
son that in addition to the charge and isoelectric properties of
peptides and protein localization sequences, also the charge dis-
tribution plays a key role in mediating nucleolar accumulation.
Discussion
In this study, we have analyzed the requirements of peptides
and proteins to accumulate in the nucleoli of living cells. It has
been already established that specific sequences in proteins are
responsible for the nuclear import (NLS) and further for the
localization in the nucleoli (NoLS).16,56 The systematic analysis
of experimentally confirmed NoLS has shown that a high content
of basic amino acids is common among nucleolar but also nuclear
targeting signals, which makes it difficult to differentiate between
NoLS and NLS. This difficulty is further aggravated by the fact
that validated and predicted NoLS depict high sequence
diversity.18,57
Our results show first that all poly-K and poly-R peptides
ranging from 5–12 amino acids accumulate in the cell nucleus
compared to the cytoplasmic level and, therefore, match the crite-
ria for nuclear localization sequences. Similarly, all NLS bearing
GFP versions tested show a nuclear accumulation, which is gen-
erally a feature of nuclear proteins bearing a NLS.57 In line with
this interpretation, the GFP protein without NLS shows a homo-
geneous distribution between nucleus and cytoplasm. Interest-
ingly, the mean cytoplasmic fluorescence intensity of all
L-peptides tested (0.61 to 0.76 fold) is much higher than for any
of the NLS containing GFP versions (0.08 to 0.39) showing that
passive nuclear pore leakage is less efficient and slower for larger
molecules. The distribution test for the same peptides with differ-
ent chirality showed that FITC-R10 composed of D-amino acids
has a reduced concentration in the nucleoplasm compared to the
L-amino acid peptide. We interpret this observation as lack of
specific binding to nuclear im/export factors together with a
sequestration of the D-peptide in nucleoli. In addition, the
potential degradation of L-amino acid peptides during the
experiments, would result in freely diffusing FITC molecules not
bound to peptides and increase their nucleoplasmic signal
altogether.
The nucleolar accumulation of peptides is dependent on the
amino acid composition as poly-R peptides, except R5, show
strong accumulation whereas poly-K peptides accumulate only
slightly and, in most cases, not significantly. A sequence of at
least 6 arginines per peptide is required, while even 12 lysines
show only very little effect. These findings indicate the existence
of an isoelectric threshold to reach accumulation in nucleoli,
although the pI difference between R5 and R6 is rather small
with 12.6 and 12.7 respectively (Fig. 5).
Surprisingly, already the fusion of 4 arginines residues to
NLS-GFP results in a strong protein accumulation in the nucleo-
lus. The level of accumulation is even higher than for all FITC
labeled poly-R peptides tested, while the pI of 12.61 for the
domain containing the NLS-4R is virtually the same as for the
non-accumulating R5 peptide. In this case, a cumulative effect of
the poly-R sequence and the adjacent NLS within a short region
of 15 amino acids, containing an additional arginine as well as
further lysine residues, generates an effective motif that binds to
nucleolar constituents. It has been shown a long time ago, that E.
coli ribosomes contain at least 21 proteins with extremely high pI
values >12.0, similar to the poly-R peptides and NLS-poly-R
domains fused to GFP.58
These data suggest that, in addition to the peptide and protein
domain charge alone, the surface charge density is an important
determinant of interaction with nucleolar constituents. A protein
domain surface with a larger distribution of positive charges
below a pI of 12.7 is also effective to promote sufficient interac-
tion to accumulate in nucleoli. On the other hand, sequences
with even more lysine residues or shorter examples with few
lysines and arginines can also serve as NoLS as found in a previ-
ous systematic analysis and predicted by the Nucleolar Localiza-
tion Sequence Detector webtool.18 The other tracer proteins
GFP, NLS-GFP and those in fusion with neutral or positively
charged amino acids show no accumulation in nucleoli. In fact,
they are rather largely “apparently” excluded from nucleoli. Nev-
ertheless, it has been shown that even those molecules enter and
rapidly traverse nucleoli.26 On the contrary, even the non-accu-
mulating poly-K peptides and others have been found to homo-
geneously distribute in nucleoplasm and nucleoli. These findings
suggest a volume exclusion or molecular sieve effect of the nucle-
olar compartment similar to the size dependent passive diffusion
through nuclear pore channels.
The requirement of a strong positive charge mediated by basic
amino acids distributed over a certain molecular interaction sur-
face seems to be a hallmark of the potential to accumulate pro-
teins in the nucleolus. The nucleolar interaction partners are
either more abundant than in the surrounding nucleoplasm or
lead to a strong retention within this subnuclear compartment.59
A charge and isoelectric properties driven accumulation has to be
mediated by a countercharged nucleolar component. Highly
abundant and integral functional determinant of nucleoli is
rRNA, which can be considered as large negatively charged com-
plexes. Several ribosomal proteins possess high pI values, thus,
are positively charged and are very likely to electrostatically inter-
act with RNA. We could indeed show the presence of a more
acidic pH in the nucleoli by the live-cell pH sensitive dye
SNARF-4F. The RNA transcribed in nucleoli is a prime candi-
date for the locally constrained proton donor that is also an ideal
target for protein and peptide nucleolar localization sequences.
Our suggestion is supported by a report on protein immobiliza-
tion in the nucleolus by noncoding RNA via the nucleolar deten-
tion sequence (NoDS). In this study, the deletion of arginine
motifs in the NoDS of Hsp70 prevents nucleolar accumulation
as well as the precipitation of a peptide NoDS failed without
arginines in the motif.60 Sequence alignment of the NoLS for the
www.tandfonline.com 323Nucleus
4.3 Principles of protein targeting to the nucleolus
129
human La protein with several other nucleolar localization
domains of human proteins revealed a (R/K) (R/K) £ (R/K)
motif appearing frequently as single or multiple copies and simi-
lar motifs had been known before.61,62 The importance of argi-
nines has also been shown for a number of RNA binding
proteins with arginine rich motifs.63 In addition, a large-scale
analysis of atomic contacts determined that the positively charged
amino acid residues arginine and lysine are among the most fre-
quent to interact with nucleic acids with high abundance of inter-
action with the phosphate backbone.64,65 Protein domains with
multiple functional arginines are common in RNA recognition
motifs, e.g., RGG and RGX often found in a modular composi-
tion.66,67 Furthermore, the existence of more functional amino
groups in arginines relative to lysines explains their more stable
electrostatic interaction with the phosphate groups in RNA.68
The latter has been exploited as arginine-affinity chromatography
to purify RNA.69 Our in vitro binding analyses demonstrate that
poly-R peptides and fusion proteins directly bind RNA, which is
mostly abundant in the nucleolus due to massive ribosome pro-
duction and much less in the nucleoplasm.70-73 Finally, we could
show, using cells from different species, that these principles of
nucleolar targeting are evolutionarily conserved.
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Supplementary Figure 1. Intracellular distribution of peptide tagged GFP tracer proteins in living human cells during inter-
phase and metaphase. The images in this figure show live human HeLa cells transfected with NLS-GFP constructs also shown 
in Figure 2 to validate the same distribution pattern of the charged GFP tracer proteins in a different cell type of a different species. 
The first panel in A) displays the intracellular distribution of the NLS-GFP control and poly-G coupled NLS-GFP constructs. The 
second panel shows images of all poly-D containing NLS-GFP constructs. B) The images display the poly-R coupled NLS-GFP 
constructs. In A) and B) the upper row shows the GFP fluorescence with the corresponding differential interference contrast (DIC) 
image below. The corresponding quantification of the mean fluorescence intensity for each 10 cells from two independent experi-
ments is plotted in C). Area selection and quantification were done as described for peptides and protein before. The image panel 
D) shows a fixed HeLa cell in mitosis labeled with FITC-R10 peptide, which highlights the chromosomes as darker regions in the 
cell by exclusion of the peptide. The cell was further stained with antibodies against the nucleolar antigen B23/nucleophosmin to 
demonstrate the lack of nucleoli. The FITC-R10 peptide and B23 show a homogeneous distribution throughout the cell with exclu-
sion from the chromosomes aligned in the central plane of the cell. Scalebars: 5 µm.
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Supplementary Figure 2. Analyses of total RNA binding to arginine-rich cell penetrating peptides. The slot blot in A) shows 
the binding of a standard arginine-rich cell penetrating peptide (TAT) in the absence (3) and presence (1) of total RNA.Slots lacking 
RNA (3) do not show binding of TAT, while slots probed with increasing amounts of RNA show increasing TAT binding (1). Row 4 
with spotted TAT peptide shows, when compared to row 2, that only the presence of labeled peptide results in fluorescence detec-
tion but not RNA itself. B) In vitro RNA pulldown assay using NLS-R7-GFP immobilized to sepharose beads via the GFP binding 
protein (GBP) (scheme). RNA was stained using fluorescently labeled TAT. TAT binding to RNA was imaged by confocal microsco-
py. Scale bars: 100 µm. 
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Supplementary Table 1. List of oligonucleotides used to generate the GFP fusions. 	
GFP version primer sequence (5'-3') 	
4R-GFP 
Fw CCGGTGCACCGCCGGCGCCGG 
Rev CCGGCCGGCGCCGGCGGTGCA 	
5R-GFP 
Fw CCGGTGCACCGCCGGCGCCGCCGG 
Rev CCGGCCGGCGGCGCCGGCGGTGCA 	
6R-GFP 
Fw CCGGTGCACCGCCGGCGCCGCCGCCGG 
Rev CCGGCCGGCGGCGGCGCCGGCGGTGCA 	
7R-GFP 
Fw CCGGTGCACCGCCGCCGCCGCCGCCGCCGC 
Rev CCGGGCGGCGGCGGCGGCGGCGGCGGTGCA 	
4D-GFP 
Fw CCGGTCGACGATGACGAT 
Rev CCGGATCGTCATCGTCGA 	
5D-GFP 
Fw CCGGTCGACGATGACGATGAC 
Rev CCGGGTCATCGTCATCGTCGA 	
6D-GFP 
Fw CCGGTCGACGATGACGATGACGAT 
Rev CCGGATCGTCATCGTCATCGTCGA 	
7D-GFP 
Fw CCGGTCGACGATGACGATGACGATGAC 
Rev CCGGGTCATCGTCATCGTCATCGTCGA 	
8D-GFP 
Fw CCGGTCGACGACGACGACGACGACGACGAC 
Rev CCGGGTCGTCGTCGTCGTCGTCGTCGTCGA 	
8G-GFP 
Fw CCGGGCGGCGGCGGCGGCGGCGGCGGTGCA 
Rev CCGGTGCACCGCCGCCGCCGCCGCCGCCGC 	
Supplementary Table 2. Lists of normalized  mean  fluorescence  intensity  values  
measured  for  the  fluorescent  peptides  and  proteins  in  cytoplasm, nucleoplasm 
and nucleoli and their statistical significance (P-values). 
A 
             
 
 K5 K6 K7 K8 K9 K10 K11 K12 
    
 
cytopl
asm 0.73 0.73 0.76 0.77 0.72 0.73 0.73 0.73 
    
 
nucleu
s 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
    
 
nucleo
lus 1.06 1.06 1.04 1.04 1.06 1.02 1.05 1.06 
    
 
p-
value 
0.06
8 
0.19
9 
0.29
0 
0.32
6 
0.19
9 
0.76
2 
0.09
6 
0,01
6* 
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B 
             
 
 R5 R6 R7 R8 R9 R10 R11 R12 
    
 
cytopl
asm 
0.61
3 
0.70
2 
0.70
6 
0.71
5 
0.73
2 
0.67
6 
0.64
9 
0.66
3 
    
 
nucleu
s 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
    
 
nucleo
lus 
1.04
5 
1.17
8 
1.15
5 
1.16
2 
1.22
3 
1.16
2 
1.12
3 
1.14
1 
    
 
p-
value 
0.40
6 
0,00
2** 
0,01
0** 
0,00
5** 
0,00
4** 
0,03
4* 
0,01
0** 
0,04
1* 
    
              C 
             
 
  
L-
R10 
D-
R10 
          
 
cytopl
asm 0.68 2.88 
          
 
nucleu
s 1.00 1.00 
          
 
nucleo
lus 1.16 3.72 
          
 
p-
value 
0,03
4* 
0,00
02** 
          
              D 
             
 
  GFP 
NLS-
GFP 
8G-
GFP 
4D-
GFP 
5D-
GFP 
6D-
GFP 
7D-
GFP 
8D-
GFP 
4R-
GFP 
5R-
GFP 
6R-
GFP 
7R-
GFP 
 
cytopl
asm 0.90 0.39 0.25 0.19 0.23 0.15 0.23 0.27 0.25 0.08 0.09 0.10 
 
nucleu
s 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
 
nucleo
lus 0.70 0.68 0.63 0.67 0.66 0.60 0.64 0.51 1.74 2.45 2.67 2.71 
 
p-
value 
0,01
01* 
0,00
02** 
0,00
39** 
0,02
33* 
0,01
01* 
0,01
01* 
0,00
02** 
0,01
63* 
0,03
04* 
0,00
05** 
0,00
02** 
0,00
90** 
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E 
             
 
    
NLS-
GFP 
8G-
GFP 
4D-
GFP 
5D-
GFP 
6D-
GFP 
7D-
GFP 
8D-
GFP 
4R-
GFP 
5R-
GFP 
6R-
GFP 
7R-
GFP 
 
cytopl
asm   0.30 0.30 0.30 0.30 0.20 0.20 0.20 0.40 0.20 0.40 0.40 
 
nucleu
s   1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
 
nucleo
lus   0.90 0.80 0.70 0.70 0.70 0.70 0.70 2.20 2.90 3.00 2.90 
 
p-
value   
0.44
935 
0.13
057 
0.19
86 
0.17
362 
0.01
0* 
0.05
87 
0.09
618 
0.01
39* 
0.00
25** 
0.00
02** 
0.00
03** 	
The p-value was calculated for the nucleoplasm versus the nucleolus mean intensity measurements 
only with a non-parametric Kruskal-Wallis-ANOVA test. The p-values represent a measure of 
significance for the mean intensity values from the nucleoplasm and nucleolus belonging to the same or 
different population of measurements. Significant different distributions are found for nucleolar 
accumulation but also nucleolar exclusion of proteins. At the level of p < 0.05 the measurements of 
mean fluorescence intensity in nucleoplasm and nucleoli for one peptide or protein are significantly 
different and indicated by asterisk (*). Highly significant differences (p < 0.01) are indicated by double 
asterisk (**). A) shows the values for the FITC labeled poly-K peptides K5 to K12. B) lists values for the 
FITC labeled poly-R peptides R5 to R12. C) shows the mean fluorescence intensity and p-values for the 
comparison of L-R10 versus D-R10 peptide distribution. Note that the high levels of accumulation of the 
D-R10 peptide in cytoplasm and nucleolus reflect the low intensity measured in the nucleoplasm, 
which is used as the reference level to normalize for nucleolar accumulation. D) shows the normalized 
fluorescence intensity and p-values for the mean fluorescence of GFP and all versions of it with NLS as 
well as additional fusion of poly-G, poly-D and poly-R sequences in mouse C2C12 cells. In E) are the 
corresponding values for the mean fluorescence in human HeLa cells. 
	
For Supplementary Table 3, go to:	
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4615656/	
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4.4 Visualization of the Nucleolus in Living Cells with Cell-Penetrating Fluorescent
Peptides
A.K. Ludwig revised the manuscript.
A.K. Ludwig prepared figure 2 and wrote the respective figure legend.
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Figure 2: Intracellular distribution of nucleolar markers in living cells of various species and origin.
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 Chapter 6 
 Visualization of the Nucleolus in Living Cells with 
Cell- Penetrating Fluorescent Peptides 
 Robert  M.  Martin ,  Henry  D.  Herce ,  Anne  K.  Ludwig , 
and  M.  Cristina  Cardoso 
 Abstract 
 The nucleolus is the hallmark of nuclear compartmentalization and has been shown to exert multiple roles 
in cellular metabolism besides its main function as the place of ribosomal RNA synthesis and assembly of 
ribosomes. The nucleolus plays also a major role in nuclear organization as the largest compartment within 
the nucleus. The prominent structure of the nucleolus can be detected using contrast light microscopy 
providing an approximate localization of the nucleolus, but this approach does not allow to determine 
accurately the three-dimensional structure of the nucleolus in cells and tissues. Immunofl uorescence stain-
ing with antibodies specifi c to nucleolar proteins albeit very useful is time consuming, normally antibodies 
recognize their epitopes only within a small range of species and is applicable only in fi xed cells. Here, we 
present a simple method to selectively and accurately label this ubiquitous subnuclear compartment in liv-
ing cells of a large range of species using a fl uorescently labeled cell-penetrating peptide. 
 Key words  Cell permeable nucleolar marker ,  Cell-penetrating peptide ,  Fluorescence microscopy , 
 Living cells ,  Nucleolus ,  Poly-arginine 
1  Introduction 
 In 1831, a Scottish botanist Robert Brown described for the fi rst 
time the “nuclei” in plant cells [ 1 ]. A few years later, in 1836, 
Gabriel Gustav Valentin working with neuronal cells described 
within nuclei a prominent substructure later termed “nucleolus” 
[ 2 ]. It was only one century later, in the 1960s, that fi ndings 
derived from electron microscopic autoradiography of [ 3 H]uridine 
incorporation established the major function of the nucleolus in 
 rRNA synthesis, rRNA  processing , and ribosome  biogenesis [ 3 ,  4 ]. 
Several other tasks have been more recently added to the func-
tional portfolio of the nucleolus (reviewed in [ 5 ,  6 ]). 
 The nucleolus is a self-organizing structure not delimited by 
membranes that gets disassembled and reassembled around the 
rDNA loci at every cell division cycle ([ 7 ]; reviewed in [ 8 ]). 
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Transcription of  ribosomal genes , which make up the fi brillar  centers , 
takes place surrounding this structure and creates the so-called dense 
fi brillar  component [ 9 ,  10 ]. Further processing of the precursor RNA 
and multiple proteins gives rise to ribosome precursor particles, which 
form the granular  component (reviewed in [ 11 ]). Over 300 nucleolar 
proteins have been identifi ed by  proteomics [ 12 ]. The fi rst nucleolar 
 targeting sequences were identifi ed in viral proteins ([ 13 ,  14 ]; 
reviewed in [ 15 ]) and further shown to be able to cross cellular mem-
branes [ 16 ,  17 ]. Recently, we performed a systematic analysis of pep-
tide sequences suffi cient for nucleolar targeting [ 18 ]. We found that 
six or more arginines are suffi cient to label the nucleolus by binding 
to RNA. Hence, these peptide sequences can label the nucleolus in all 
species tested (insect, fi sh,  mouse , human, and very likely also  yeast ). 
Importantly, in particular nona- and deca-arginine peptides are simi-
larly highly active in cell membrane permeation [ 19 ]. 
 In this chapter, we describe how adding these peptides conju-
gated to a fl uorescent label directly to the cell culture medium with-
out the need for transient or stable transfections of the cells provides 
a live cell fl uorescent nucleolar marker in a variety of species [ 20 ]. 
The nucleolar  marker is membrane permeable and reaches its target 
within minutes. To prevent proteolytic degradation the peptide can 
be synthetized with  D -amino acids. The  cell- penetrating- peptide -
based marker provides a method for the noninvasive marking of the 
nucleolus in living cells, allowing the three-dimensional reconstruc-
tion of the nucleolus, which is not possible with contrast micros-
copy techniques. Besides that, it can easily be used in combination 
with different fl uorophores like fl uorescent proteins or DNA dyes 
to correlate different aspects of nuclear structures with the nucleo-
lus. In addition, nucleolar labeling is also preserved during fi xation 
and staining of the cells. Furthermore, it does not affect cellular 
viability, proliferation, and rDNA transcription. 
2  Materials 
 Prepare all solutions at room temperature unless otherwise noted. 
Solutions used to culture and prepare cells should be warmed to 
37 °C prior to use. All solutions and materials in contact with live 
cells must be sterile and have to be handled inside a tissue culture 
biosafety cabinet. Disposal of reagents, solutions, and cell material 
has to be carried out following the specifi c regulations in effect. 
  1.  Human  HeLa cervix epithelium adenocarcinoma cells. 
  2.  Adult  rat ventricular cardiomyocytes. 
  3.  Mouse C2C12 myoblast cells. 
  4.  Pac2  zebrafi sh fi broblast cells ( Danio rerio ). 
  5.  Sf9 insect ovary cells ( Spodoptera  frugiperda ). 
2.1  Cells 
and Materials for Cell 
Culture
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  6.  High-glucose (4.5 g/L) Dulbecco’s Modifi ed Essential 
Medium (DMEM). 
  7.  Leibovitz L-15 medium. 
  8.  EX-CELL ® 420 Insect Serum Free medium. 
  9.  Glutamine. 
  10.  Gentamicin. 
  11.  Penicillin/Streptomycin 100×. 
  12.  Fetal calf serum (FCS). Aliquots of 50 mL are stored at −20 °C. 
  13.  Standard medium for  HeLa cell culture: DMEM ( item 6 ) was 
supplemented with 5 mM  L -glutamine ( item 9 ), 5 μg/mL 
gentamycin ( item 10 ), and 10 % FCS ( item 12 ). Prepare a 
500 mL bottle under sterile conditions and store at 4 °C. 
  14.  Standard medium for adult  rat ventricular cardiomyocytes was 
10 mM HEPES buffer with 0.3 mM Ca 2+ and 0.5 % bovine 
serum albumin stored at 4 °C. 
  15.  Standard medium for  C2C12 cell culture: DMEM ( item 6 ) 
was supplemented with 5 mM  L -glutamine ( item 9 ), 5 μg/mL 
gentamycin ( item 10 ), and 20 % FCS ( item 12 ). Prepare a 
500 mL bottle under sterile conditions and store at 4 °C. 
  16.  Standard medium for Pac2 cells: Leibovitz L-15 medium ( item 
7 ) was supplemented with 15 % FCS ( item 12 ) and 1 % penicil-
lin–streptomycin ( item 11 ) from the 100× stock solution and 
stored at 4 °C. 
  17.  Standard medium for  Sf9 cells: EX-CELL ® 420 Insect Serum 
Free medium ( item 8 ) was supplemented with 5 mM  L - 
glutamine ( item 9 ) and 10 % FCS ( item 12 ) and stored at 4 °C. 
  18.  Phosphate buffered saline (PBS) supplemented or not with 
0.5 mM EDTA (PBS/EDTA). 
  19.  HEPES buffer 1 M, pH 7.2–7.5. 
  20.  0.25 % trypsin in PBS/EDTA prepared from trypsin powder. 
 Deca-arginine peptides containing amino-terminal fl uorescein 
label (FITC-R 10 ) were synthesized using  D -amino acids by Peptide 
Specialty Laboratories (Heidelberg, Germany). After synthesis the 
peptides were HPLC purifi ed and their molecular weight was con-
fi rmed by mass  spectrometry . 
 Ultrapure water is used to resuspend the lyophilized peptides. 
  1.  μ-dish 35 mm low with Ibidi standard bottom (Ibidi ® ). 
  2.  Chambered coverslip μ-slide 8 well (Ibidi ® ). 
  3.  Chambered coverglass 4 and 8 well (Thermo Fisher Scientifi c, 
Nunc™ Lab-Tek™). 
  4.  Coverslips, 12 mm diameter. 
  5.  Parafi lm ® . 
2.2  Peptides
2.3  Chamber 
Systems 
and Coverslips for Live 
Cell Labeling 
of Nucleoli
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 For live cell microscopy any suitable  confocal microscope system 
can be used. We use a Zeiss LSM510Meta confocal setup 
mounted on an Axiovert 200 M inverted microscope equipped 
with a 63× phase contrast plan-apochromat oil objective NA1.4. 
During all acquisitions, the main beam splitter was a HFT 
UV/488/543/633 and the parameters for the detection of 
FITC were as follows:
 Excitation wavelength: 488 nm. 
 Emission fi lter: BP500-530 nm. 
 For live cell microscopy any suitable microscope incubation system 
can be used. The microscope is housed in an environmental cage 
incubator, which is connected to a heating system providing a con-
stant temperature of 37 °C. In addition, a chambered stage incu-
bation system is used that provides a temperature of 37 °C and 
humidifi ed 5 % CO 2 atm (all incubation components from Okolab, 
Ottaviano, Italy). Cells grown in chambered coverslip systems are 
kept inside the stage incubation system during  imaging to maintain 
stable environmental conditions. 
 For the analysis of microscopic images any suitable software pack-
age can be applied. We used  ImageJ ( http://imagej.nih.gov/ij/ ) 
to measure, e.g., relative fl uorescence intensities in nucleoli com-
pared to the nucleoplasm. 
3  Methods 
  1.  HeLa and  C2C12 cells ( items 1 and  3 in Subheading  2.1 ) are 
grown in p100 dishes in the cell culture incubator at 37 °C 
and 5 % CO 2 atm, until they reach 70–80 % confl uence. Adult 
 rat ventricular cardiomyocytes primary cells ( item 2 in 
Subheading  2.1 ) cannot be maintained in culture and are used 
the day they are isolated. 
  2.  Cells are grown in standard medium as indicated in 
Subheading  2.1 . 
  3.  To split cells, aspirate medium and rinse with 1× PBS/EDTA 
prewarmed to 37 °C. 
  4.  Directly apply 1.0 mL of Trypsin–EDTA ( item 20 in 
Subheading  2.1 ) solution prewarmed to 37 °C to the cell layer 
and tilt the dish gently. Leave fl ask in the incubator for approx-
imately 1–3 min. 
  5.  Hit the side of the dish with the palm of one hand several 
times to detach the cells, avoid spilling of fl uid to the side and 
lid of the dish. 
2.4  Microscopy
2.4.1  Confocal Laser 
Scanning Microscope
2.4.2  Environmental 
Chamber and Stage 
Incubation System
2.5  Image Analysis
3.1  Cell Culture
3.1.1  Maintaining 
Mammalian Cells 
in Culture
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  6.  When all cells have detached, add 9.0 mL of growth medium to 
the fl ask and resuspend the cells by gentle pipetting up and 
down several times. Avoid creating bubbles and foam. Transfer 
between 1.0 (1:10) and 2.0 (1:5) mL to a new cell culture dish. 
  7.  Fill up to a fi nal volume of 10 mL with standard medium. 
  8.  Place the dish in a cell culture incubator and examine the cells 
daily using a cell culture microscope. 
  1.  Pac2 cells ( item 4 in Subheading  2.1 ) are grown in p25 fl asks 
in a cell culture incubator at 28 °C without CO 2 enriched 
atmosphere. 
  2.  Pac2 cells are grown in standard medium ( item 16 in 
Subheading  2.1 ). 
  3.  To split cells, aspirate medium and rinse twice with 1× PBS/
EDTA ( item 18 in Subheading  2.1 ). 
  4.  Directly apply suffi cient trypsin–EDTA solution ( item 20 in 
Subheading  2.1 ) to cover the cell layer, tilt the dish gently, and 
incubate for 5 min at room temperature. 
  5.  Dilute the detached cells with standard medium and pipette up 
and down several times to completely detach all cells and dis-
perse cell clots. 
  6.  Transfer 20 % of the volume to a new fl ask and fi ll up with stan-
dard medium and place in the incubator at 28 °C. 
  1.  Sf9 cells ( item 5 in Subheading  2.1 ) are maintained in p25 
fl asks as suspension culture in an orbital shaker with ambient 
atmosphere at 28 °C. 
  2.  For labeling experiments with microscopic observation, cells 
are grown in an incubator with ambient atmosphere at 28 °C. 
  3.  Sf9 cells are grown in standard medium ( item 17 in 
Subheading  2.1 ). 
  4.  To subculture cells, resuspend cells gently by using a plastic 
pipette and transfer 1.0 mL to a new fl ask, fi ll up with standard 
medium and place in the orbital shaker at 28 °C. 
  1.  Peptides are delivered lyophilized and therefore have to be 
resuspended. 
  2.  Add sterile deionized ultrapure water to the lyophilized pep-
tides to prepare peptide stock solutions at a fi nal concentration 
of 1 mM, vortex to completely dissolve and homogenize the 
peptide solution. 
  3.  Spin down peptide solution and prepare aliquots of 50 μL in 
sterile Eppendorf tubes and store at −20 °C until further use. 
3.1.2  Maintaining Fish 
Cells in Culture
3.1.3  Maintaining Insect 
Cells in Culture
3.1.4  Preparation 
of Peptides for the Labeling 
of Live Cells
Live Cell Visualization of the Nucleolus
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  1.  Take live cell chambers out of sterile packaging and place into 
an empty sterile p100 dish ( see  Note  1 ). 
  2.  Wash, trypsinize, and resuspend  HeLa and  C2C12 cells as 
described in Subheading  3.1.1 . 
  3.  Wash, trypsinize, and resuspend Pac2 cells as described in 
Subheading  3.1.2 . 
  4.  Use directly the suspension culture of  Sf9 cells as described in 
Subheading  3.1.3 , pipette up and down to disperse cells. 
  5.  Seed equal volumes of cell suspension into each well of a sterile 
live cell chamber system at 60–70 % confl uence. 
  6.  Typically 100 μL of cell suspension were seeded into one well 
of an 8-well LabTek or Ibidi chamber and correspondingly 
200 μL were seeded into 4 well chambers. These amounts cor-
respond to a split ratio of around 1: 2.5 taking into account the 
dish and chamber surface areas with cells grown to 70–80 % 
confl uence. Amounts of cells seeded have to be adapted to the 
respective cell type that will be used. 
  7.  Fill up chambers up to half of the volume with growth medium 
and close the lid. To avoid contamination on the way to the 
incubator, close additionally the p100 dish containing the live 
cell chamber. 
  8.  Human  HeLa ,  mouse  C2C12 , and Pac2 fi sh cells are grown 
under the conditions described in Subheadings  3.1.1 and 
 3.1.2 , respectively.  Sf9 insect cells, however, are grown in an 
incubator with ambient atmosphere at 28 °C without shaking 
to allow attachment of the cells to the chamber surface. 
  9.  Cells are grown over night and used the next day for nucleolar 
labeling with the transducible peptide marker ( see  Note  2 ). 
  1.  Place 12 mm coverslips in a dedicated holder inside a closed 
container and immerse in pure 100 % ethanol for several hours. 
  2.  Use fi ne tip forceps to place the desired number of coverslips 
into an empty sterile cell culture dish. 
  3.  Leave the dish with the lid half open inside the laminar fl ow 
cabinet until all traces of ethanol evaporated. 
  4.  Immediately before starting to split cells to seed onto cover-
slips, use 1× PBS and fi ll carefully into the dish with the cover-
slips until all coverslips are covered. Avoid coverslips to adhere 
to each other by applying PBS slowly and carefully at the side 
of the dish without moving the coverslips. 
  5.  Aspirate PBS and continue with washing, trypsinizing, and 
resuspending cells as described in Subheadings  3.1.1 ,  3.1.2, 
and  3.1.3 , respectively. 
3.2  Preparation 
of Cells and Peptides 
for Nucleolar Labeling 
and  Imaging 
3.2.1  Culturing Cells 
in Live Cell Chamber 
Systems
3.2.2  Preparation 
of Coverslips for Fixation 
of Cells After Labeling 
the Nucleoli
Robert M. Martin et al.
4.4 Visualization of the Nucleolus in Living Cells with Cell-Penetrating Fluorescent Peptides
145
77
  6.  Seed the required volume of resuspended cells to reach 70 % 
confl uence and fi ll up with growth medium. Avoid disturbance 
to prevent coverslips fl oating around. 
  7.  Place the dish inside the cell culture incubator at 37 °C and 5 % 
CO 2 until use, typically on the next day. 
  1.  Dilute deca-arginine peptides in DMEM without FCS to a 
fi nal concentration of 10 μM just before the start of the label-
ing experiments and keep at 4 °C until use ( see  Notes  3 and  4 ). 
  2.  For  imaging experiments place cells grown in chambered cov-
erslips or microscopy dishes inside the stage incubation system, 
fi x using metal clips or similar devices to prevent movements 
and leave for at least 30 min to adapt to the environment and 
observe cells by phase contrast microscopy. 
  3.  Remove all growth medium from the fi rst well to be labeled 
and immediately apply with great care the peptide in DMEM 
solution ( see  Note  5 ). 
  4.  Close the chamber lid and the stage incubation system. Adjust 
the microscope objective to focus the cells. It is possible to 
observe cells at this stage by microscopy; however, excess 
labeled peptide and the high concentration of fl uorophores in 
the medium will cause very high intensities when observing 
the peptide fl uorescence. 
  5.  Incubate the cells for 30 min to 1 h with the peptides in 
DMEM. Aspirate all peptide solution, wash cells one time in 
DMEM without FCS or alternatively in 1× PBS to remove 
excess fl uorescent peptides, aspirate the washing solution, and 
apply the standard growth medium to the cells. 
  6.  Close the chambered coverslip and the stage incubation sys-
tem, focus the cells, and start the experimental observations 
and image acquisition. 
  7.  For cells grown on coverslips, aspirate medium carefully from 
the dish and apply the peptides in DMEM at the side of the 
dish, not directly on the coverslips ( see  Note  6 ). After removal 
of the peptide in DMEM solution use forceps to place the cov-
erslips with cells turned upward on Parafi lm in a humidifi ed 
chamber for further treatment. 
  8.  Perform the washing steps with 1× PBS on individual coverslips 
in the humidifi ed chamber and proceed with a protocol for cell 
fi xation, permeabilization, and immunostaining ( see  Note  7 ). 
  9.  Alternatively, the application of peptides in DMEM, as well as 
the washing step can be performed in a laminar fl ow biosafety 
cabinet. In this case, cells are kept in the cell culture incubator 
for the peptide uptake incubation. Microscopic observation 
can start after labeling or any time later ( see  Note  8 ). 
3.2.3  Labeling 
of the Nucleoli in Living 
Cells Using a  Cell- 
Penetrating Peptide Marker 
( See Fig.  1 )
Live Cell Visualization of the Nucleolus
4 RESULTS
146
78
  10.  For cells in suspension culture, we suggest mild centrifugation 
steps to remove growth medium, resuspension of cells in 
DMEM with diluted peptides followed by mild centrifugation 
for peptide removal and washing steps. 
  11.  Additional labeling of cells with cell permeable dyes like 
DRAQ5 [ 21 ] can be performed before or after peptide label-
ing of nucleoli ( see  Note  9 ). 
  1.  Place the dish containing the cells treated with the nucleolar 
 marker on the microscope stage. Close the incubation cham-
ber and wait 30–60 min to allow the sample to acclimatize to 
the chamber temperature before starting with image acquisi-
tion. This will avoid focus drift while imaging. 
3.3  Imaging ( See 
Fig.  2 )
 Fig. 1  Application of a fl uorescent  cell-penetrating-peptide -based nucleolar 
 marker . The  upper row shows schematically the steps for the labeling of nucleoli 
in live cells with the cell-penetrating peptide marker. Cells are cultivated in 
microscopy dishes and after removal of the growth medium incubated with the 
peptide marker diluted in DMEM. After an incubation time of about 30 min, the 
peptide solution is removed and cells are washed with fresh DMEM or PBS to 
remove excess fl uorescent peptides. Finally the cells are supplied with standard 
growth medium followed by immediate microscopic observation of the fl uores-
cently labeled nucleoli. The  lower panel shows exemplary images of a culture of 
human  HeLa cells at the different stages of the labeling process depicted in the 
scheme earlier. The  upper image row shows FITC fl uorescence of the cell- 
penetrating peptide marker with the corresponding phase contrast image below. 
Note the lack of signals inside the cell after application of the fl uorescent peptide 
in the second step, while after 30 min of incubation in step 3, nucleolar labeling 
is already visible. After washing away excess peptide, the fl uorescently labeled 
nucleoli are distinctively visible in the vast majority of cells against the darker 
nucleoplasmic surrounding. Scale bar 10 μm 
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  2.  Focus the cells using the transmitted light channel (i.e., differential 
interference contrast (DIC), phase contrast, etc.). 
  3.  Adjust the microscope settings, in particular, the 488 nm laser 
wavelength intensity and exposure time to optimize the visual-
ization of the nucleoli (minimizing overexposure of the sam-
ple). To capture the entire volume of the nucleolus it is required 
to image optical sections that span approximately −4 μm to 
7 μm from the focal plane (for  HeLa cells,  see  Note  10 ). 
  4.  Image the cells. 
  5.  Export the images as tiff fi les for further processing using  ImageJ . 
 Segmentation of Nucleoli 
  1.  Open the image stack (or single image) in  ImageJ . 
  2.  Select the cell of interest using the “rectangular” selection 
option in the tools menu bar. 
  3.  Crop (“Image” menu > “Crop”), Fig.  3a . 
  4.  Separate the stack into single images (“Image” menu > 
“Stacks” > “Stacks to Images”), Fig.  3b . 
  5.  Close without saving the images that do not contain any frac-
tion of the  nucleus . The marker distributes strongly in the 
cytosol and nucleoli and is weakly distributed over the nucleo-
plasm. This can be used to easily recognize the nucleus with-
out the need of any extra nuclear marker. 
 For Each Stack Image 
  6.  Select the nucleus using the “Freehand selections” in the tools 
menu bar, Fig.  3c . 
3.4  Image Analysis 
( See Fig.  3 )
 Fig. 2  Intracellular distribution of nucleolar  markers in living cells of various species and origin. Shown are 
mid-optical sections of cultured cell lines and terminally differentiated primary cells as indicated earlier. For 
visualization of nucleoli in situ, cells were treated for 30 min with medium containing the nucleolar marker, 
washed in PBS, and incubated in medium for  live cell imaging on a  confocal microscope equipped with a cli-
matization chamber to maintain a constant temperature of 37 °C, 5 % CO 2 , and 60 % humidity. The  lower 
image row shows FITC fl uorescence of the  cell-penetrating peptide marker with the corresponding phase/
differential interference contrast (PC/DIC) image below. Scale bar 10 μm 
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  7.  Clear the marker signal outside the nucleus (“Edit” 
menu > “Clear Outside”), Fig.  3d . 
  8.  Convert the image to a binary form to isolate the nucleoli 
region (“Process” menu > “Binary” > “Make Binary” and use 
the “Otsu” fi lter ( see  Note  11 ), Fig.  3e ). 
  9.  For further processing each image can be used individually as a 
mask for the nucleolus or the images can be collected into a 
single stack (“Image” menu > “Stacks” > “Images to Stacks”). 
  10.  Save resulting individual images or image stack as tiff (click 
selected image and “File” menu > “Save as” > “tiff”). 
  11.  The 3D stack can be visualized using the  ImageJ plug-in “3D 
Viewer” (“Plugins” menu > 3D > “Volume Viewer”), select view 
angle and options and save as an image “Save View,” Fig.  3f . 
4  Notes 
  1.  We place the chambered coverslip systems and microscopy 
dishes inside p100 cell culture dishes for better handling, easy 
transport, and sterility between laminar fl ow biosafety cabinet, 
incubator, and microscope incubator. 
 Fig. 3  Image analysis steps for  segmentation of nucleoli. ( a ) Image stack of a 
single  HeLa cell visualized using Volocity.  xy as well as  xz and  yz views of the cell 
are shown. ( b ) Example image from z-stack for  segmentation . ( c )  Nucleus selec-
tion ( yellow line ). ( d ) Clearance of signal outside the nucleus. ( e ) Binary image of 
the nucleoli. ( f ) Overlay of image stack in ( a ) and a mesh representation of the 
surface of the 3D rendered nucleoli. Scale bar 10 μm 
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  2.  For primary cells, e.g., freshly isolated cardiomyocytes it is rec-
ommended to perform the peptide labeling and washing steps 
as soon as possible after preparation of the sample due to their 
very limited lifespan [ 20 ]. In the case of other primary cell 
cultures with longer survival time, it might be possible to delay 
the labeling after sample preparation. 
  3.  The effi ciency of uptake of  cell-penetrating peptide markers is 
a function of peptide length and concentration but is also 
cell type specifi c. A concentration of 10 μM FITC labeled 
deca- L - arginine was suffi cient to label a range of different 
cell types from different species ( see Fig.  2 and [ 18 ]). 
However, for certain cell types the concentration of FITC-R10 
might be elevated up to 50 μM to achieve effi cient nucleolar 
labeling with a low to moderate rate of toxicity [ 22 ]. Higher 
concentrations of R10 peptide might result in high frequency 
of damaged or dead cells. 
  4.  For the peptide transduction we prepare a volume of peptides 
diluted in DMEM suffi cient to completely cover all cells in the 
respective number of chambers to be labeled. Typically in a 
single well of a 4-well chamber it is suffi cient to apply 200 μL 
of diluted peptide in DMEM to cover all cells completely and 
provide enough volume to prevent dry spots in the center of 
the well due to the fl uid meniscus. Accordingly, a volume of 
100 μL is suffi cient in one well of an 8-well chamber. 
  5.  When applying the peptide diluted in DMEM to the cells, 
place the tip of the pipette into one corner of the well, close to 
the bottom but not touching it and slowly release the fl uid to 
immerse the cells. Avoid drops of liquid falling on the cells to 
prevent detaching of cells. When the chamber bottom surface 
is covered with liquid, add the rest of the volume slightly faster 
but still with great care. Perform washing steps and the fi nal 
application of growth medium in the same way. 
  6.  For increased effi ciency of peptide uptake into cells to be fi xed, 
we incubated cells with the peptide up to 1 h. 
  7.  Membrane permeable peptides are not recommended for 
labeling of nucleoli postfi xation [ 20 ]. 
  8.  The persistence of the nucleolar labeling in living cells was suc-
cessfully observed up to 24 h after the labeling event. 
  9.  For additional labeling of cellular components by transient 
transfection of cells with, e.g.,  plasmids encoding proteins 
tagged with red fl uorescent proteins, we suggest to perform 
the transfection the day before the nucleolar labeling with 
the peptides. 
  10.  This range depends signifi cantly on the specifi c cell type and 
stage of the cell cycle. 
  11.  Most fi lters (e.g., “MaxEntropy,” “Mean,” etc.) can be used 
here with very similar results. 
Live Cell Visualization of the Nucleolus
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5 General Conclusions and
Perspectives
I n chapter 1 of this thesis, we analyzed the effect ofmethyl-CpG binding domain proteins on the dioxy-
genase activity and DNA binding ability of Ten eleven
translocation proteins. Our data demonstrate an anti-
correlation between Tet1 activity/DNA binding capa-
city and long-lasting DNA coverage by MBD proteins in
a non-sequence specific, but concentration-dependent
manner. Mutations in the MECP2 (Methyl-CpG bind-
ing protein 2) gene give rise to Rett syndrome, a de-
bilitating neurological disease [1], which is character-
ized by global changes in neuronal chromatin structure
and elevated transcriptional noise [2, 3]. Consistent
with this, we found increased levels of the Tet oxida-
tion product 5hmC in neurons of Mecp2 deficient mice,
with concomitant transcriptional reactivation of epige-
netically silenced major satellite repeats (Figure 1). Us-
ing triple Tet knockout mouse embryonic stem cells, we
were able to attribute the observed increase in tandem
repeat expression to unconfined Tet activity. Finally, our
data indicate that ectopic expression of Mecp2 is suffi-
cient to rescue the aberrant, Tet1-mediated transcrip-
tional increase of major satellite repeats. In chapter 2,
we expanded our analyses to long interspersed nuclear
elements in human cells. Similar to tandem repeats,
expression and retrotransposition of interspersed ele-
ments was activated by Ten-eleven translocation pro-
tein 1 and repressed by methyl-CpG binding domain
proteins (Figure 1).
Consistently, previous studies have demonstrated sta-
bilized or reversed symptoms upon systemic adminis-
tration of functional Mecp2 into female Rett mice [6].
One plausible explanation may be a direct interaction of
Mecp2 with the Tet oxidation product 5hmC. However,
recent studies analyzing the binding ability of Mecp2 to
hmCpG are highly contentious. Mellen and colleagues
identified Mecp2 as the major 5hmC-binding protein in
the brain with similar binding affinities for 5mC and
5hmC containing substrates [7]. Spruijt et al. deter-
mined Mecp2 as a reader of 5hmC in mouse embryonic
stem cells, albeit with lower affinity compared to 5mC
[8]. Two independent in vitro studies demonstrated a
greatly reduced binding affinity of Mecp2 to oxidative
derivatives of 5mC [9, 10]. Lastly, conversion of 5mC
to 5hmC was shown to completely abolish binding of
Mecp2 to oligonucleotides in vitro [11]. Previous studies
have shown that almost all mature, postmitotic neurons
express abundant levels of the DNA methyltransferases
Figure 1: Scheme summarizing the main conclusions drawn from our studies in Chapter 1 and 2. Binding of Mecp2 and Mbd2
to DNA preserves chromatin composition and thus genomic integrity through regulation of Tet1 activity.
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Dnmt1 and Dnmt3a [12, 13]. Based on these data, we
consider following procedure as another potential Rett
symptom reversing mechanism: Oxidation of 5mC by
Tet proteins, removal of the oxidized derivatives by gly-
cosylases and enzymes of the base excision repair path-
way [14, 15, 16], re-methylation of cytosines by DNA
methyltransferases, binding and protection of 5mC by
exogenous wild type Mecp2 proteins. However, future
work will be necessary to achieve certainty, whether
and which of the two mechanisms occurs in vivo. In con-
clusion, our data suggest an additional role for Mecp2
and Mbd2 as guardians of the epigenome through regu-
lation of aberrant Tet activity and argue for a potential
pathophysiological function of Tet proteins in Rett syn-
drome (Figure 1).
Similar to epigenetic marks in DNA, some RNA modifi-
cations were recently shown to be reversible. Fu and
coworkers detected 5hmC in RNA of mammalian cells
and tissue and demonstrated Tet-catalyzed oxidation
of ribonucleic 5mC to 5hmC both in vitro and in vivo
[17]. The identification of 5-formylcytidine (5fC) and
5-carboxylcytosine (5caC) in cellular RNA of mammals
[18], as well as the formation of 5fC and 5caC by Tet1 in
different RNA contexts [19] provided further evidence
that the dioxygenase activity of Tet proteins may not
be restricted to DNA, but might be extended to post-
transcriptional regulation of RNA function.
In accordance with this, recent studies have shown that
hydroxymethylation of mRNA can favor translation [20].
Hence, one could envision a similar role for 5hmC in
ribosomal RNA (rRNA), which is synthesized in a re-
latively acidic subnuclear compartment, the nucleolus
[21, 22, 23]. Many processes that take place in the
nucleolus, including methylation of rRNA, require re-
Figure 2: Immunostaining and colocalization analysis of Tet proteins with nucleoli. (A) Fluorescent images of J1 mouse em-
bryonic stem cells (J1 mESC) immunologically stained for Tet1 (left), Tet2 (middle) and Tet3 (right) as previously described [4].
Nucleoli were labeled with the TAMRA-tagged nucleolar marker cR10 (cyclic deca-arginine [5]). DIC: Differential interference
contrast. DNA was counterstained with DAPI. Scale bar: 5 µm. Nucleoli are marked with red dashed lines. (B) Line intensity
plots of cR10 (red) and Tet protein (green) distribution through a nucleus of J1 mESC.
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location of various functional proteins to this nuclear
subcompartment, which is often mediated by specia-
lized amino acid motifs [24, 25].
In chapter 3 of this thesis, we determined experimen-
tally the molecular requirements that are necessary and
sufficient for the localization of proteins and peptides
in the nucleolus. We demonstrate that besides amino
acid composition, isoelectric properties, as well as the
charge distribution of proteins and peptides determine
the extent of nucleolar accumulation. Consistent with
this, peptide units composed of consecutive arginines
with an isoelectric point at and above 12.6 were shown
to facilitate localization to the nucleolar subcompart-
ment. Accordingly, we demonstrate that six consecu-
Figure 3: Subnuclear distribution of endogenous, GFP-tagged (A) Tet1 and (B) Tet2 proteins in stable J1 mESC cell lines. (left)
Domain structures of wild type Tet proteins and analyzed Tet deletion mutants. LCI: low complexity insert. (right) Mid-confocal
optical sections of J1 mESC immunostained for 5hmC (without RNase treatment). The signals of endogenous GFP-tagged Tet
proteins were enhanced using an anti-GFP nanobody coupled to an ATTO-488 fluorophore (GFP-booster, ChromoTek GmbH,
Munich, Germany). DNA was counterstained with DAPI. Scale bar: 5 µm. Nucleoli are marked with red dashed lines. The extent
of nucleolar accumulation for each deletion mutant is indicated as plus and minus. Immunofluorescent images were taken from
the Master Thesis of Mario Hofweber, Leonhardt laboratory, LMU Munich.
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tive arginine residues in a peptide and four successive
arginines in combination with a nuclear localization sig-
nal (NLS) provide sufficient positive surface charge to
mediate nucleolar accumulation. Finally, we were able
to show that poly-R peptides and fusion proteins di-
rectly bind negatively charged RNA molecules in vitro,
which explains the conservation of this nucleolar targe-
ting principle during evolution. In conclusion, our data
unveil effective amino acid motifs, capable of mediat-
ing nucleolar accumulation of short peptides and pro-
teins and, as shown in chapter 4, provide an efficient
tool for the visualization of the nucleolus in living cells.
To investigate a putative role of Tet proteins as rRNA
dioxygenases, we made use of this nucleolar visual-
ization tool to study the subnuclear distribution of all
three Tet protein family members in mouse embryonic
stem cells (mESC). Line intensity plots of the nucleolar
marker cR10 [5] (red) and Tet protein (green) distribu-
tion through mESC nuclei revealed an anticorrelation of
Tet1 and Tet2 with cR10 (Figure 2), indicating that under
the given conditions, Tet proteins do not accumulate in
the nucleolus. Consistent with this, several studies have
shown that the nucleolar proteome is highly dynamic.
Many helicase family proteins, such as WRN, BLM or
RECQL4 have been shown to accumulate in the nucleo-
lus only at specific cell cycle stages or in response to
specific stimuli, including oxidative stress [26, 27, 28].
Nucleolar accumulation of Apurinic/apyrimidinic endo-
nuclease 1 (APE1), the main abasic endonuclease of
the base excision repair pathway, depends on positively
charged lysine residues within its N-terminal domain
that undergo acetylation and thus neutralization upon
genotoxic stress [29]. These data suggest that post-
translational modifications (PTMs) regulate localization
Figure 4: In silico analysis of Tet protein sequences (A) pH scale with indicated isoelectric points (pI) of Tet proteins (cyan)
and pH value of nucleoli [23] (magenta). Net charges of Tet proteins above and below the respective pI are shown as +/-. A
representative phase contrast (DIC) and fluorescent image of a mouse cell incubated with the TAMRA-tagged nucleoli marker
cR10 [5] (cyclic deca-arginine peptide) is shown below. Scale bar: 5 µm. (B) Protein schemes of Tet dioxygenases with putative
nucleolar localization signals (NoLS) labeled by roman numerals.
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of proteins to the nucleolus. Recent studies have shown
that Tet proteins are subjected to a variety of PTMs that
mostly occur at the N-terminal domain and the low-
complexity insert [30]. Interestingly, N-term deletion
of Tet2 (Figure 3B), but not Tet1 (Figure 3A), resulted
in strong nucleolar accumulation. Additional removal of
the cysteine-rich region, however, did not affect their
subnuclear localization. From this we conclude that the
N-terminal domain is likely to regulate the nucleolar lo-
calization of Tet2. Whether this regulation is mediated
through post-translational modifications has to be vali-
dated in the future.
To achieve nucleolar accumulation, some proteins, such
as the putative rRNA MTase p120, contain arginine-rich
regions [25], which, as shown in chapter 3 of this thesis,
act as high-affinity binding sites for (ribosomal) RNA. As
demonstrated in Figure 4B, we identified four consecu-
tive arginine residues within the low complexity insert
of Tet2, which are sufficient for strong nucleolar accu-
mulation of proteins that are fused to a nuclear locali-
zation signal (NLS) (see Chapter 3). Interestingly, addi-
tional removal of the low complexity insert diminished
the previously described nucleolar accumulation of Tet2
N-term deletion mutants (Figure 3B), which led to the
conclusion that the tetra-arginine motif within the LCI of
Tet2 may indeed serve as nucleolar localization signal
(NoLS).
In addition to arginine-rich motifs, numerous nucleolar
localization sequences (NoLS) composed of short basic
motifs have been identified in unrelated human proteins
and were used as a training set to computationally pre-
dict NoLS for the entire human proteome [24]. With re-
gard to a putative role of Tet proteins as rRNA dioxyge-
nases, we made use of the resultant "Nucleolar Locali-
zation Signal Detector" tool [31] to search whether be-
sides the arginine-rich motif in Tet2, Tet proteins are pre-
dicted to harbor additional NoLS. Indeed, several poten-
tial nucleolar localization sequences were detected in all
three Tet protein sequences (Figure 4B). While the seven
NoLS predicted for mouse Tet1 distributed over the en-
tire length of the protein, the three nucleolar targeting
motifs of Tet2 and Tet3 clustered in the catalytic domain
and N-terminal region, respectively. To validate these
data, further experiments are required to test whether
each of the predicted motifs is sufficient to target re-
porter proteins to the nucleolus. Moreover, point mu-
tations of these sequences should be tested for disrup-
tion of nucleolar localization of the respective Tet en-
zyme, once the conditions for accumulation in nucleoli
are identified.
Since the subnuclear localization of proteins does not
only depend on their amino acid composition, but also
on their isoelectric properties and charge (see Chapter
3), we additionally assessed the nucleolar accumula-
tion potential of Tet proteins based on these parame-
ters. Within the acidic electrochemical environment of
the nucleolus (pH<7.2), all three Tet proteins carry a po-
sitive net charge. Tet1, with an isoelectric point (pI) of
8.6, has the highest theoretical net charge, shortly fol-
lowed by Tet2 (pI = 8.2) and Tet3 (pI = 7.9) (Figure 4A).
Hence, Tet proteins possess various features that sug-
gest a potential role in the nucleolus. The function of
rRNA hydroxymethylation, however, has to be investi-
gated in future work. To determine, whether oxidation
of 5mC in rRNA may influence the translation efficiency,
the sizes and amounts of in vitro synthesized proteins
need to be determined by the use of unmethylated,
methylated and hydroxymethylated ribosomes, respec-
tively.
In conclusion, various studies argue for a role of Tet
proteins in modifying different classes of RNA. Hypo-
methylated RNA molecules, however, have been shown
to stimulate the innate immune system through activa-
tion of Toll-like receptors [32]. Accordingly, Tet activity
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has to be precisely regulated on the RNA level. In Chap-
ter 1 and 2 of this thesis, we have demonstrated that
binding of Mecp2 to DNA protects 5mC from Tet1 me-
diated oxidation. Interestingly, previous studies have
shown that Mecp2 associates with RNA and regulates
mRNA splicing [33]. Whether this interaction serves the
protection of 5mC in RNA, however, still has to be deter-
mined.
In summary, the functional network of Tet proteins is
rapidly growing and the identification of proteins con-
trolling its activity and subnuclear localization will con-
tribute to understanding the dynamic regulation and
role of DNA and RNA modifications in various metabolic
processes in and outside of the nucleolus.
References
[1] R. E. Amir, I. B. Van den Veyver, M. Wan, C. Q.
Tran, U. Francke, and H. Y. Zoghbi, “Rett syndrome
is caused by mutations in x-linked mecp2, en-
coding methyl-cpg-binding protein 2,” Nat Genet,
vol. 23, no. 2, pp. 185–8, 1999. [Online]. Available:
https://www.ncbi.nlm.nih.gov/pubmed/10508514
[2] A. P. Bird, “Gene number, noise reduction and
biological complexity,” Trends Genet, vol. 11,
no. 3, pp. 94–100, 1995. [Online]. Available:
https://www.ncbi.nlm.nih.gov/pubmed/7732579
[3] P. J. Skene, R. S. Illingworth, S. Webb, A. R.
Kerr, K. D. James, D. J. Turner, R. Andrews,
and A. P. Bird, “Neuronal mecp2 is expressed
at near histone-octamer levels and globally al-
ters the chromatin state,” Mol Cell, vol. 37,
no. 4, pp. 457–68, 2010. [Online]. Available:
https://www.ncbi.nlm.nih.gov/pubmed/20188665
[4] A. K. Ludwig, P. Zhang, F. D. Hastert,
S. Meyer, C. Rausch, H. D. Herce, U. Muller,
A. Lehmkuhl, I. Hellmann, C. Trummer, C. Storm,
H. Leonhardt, and M. C. Cardoso, “Binding
of mbd proteins to dna blocks tet1 func-
tion thereby modulating transcriptional noise,”
Nucleic Acids Res, 2016. [Online]. Available:
https://www.ncbi.nlm.nih.gov/pubmed/27923996
[5] G. Lattig-Tunnemann, M. Prinz, D. Hoffmann,
J. Behlke, C. Palm-Apergi, I. Morano, H. D.
Herce, and M. C. Cardoso, “Backbone rigid-
ity and static presentation of guanidinium
groups increases cellular uptake of arginine-
rich cell-penetrating peptides,” Nat Commun,
vol. 2, p. 453, 2011. [Online]. Available:
https://www.ncbi.nlm.nih.gov/pubmed/21878907
[6] S. K. Garg, D. T. Lioy, H. Cheval, J. C. Mc-
Gann, J. M. Bissonnette, M. J. Murtha, K. D.
Foust, B. K. Kaspar, A. Bird, and G. Mandel,
“Systemic delivery of mecp2 rescues behavioral
and cellular deficits in female mouse mod-
els of rett syndrome,” J Neurosci, vol. 33,
no. 34, pp. 13 612–20, 2013. [Online]. Available:
https://www.ncbi.nlm.nih.gov/pubmed/23966684
[7] M. Mellen, P. Ayata, S. Dewell, S. Kriaucio-
nis, and N. Heintz, “Mecp2 binds to 5hmc
enriched within active genes and accessible chro-
matin in the nervous system,” Cell, vol. 151,
no. 7, pp. 1417–30, 2012. [Online]. Available:
https://www.ncbi.nlm.nih.gov/pubmed/23260135
[8] C. G. Spruijt, F. Gnerlich, A. H. Smits, T. Pfaf-
feneder, P. W. Jansen, C. Bauer, M. Munzel,
M. Wagner, M. Muller, F. Khan, H. C. Eberl,
A. Mensinga, A. B. Brinkman, K. Lephikov,
U. Muller, J. Walter, R. Boelens, H. van In-
gen, H. Leonhardt, T. Carell, and M. Vermeulen,
“Dynamic readers for 5-(hydroxy)methylcytosine
and its oxidized derivatives,” Cell, vol. 152,
158
REFERENCES
no. 5, pp. 1146–59, 2013. [Online]. Available:
https://www.ncbi.nlm.nih.gov/pubmed/23434322
[9] C. Frauer, T. Hoffmann, S. Bultmann, V. Casa,
M. C. Cardoso, I. Antes, and H. Leon-
hardt, “Recognition of 5-hydroxymethylcytosine
by the uhrf1 sra domain,” PLoS One, vol. 6,
no. 6, p. e21306, 2011. [Online]. Available:
https://www.ncbi.nlm.nih.gov/pubmed/21731699
[10] S. Khrapunov, C. Warren, H. Cheng, E. R.
Berko, J. M. Greally, and M. Brenowitz, “Unusual
characteristics of the dna binding domain of
epigenetic regulatory protein mecp2 determine
its binding specificity,” Biochemistry, vol. 53,
no. 21, pp. 3379–91, 2014. [Online]. Available:
https://www.ncbi.nlm.nih.gov/pubmed/24828757
[11] V. Valinluck, H. H. Tsai, D. K. Rogstad,
A. Burdzy, A. Bird, and L. C. Sowers, “Ox-
idative damage to methyl-cpg sequences in-
hibits the binding of the methyl-cpg bind-
ing domain (mbd) of methyl-cpg binding pro-
tein 2 (mecp2),” Nucleic Acids Res, vol. 32,
no. 14, pp. 4100–8, 2004. [Online]. Available:
https://www.ncbi.nlm.nih.gov/pubmed/15302911
[12] K. Goto, M. Numata, J. I. Komura, T. Ono,
T. H. Bestor, and H. Kondo, “Expression
of dna methyltransferase gene in mature
and immature neurons as well as proliferat-
ing cells in mice,” Differentiation, vol. 56,
no. 1-2, pp. 39–44, 1994. [Online]. Available:
https://www.ncbi.nlm.nih.gov/pubmed/8026645
[13] D. Watanabe, K. Uchiyama, and K. Hanaoka,
“Transition of mouse de novo methyltransferases
expression from dnmt3b to dnmt3a during neural
progenitor cell development,” Neuroscience, vol.
142, no. 3, pp. 727–37, 2006. [Online]. Available:
https://www.ncbi.nlm.nih.gov/pubmed/16973295
[14] S. Ito, L. Shen, Q. Dai, S. C. Wu, L. B. Collins,
J. A. Swenberg, C. He, and Y. Zhang, “Tet proteins
can convert 5-methylcytosine to 5-formylcytosine
and 5-carboxylcytosine,” Science, vol. 333, no.
6047, pp. 1300–3, 2011. [Online]. Available:
https://www.ncbi.nlm.nih.gov/pubmed/21778364
[15] Y. F. He, B. Z. Li, Z. Li, P. Liu, Y. Wang, Q. Tang,
J. Ding, Y. Jia, Z. Chen, L. Li, Y. Sun, X. Li, Q. Dai, C. X.
Song, K. Zhang, C. He, and G. L. Xu, “Tet-mediated
formation of 5-carboxylcytosine and its excision
by tdg in mammalian dna,” Science, vol. 333,
no. 6047, pp. 1303–7, 2011. [Online]. Available:
https://www.ncbi.nlm.nih.gov/pubmed/21817016
[16] A. Maiti and A. C. Drohat, “Thymine dna glyco-
sylase can rapidly excise 5-formylcytosine and 5-
carboxylcytosine: potential implications for active
demethylation of cpg sites,” J Biol Chem, vol. 286,
no. 41, pp. 35 334–8, 2011. [Online]. Available:
https://www.ncbi.nlm.nih.gov/pubmed/21862836
[17] L. Fu, C. R. Guerrero, N. Zhong, N. J. Amato, Y. Liu,
S. Liu, Q. Cai, D. Ji, S. G. Jin, L. J. Niedernhofer,
G. P. Pfeifer, G. L. Xu, and Y. Wang, “Tet-
mediated formation of 5-hydroxymethylcytosine
in rna,” J Am Chem Soc, vol. 136,
no. 33, pp. 11 582–5, 2014. [Online]. Available:
https://www.ncbi.nlm.nih.gov/pubmed/25073028
[18] H. Y. Zhang, J. Xiong, B. L. Qi, Y. Q. Feng, and B. F.
Yuan, “The existence of 5-hydroxymethylcytosine
and 5-formylcytosine in both dna and rna in
mammals,” Chem Commun (Camb), vol. 52,
no. 4, pp. 737–40, 2016. [Online]. Available:
https://www.ncbi.nlm.nih.gov/pubmed/26562407
159
REFERENCES
[19] M. Basanta-Sanchez, R. Wang, Z. Liu, X. Ye,
M. Li, X. Shi, P. F. Agris, Y. Zhou,
Y. Huang, and J. Sheng, “Tet1-mediated oxida-
tion of 5-formylcytosine (5fc) to 5-carboxycytosine
(5cac) in rna,” Chembiochem, vol. 18,
no. 1, pp. 72–76, 2017. [Online]. Available:
https://www.ncbi.nlm.nih.gov/pubmed/27805801
[20] B. Delatte, F. Wang, L. V. Ngoc, E. Collignon,
E. Bonvin, R. Deplus, E. Calonne, B. Hass-
abi, P. Putmans, S. Awe, C. Wetzel, J. Kreher,
R. Soin, C. Creppe, P. A. Limbach, C. Gueydan,
V. Kruys, A. Brehm, S. Minakhina, M. Defrance,
R. Steward, and F. Fuks, “Rna biochemistry.
transcriptome-wide distribution and function of
rna hydroxymethylcytosine,” Science, vol. 351,
no. 6270, pp. 282–5, 2016. [Online]. Available:
https://www.ncbi.nlm.nih.gov/pubmed/26816380
[21] D. D. Brown and J. B. Gurdon, “Absence of
ribosomal rna synthesis in the anucleolate mutant
of xenopus laevis,” Proc Natl Acad Sci U S A,
vol. 51, pp. 139–46, 1964. [Online]. Available:
https://www.ncbi.nlm.nih.gov/pubmed/14106673
[22] N. Granboulan and P. Granboulan, “[ultra-
structure cytochemistry of the nucleolus. ii.
study of the sites of rna synthesis in the
nucleolus and the nucleus],” Exp Cell Res,
vol. 38, pp. 604–19, 1965. [Online]. Available:
https://www.ncbi.nlm.nih.gov/pubmed/14330679
[23] R. M. Martin, G. Ter-Avetisyan, H. D. Herce,
A. K. Ludwig, G. Lattig-Tunnemann, and
M. C. Cardoso, “Principles of protein tar-
geting to the nucleolus,” Nucleus, vol. 6,
no. 4, pp. 314–25, 2015. [Online]. Available:
https://www.ncbi.nlm.nih.gov/pubmed/26280391
[24] M. S. Scott, F. M. Boisvert, M. D. McDowall,
A. I. Lamond, and G. J. Barton, “Characteriza-
tion and prediction of protein nucleolar locali-
zation sequences,” Nucleic Acids Res, vol. 38,
no. 21, pp. 7388–99, 2010. [Online]. Available:
https://www.ncbi.nlm.nih.gov/pubmed/20663773
[25] W. C. Gustafson, C. W. Taylor, B. C. Valdez,
D. Henning, A. Phippard, Y. Ren, H. Busch,
and E. Durban, “Nucleolar protein p120 con-
tains an arginine-rich domain that binds to
ribosomal rna,” Biochem J, vol. 331 ( Pt
2), pp. 387–93, 1998. [Online]. Available:
https://www.ncbi.nlm.nih.gov/pubmed/9531475
[26] R. A. Marciniak, D. B. Lombard, F. B. John-
son, and L. Guarente, “Nucleolar localization
of the werner syndrome protein in human
cells,” Proc Natl Acad Sci U S A, vol. 95,
no. 12, pp. 6887–92, 1998. [Online]. Available:
https://www.ncbi.nlm.nih.gov/pubmed/9618508
[27] L. L. Woo, K. Futami, A. Shimamoto, Y. Furuichi,
and K. M. Frank, “The rothmund-thomson gene
product recql4 localizes to the nucleolus in re-
sponse to oxidative stress,” Exp Cell Res, vol. 312,
no. 17, pp. 3443–57, 2006. [Online]. Available:
https://www.ncbi.nlm.nih.gov/pubmed/16949575
[28] V. Yankiwski, R. A. Marciniak, L. Guarente, and
N. F. Neff, “Nuclear structure in normal and bloom
syndrome cells,” Proc Natl Acad Sci U S A, vol. 97,
no. 10, pp. 5214–9, 2000. [Online]. Available:
https://www.ncbi.nlm.nih.gov/pubmed/10779560
[29] L. Lirussi, G. Antoniali, C. Vascotto, C. D’Ambrosio,
M. Poletto, M. Romanello, D. Marasco, M. Leone,
F. Quadrifoglio, K. K. Bhakat, A. Scaloni, and
G. Tell, “Nucleolar accumulation of ape1 depends
160
REFERENCES
on charged lysine residues that undergo acety-
lation upon genotoxic stress and modulate its
ber activity in cells,” Mol Biol Cell, vol. 23,
no. 20, pp. 4079–96, 2012. [Online]. Available:
https://www.ncbi.nlm.nih.gov/pubmed/22918947
[30] C. Bauer, K. Gobel, N. Nagaraj, C. Colan-
tuoni, M. Wang, U. Muller, E. Kremmer,
A. Rottach, and H. Leonhardt, “Phosphory-
lation of tet proteins is regulated via o-
glcnacylation by the o-linked n-acetylglucosamine
transferase (ogt),” J Biol Chem, vol. 290,
no. 8, pp. 4801–12, 2015. [Online]. Available:
https://www.ncbi.nlm.nih.gov/pubmed/25568311
[31] M. S. Scott, P. V. Troshin, and G. J. Barton,
“Nod: a nucleolar localization sequence detector
for eukaryotic and viral proteins,” BMC Bioinfor-
matics, vol. 12, p. 317, 2011. [Online]. Available:
https://www.ncbi.nlm.nih.gov/pubmed/21812952
[32] K. Kariko, M. Buckstein, H. Ni, and D. Weissman,
“Suppression of rna recognition by toll-like recep-
tors: the impact of nucleoside modification and
the evolutionary origin of rna,” Immunity, vol. 23,
no. 2, pp. 165–75, 2005. [Online]. Available:
https://www.ncbi.nlm.nih.gov/pubmed/16111635
[33] J. I. Young, E. P. Hong, J. C. Castle, J. Crespo-Barreto,
A. B. Bowman, M. F. Rose, D. Kang, R. Richman,
J. M. Johnson, S. Berget, and H. Y. Zoghbi, “Regula-
tion of rna splicing by the methylation-dependent
transcriptional repressor methyl-cpg binding pro-
tein 2,” Proc Natl Acad Sci U S A, vol. 102,
no. 49, pp. 17 551–8, 2005. [Online]. Available:
https://www.ncbi.nlm.nih.gov/pubmed/16251272
161

6 Annex
6.1 Abbreviations
A Adenine
aa Amino acid
Abobec Apolipoprotein B mRNA Editing Enzyme Catalytic Polypeptide-Like
ADP Adenosine diphosphate
Aid Activation-induced cytidine
AlkB Alpha-ketoglutarate-dependent dioxygenase
ALKBH5 AlkB Homolog 5
Alu Arthrobacter luteus
AML Acute myeloid leukemia
APCMin Adenomatous polyposis coli gene
APE1 Apurinic/apyrimidinic endonuclease 1
ATP Adenosine triphosphate
ATPase Adenosine triphosphate synthetase
BAZ2A/B Bromodomain Adjacent To Zinc Finger Domain 2A/B
BDEPE 2-bromo-1-(4-diethylaminophenyl)-ethanone
BER Base excision repair
BGT β-glucosyltransferase
BLM Bloom Syndrome RecQ Like Helicase
BTB/POZ Bric-a-brac, tramtrack, broad complex/poxvirus and zinc finger
c-Myc cellular Myelocytomatosis
C Cytosine
CAF-1 Chromatin assembly factor 1
CC Chromocenter
CDK cyclin-dependent kinase
CGI CpG island
CoREST Co-repressor of RE1 silencing transcription factor
CPP Cell penetrating peptide
cR10 cyclic deca-arginine
CTD C-terminal domain
DAPI 4’,6-diamidino-2-phenylindole
DFC Dense fibrillar components
DIC Differential interference contrast
DMAP Dnmt1-associated protein
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DMEM Dulbecco’s modified eagle medium
DNA Deoxyribonucleic acid
Dnmt DNA methyltransferase
dNTP deoxyribonucleoside 5’-triphosphate
Dpp3 Developmental pluripotency associated 3
DSBH Double-stranded beta helix
DTT Dithiothreitol
dUTP 2’-deoxyuridine 5’-triphosphate
EDTA Ethylenediaminetetraacetic acid
EMSA Electrophoretic mobility shift assay
ESC embryonic stem cell
FACS Fluroescence activated cell sorting
FBS Fetal bovine serum
FC Fibrillar centers
Fe Iron
FISH Fluorescence in situ hybridization
FRAP Fluorescence recovery after photobleaching
G-phase Gap-phase
G Guanine
Gadd45 Growth arrest and DNA damaga inducible protein 45
GAL4 Galactose-responsive transcription factor GAL4
GBP GFP binding protein
GC Granular component
gDNA genomic DNA
GFP Green fluorescent protein
H3K9me3 Tri-methylation of histone 3 at lysine 9
HBSS Hank’s Balanced Salt Solution
HDAC Histone deacetylase
HEK Human embryonic kidney
HPG Hippocampus/parahippocampal gyrus
HRP Horseradish peroxidase
IAP Intracisternal particle A
ICBP90 Inverted CCAAT box binding protein of 90 kDa
ICF Immunodeficiency, chromosomal instability, and facial anomalies
ID Intervening domain
Idax Inhibition of the Dvl and Axin complex
Idh1/2 Isocitrate dehydrogenase 1/2
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JHDM1A/B Jumonji C domain-containing histone demethylases 1A/1B
kDA Kilo Dalton
Klf4 Kruppel-like factor 4
KO Knock out
LC-MS Liquid chromatography mass spectrometry
LIF Leukemia inhibitory factor
LINE1 Long interspersed nuclear element 1
MaSat Major Satellite
MBD Methyl-CpG binding domain
Mbd1-6 Methyl-CpG binding domain proteins 1-6
MBP Methyl-CpG binding protein
mCpG methylated CpG dinucleotide
Mecp2 Methyl-CpG binding protein 2
mESC mouse embryonic stem cells
mNSC mouse neuronal stem cells
MLL Mixed lineage leukemia
MTase Methyltransferase
MTF Mouse tail fibroblast
NCoR Nuclear receptor corepressor
Neil Nei-like
NeuN Neuronal nuclear antigen
NIRF Np95/ICBP90-like RING finger protein
NLS Nuclear localization signal
NoDS nucleolar detention sequence
NoLS Nucleolar localization signal
Np95 Nuclear protein (with molecular weight of 95 kilo Daltons)
Np97 Nuclear protein (with molecular weight of 97 kilo Daltons)
NPC Neural progenitor cell
nt nucleotides
NTD N-terminal domain
NuRD Nucleosome Remodeling Deacetylase
Oct4 Octamer-binding transcription factor 4
OGT O-linked β-N-acetylglucosamine transferase
p21CIP1 Cdk-interacting protein 1 of 21 kDa
p53 Tumor suppressor protein of 53 kDa
PBD PCNA binding domain
PBHD Polybromo-1 protein homologous domain
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PBS Phosphate buffered saline
PBST PBS containing Tween
PC Phase contrast
PCNA Proliferating cell nuclear antigen
PCNP PEST containing nuclear protein
PCR Polymerase chain reaction
PEI Polyethylenimine
PGC Primordial germ cell
PHD Plant homeodomain
pI Isoelectric point
Poly-K Poly-lysine
PolyR Poly-arginine
pRB retinoblastoma protein
PTM Post-translational modification
PWWP proline-tryptophan-tryptophan-proline motif
R10 Deca-arginine
rDNA ribosomal DNA
RECQL4 RecQ like helicase 4
rRNA ribosomal RNA
RING Really interesting new gene
RNA-seq RNA sequencing
RNA ribonucleic acid
rRNA ribosomal RNA
RT-qPCR reverse transcription quantitative polymerase chain reaction
RTT Rett syndrome
S-phase Synthesis-phase
SETDB1 SET domain, bifurcated 1
Sin3a Sin3 transcription regulator family member A
SINE Short interspersed nuclear element
SMRT Silencing mediator of retinoic acid and thyroid receptor
Sox2 SRY (sex determining region Y)-box 2
SRA SET and RING finger associated
SSC Saline-sodium citrate
T Thymine
TALE Transcription activator-like effector
TAT Trans-Activator of Transcription
Tdg Thymine DNA glycosylase
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TET Ten eleven translocation
Tet1CD Catalytically active domain of Tet1
Tet1CDmut Catalytically inactive domain of Tet1
TRD Transcriptional repression domain
TS Targeting sequence
TSA Trichostatin A
TSS Transcription start site
TTD Tandem tudor domain
Ubl Ubiquitin-like domain
Uhrf1 Ubiquitin-like with plant homeodomain and ring finger domains 1
Wnt fusion of the terms wingless and proto-oncogene integration-1
WRN Werner syndrome ATP-dependent helicase
wt Wild type
YFP Yellow fluorescent protein
Zbtb38 Zinc finger and BTB domain containing 38
Zbtb4 Zinc finger and BTB domain containing 4
2-KG 2-Ketoglutarate
2i 2 inhibitors (Gsk3β and MEK inhibitors)
5caC 5-carboxylcytosine
5fC 5-formylcytosine
5hmC 5-hydroxymethylcytosine
5hmU 5-hydroxymethyluracil
5mC 5-methylcytosine
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